var title_f26_59_27568="Survival rates for gallbladder cancer";
var content_f26_59_27568=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F80678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F80678&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 582px\">",
"   <div class=\"ttl\">",
"    Observed survival rates for 10,705 gallbladder cancers",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 562px; height: 471px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Data from the National Cancer Data Base (Commission on Cancer of the American College of Surgeons and the American Cancer Society) diagnosed in years 1989-1996.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27568=[""].join("\n");
var outline_f26_59_27568=null;
var title_f26_59_27569="Resisted thumb opposition";
var content_f26_59_27569=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F76098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F76098&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Resisted thumb opposition",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 264px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the photograph above, the clinician is trying to disrupt the circle formed by the patient's fingertip and opposing thumb-tip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27569=[""].join("\n");
var outline_f26_59_27569=null;
var title_f26_59_27570="Patient information: Fecal incontinence in children (The Basics)";
var content_f26_59_27570=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/86715\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/37/15957\">",
"         Encopresis diagram",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/27/14769\">",
"          Anatomy of the urinary tract in children",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/45/6865\">",
"           Stool diary (sample)",
"          </a>",
"          <li>",
"           <a class=\"graphic graphic_table\" href=\"UTD.htm?28/61/29661\">",
"            Amount of fiber in different foods",
"           </a>",
"          </li>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?36/39/37489\">",
"         Patient information: Bedwetting in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/2/43041\">",
"         Patient information: Constipation in children (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?15/7/15477\">",
"         Patient information: Constipation in infants and children (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/45/43730\">",
"         Patient information: Toilet training (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Fecal incontinence in children (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H75305677\">",
"      <span class=\"h1\">",
"       What is fecal incontinence in children?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Fecal incontinence in children is when a toilet-trained child often has bowel movements in places other than the toilet. It happens when a child loses control of his or her bowels. For example, a child might leak a bowel movement into his or her underwear or have a bowel movement while asleep.",
"     </p>",
"     <p>",
"      Another term for fecal incontinence is &ldquo;encopresis.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305692\">",
"      <span class=\"h1\">",
"       What causes fecal incontinence in children?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Constipation is the most common cause of fecal incontinence in children. Constipation can make bowel movements hurt. Constipation can also cause bowel movements to be small or happen less often than normal. (Most children normally have about 1 soft bowel movement a day.)",
"     </p>",
"     <p>",
"      A child with constipation might try to avoid having bowel movements. Then the nerves and muscles that control the release of bowel movements stop working as well as they should. This can make bowel movements (also called &ldquo;stool&rdquo;) build up inside the body. But some can leak out anyway. This causes fecal incontinence (",
"      <a class=\"graphic graphic_figure graphicRef69473 \" href=\"UTD.htm?15/37/15957\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Other causes of fecal incontinence can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Problems with toilet training",
"       </li>",
"       <li>",
"        Emotional stress or changes in a child&rsquo;s schedule",
"       </li>",
"       <li>",
"        Some medical conditions",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305724\">",
"      <span class=\"h1\">",
"       Should my child see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If your child often leaks bowel movements in his or her underwear or has bowel movements in places other than the toilet, talk to your doctor or nurse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305739\">",
"      <span class=\"h1\">",
"       Will my child need tests?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Maybe. The doctor or nurse will do an exam and talk with you and your child. Most children don&rsquo;t need tests. But if your child does, possible tests can include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        An X-ray of the belly &ndash; This can show if bowel movements have built up inside the body.",
"       </li>",
"       <li>",
"        Blood tests &ndash; To check for a medical condition that could cause fecal incontinence.",
"       </li>",
"       <li>",
"        Urine tests &ndash; Some children with fecal incontinence also have daytime wetting or wet the bed at night. A possible cause of this is a urinary tract infection (",
"        <a class=\"graphic graphic_figure graphicRef65630 \" href=\"UTD.htm?14/27/14769\">",
"         figure 2",
"        </a>",
"        ). So doctors might test a sample of your child&rsquo;s urine to look for infections.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305786\">",
"      <span class=\"h1\">",
"       How is fecal incontinence in children treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on the cause. For fecal incontinence from constipation, doctors can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Give medicines to get rid of bowel movements that have built up &ndash; This treatment is sometimes called a &ldquo;clean out.&rdquo;",
"       </li>",
"       <li>",
"        Give medicines to help your child have normal bowel movements &ndash; These medicines are called &ldquo;laxatives.&rdquo; They make bowel movements easier to get out.",
"       </li>",
"       <li>",
"        Show you how to help your child develop good bowel habits. Here are some things you can do:",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      <ul class=\"hyphen-block\">",
"       <li>",
"        Have your child sit on the toilet for a few minutes after each meal.",
"       </li>",
"       <li>",
"        Give your child rewards for sitting on the toilet, whether he or she has a bowel movement or not.",
"       </li>",
"       <li>",
"        Keep track of when your child has bowel movements (",
"        <a class=\"graphic graphic_figure graphicRef67114 \" href=\"UTD.htm?6/45/6865\">",
"         figure 3",
"        </a>",
"        ) &ndash; This gives you and the doctor more information on any problems.",
"       </li>",
"       <li>",
"        Stay positive and calm, even if your child still has fecal incontinence sometimes &ndash; Avoid scolding your child. This can be stressful and make the problem worse.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If another medical condition is causing fecal incontinence, doctors can find and treat it. If stress is the cause, good bowel habits can help.",
"     </p>",
"     <p>",
"      Ask your doctor if some simple diet changes could help your child. For example, it might help to:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Give your child more fruit, vegetables, cereal, and other foods with fiber (",
"        <a class=\"graphic graphic_table graphicRef52349 \" href=\"UTD.htm?28/61/29661\">",
"         table 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Avoid milk, yogurt, cheese, and ice cream",
"       </li>",
"       <li>",
"        Make sure your child drinks plenty of water",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      But if your child has fecal incontinence, making diet changes alone probably won&rsquo;t fix the problem.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305848\">",
"      <span class=\"h1\">",
"       Can fecal incontinence in children be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If constipation or stressful situations are the cause, you can reduce your child&rsquo;s chances of getting fecal incontinence again. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Give your child any medicines the doctor prescribes, exactly as directed.",
"       </li>",
"       <li>",
"        Make sure your child keeps up good bowel habits.",
"       </li>",
"       <li>",
"        Be patient. It can take several months or longer for children to get over fecal incontinence.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If the doctor or nurse prescribes laxatives, don&rsquo;t stop giving them to your child without asking the doctor. Some parents worry that laxatives are not safe or will cause problems for their child in the future. But the fact is, laxatives prescribed for children are very safe. Stopping them too early could make fecal incontinence come back or get worse.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H75305863\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/2/43041?source=see_link\">",
"       Patient information: Constipation in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/39/37489?source=see_link\">",
"       Patient information: Bedwetting in children (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/7/15477?source=see_link\">",
"       Patient information: Constipation in infants and children (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?42/45/43730?source=see_link\">",
"       Patient information: Toilet training (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?26/59/27570?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 86715 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.76.133-2ED5F37753-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27570=[""].join("\n");
var outline_f26_59_27570=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305677\">",
"      What is fecal incontinence in children?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305692\">",
"      What causes fecal incontinence in children?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305724\">",
"      Should my child see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305739\">",
"      Will my child need tests?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305786\">",
"      How is fecal incontinence in children treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305848\">",
"      Can fecal incontinence in children be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H75305863\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/86715\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/37/15957\">",
"      Encopresis diagram",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/27/14769\">",
"       Anatomy of the urinary tract in children",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/45/6865\">",
"        Stool diary (sample)",
"       </a>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"UTD.htm?28/61/29661\">",
"         Amount of fiber in different foods",
"        </a>",
"       </li>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/39/37489?source=related_link\">",
"      Patient information: Bedwetting in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/2/43041?source=related_link\">",
"      Patient information: Constipation in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/7/15477?source=related_link\">",
"      Patient information: Constipation in infants and children (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?42/45/43730?source=related_link\">",
"      Patient information: Toilet training (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_59_27571="Dipivefrin: Drug information";
var content_f26_59_27571=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Dipivefrin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?14/29/14804?source=see_link\">",
"    see \"Dipivefrin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/52/16195?source=see_link\">",
"    see \"Dipivefrin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F161378\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Ophtho-Dipivefrin&trade;;",
"     </li>",
"     <li>",
"      PMS-Dipivefrin;",
"     </li>",
"     <li>",
"      Propine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F161388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Alpha-/Beta- Agonist;",
"     </li>",
"     <li>",
"      Ophthalmic Agent, Antiglaucoma;",
"     </li>",
"     <li>",
"      Ophthalmic Agent, Vasoconstrictor",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F161380\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Glaucoma: Ophthalmic: Instill 1 drop every 12 hours into the eyes",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F161381\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15804847\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15804848\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F161364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, ophthalmic, as hydrochloride [drops]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Propine&reg;: 0.1% (10 mL [DSC]) [contains benzalkonium chloride]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F161350\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F161365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reduces elevated intraocular pressure in chronic open-angle glaucoma; also used to treat ocular hypertension, low tension, and secondary glaucomas",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F161386\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Burning, stinging",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Blepharoconjunctivitis, blurred vision, bulbar conjunctival follicles, cystoid macular edema, ocular congestion, ocular pain, mydriasis, photophobia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Arrhythmias, hypertension",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F161369\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to dipivefrin, any component of the formulation, or epinephrine; angle-closure glaucoma",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F161354\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use with caution in patients with cardiovascular disease.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypertension: Use with caution in patients with hypertension.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Aphakic patients: Use with caution in aphakic patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sodium metabisulfite: Product may contain sodium metabisulfite.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299222\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F161358\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alpha1-Blockers: May diminish the hypertensive effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize hypotensive effects of Alpha1-Blockers. Alpha1-Blockers may diminish the vasoconstricting effect of Alpha-/Beta-Agonists. Similarly, Alpha-/Beta-Agonists may antagonize Alpha1-Blocker vasodilation.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: May enhance the tachycardic effect of Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ergot Derivatives: May enhance the hypertensive effect of Alpha-/Beta-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ergoloid Mesylates.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iobenguane I 123: Sympathomimetics may diminish the therapeutic effect of Iobenguane I 123.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid.  Specific dose adjustment recommendations are not presently available.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serotonin/Norepinephrine Reuptake Inhibitors: May enhance the tachycardic effect of Alpha-/Beta-Agonists. Serotonin/Norepinephrine Reuptake Inhibitors may enhance the vasopressor effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Spironolactone: May diminish the vasoconstricting effect of Alpha-/Beta-Agonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F161360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13841213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events have not been observed in animal reproduction studies when administered orally. Systemic adverse events (eg, arrhythmias, hypertension) have been reported following ophthalmic application; use is not recommended in pregnancy (Razeghinejad, 2011).",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F13841215\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13841214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Systemic adverse events (eg, arrhythmias, hypertension) have been reported following ophthalmic application; use is not recommended in breast-feeding women (Razeghinejad, 2011).",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F161371\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      D Epifrin (DE);",
"     </li>",
"     <li>",
"      D'epifrin (PL);",
"     </li>",
"     <li>",
"      Difrin (IL);",
"     </li>",
"     <li>",
"      Diopine (ES, GR, NL);",
"     </li>",
"     <li>",
"      Diopine-C (MX);",
"     </li>",
"     <li>",
"      Dipoquin (NZ);",
"     </li>",
"     <li>",
"      Diprine (TW);",
"     </li>",
"     <li>",
"      Glaucothil (AT, DE);",
"     </li>",
"     <li>",
"      Glaudrops (ES);",
"     </li>",
"     <li>",
"      Oftanex (PL);",
"     </li>",
"     <li>",
"      Pivepol (PL);",
"     </li>",
"     <li>",
"      Propine (AE, AU, BE, BH, BR, CY, EG, FI, FR, GB, IE, IN, IQ, IR, IT, JO, KW, LB, LY, NO, OM, PT, QA, SA, SG, SY, TH, TR, YE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F161353\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dipivefrin is a prodrug of epinephrine which is the active agent that stimulates alpha- and/or beta-adrenergic receptors increasing aqueous humor outflow",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F161368\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Ocular pressure effect:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: ~30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: &ge;12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Mydriasis:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Onset of action: ~30 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Duration: Several hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Rapid into aqueous humor",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Converted to epinephrine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Razeghinejad MR, Tania Tai TY, Fudemberg SJ, et al, \"Pregnancy and Glaucoma,\"",
"      <i>",
"       Surv Ophthalmol",
"      </i>",
"      , 2011, 56(4):324-35.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27571/abstract-text/21620430/pubmed\" id=\"21620430\" target=\"_blank\">",
"        21620430",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9375 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-203.80.222.8-89ED0DCEDC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27571=[""].join("\n");
var outline_f26_59_27571=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161378\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161388\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161380\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161381\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804847\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15804848\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161364\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161350\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161365\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161386\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161369\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161354\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299222\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161358\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161360\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13841213\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13841215\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13841214\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161371\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161353\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F161368\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9375\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9375|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?14/29/14804?source=related_link\">",
"      Dipivefrin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?15/52/16195?source=related_link\">",
"      Dipivefrin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_59_27572="Volvulus in hiatal hernia";
var content_f26_59_27572=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F73205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F73205&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Volvulus in hiatal hernia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 383px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Paraesophageal hernias are associated with abnormal laxity of structures normally preventing displacement of the stomach, the gastrosplenic and gastrocolic ligaments. As the hernia enlarges, the greater curvature of the stomach rolls up into the thorax. Because the stomach is fixed at the gastroesophageal junction, the herniated stomach tends to rotate around its longitudinal axis, resulting in an organoaxial volvulus (top panels); infrequently, rotation occurs around the transverse axis resulting in a mesenteroaxial volvulus (bottom panels).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Peridikis G, Hinder RA. Paraesophageal hiatal hernia. In: Hernia, Nyhus LM, Condon RE (Eds), JB Lippincott, Philadelphia 1995. p.544.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27572=[""].join("\n");
var outline_f26_59_27572=null;
var title_f26_59_27573="Fissured tongue adult 1";
var content_f26_59_27573=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85871&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Fissured tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27573=[""].join("\n");
var outline_f26_59_27573=null;
var title_f26_59_27574="Albumin: Drug information";
var content_f26_59_27574=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Albumin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/2/30755?source=see_link\">",
"    see \"Albumin: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/40/20101?source=see_link\">",
"    see \"Albumin: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F130903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Albuked&trade; 25;",
"     </li>",
"     <li>",
"      Albuked&trade; 5;",
"     </li>",
"     <li>",
"      Albuminar&reg;-25;",
"     </li>",
"     <li>",
"      Albuminar&reg;-5;",
"     </li>",
"     <li>",
"      AlbuRx&reg; 25;",
"     </li>",
"     <li>",
"      AlbuRx&reg; 5;",
"     </li>",
"     <li>",
"      Albutein&reg;;",
"     </li>",
"     <li>",
"      Buminate;",
"     </li>",
"     <li>",
"      Flexbumin 25%;",
"     </li>",
"     <li>",
"      Human Albumin Grifols&reg; 25%;",
"     </li>",
"     <li>",
"      Kedbumin&trade;;",
"     </li>",
"     <li>",
"      Plasbumin&reg;-25;",
"     </li>",
"     <li>",
"      Plasbumin&reg;-5",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F130904\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Alburex&reg; 25;",
"     </li>",
"     <li>",
"      Alburex&reg; 5;",
"     </li>",
"     <li>",
"      Albutein 25%;",
"     </li>",
"     <li>",
"      Albutein 5%;",
"     </li>",
"     <li>",
"      Buminate-25%;",
"     </li>",
"     <li>",
"      Buminate-5%;",
"     </li>",
"     <li>",
"      Plasbumin&reg;-25;",
"     </li>",
"     <li>",
"      Plasbumin&reg;-5",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F130921\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Blood Product Derivative;",
"     </li>",
"     <li>",
"      Plasma Volume Expander, Colloid",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F130906\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Use",
"     <b>",
"      5%",
"     </b>",
"     solution in hypovolemic patients or intravascularly-depleted patients. Use",
"     <b>",
"      25%",
"     </b>",
"     solution in patients in whom fluid and sodium intake is restricted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Usual dose:",
"     </b>",
"     25 g; initial dose may be repeated in 15-30 minutes if response is inadequate; no more than 250 g should be administered within 48 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Hypovolemia:",
"     </b>",
"     5% albumin: 0.5-1 g/kg/dose; repeat as needed.",
"     <b>",
"      Note:",
"     </b>",
"     May be considered after inadequate response to crystalloid therapy and when nonprotein colloids are contraindicated. The volume administered and the speed of infusion should be adapted to individual response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Large-volume paracentesis (&gt;5 L) (unlabeled use):",
"     </b>",
"     25% albumin: 5-8 g for every liter removed (Garcia-Compe&aacute;n, 1993; Moore, 2003)",
"     <b>",
"      or",
"     </b>",
"     50 g total for paracentesis &gt;5 L (ATS, 2004).",
"     <b>",
"      Note:",
"     </b>",
"     Administer soon after the procedure to avoid postprocedural complications (eg, hypovolemia, hyponatremia, renal impairment) (Moore, 2003).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Spontaneous bacterial peritonitis (SBP) in patients with cirrhosis (unlabeled use):",
"     </b>",
"     25% albumin: Initial: 1.5 g/kg, followed by 1 g/kg on day 3 (in conjunction with appropriate antimicrobial therapy) (ATS, 2004; Sort, 1999).",
"     <b>",
"      Note:",
"     </b>",
"     Clinical trial employed albumin 20%; however, the difference in concentration compared with 25% albumin is deemed to be clinically inconsequential.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F130915\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/40/20101?source=see_link\">",
"      see \"Albumin: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     <b>",
"      5%",
"     </b>",
"     should be used in hypovolemic patients or intravascularly-depleted patients.",
"     <b>",
"      25%",
"     </b>",
"     should be used in patients in whom fluid and sodium intake must be minimized.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Hypovolemia:",
"     </b>",
"     I.V.: 0.5-1 g/kg/dose (10-20 mL/kg/dose of albumin 5%); maximum dose: 6 g/kg/day",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F130907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15671332\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15671333\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F130890\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [human, preservative free]: 5% [50 mg/mL] (250 mL, 500 mL); 20% [200 mg/mL] (50 mL, 100 mL); 25% [250 mg/mL] (50 mL, 100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albuked&trade; 5: 5% [50 mg/mL] (250 mL) [contains sodium 145 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albuked&trade; 25: 25% [250 mg/mL] (50 mL) [contains sodium 145 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albuminar&reg;-5: 5% [50 mg/mL] (250 mL, 500 mL) [contains potassium &le;1 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albuminar&reg;-25: 25% [250 mg/mL] (50 mL, 100 mL) [contains potassium &le;1 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Buminate: 5% [50 mg/mL] (250 mL, 500 mL); 25% [250 mg/mL] (20 mL) [contains natural rubber/natural latex in packaging, potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Flexbumin 25%: 25% [250 mg/mL] (50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasbumin&reg;-5: 5% [50 mg/mL] (50 mL, 250 mL) [contains sodium 145 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasbumin&reg;-25: 25% [250 mg/mL] (20 mL, 50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium ~145 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution [human/low aluminum formulation, preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AlbuRx&reg; 5: 5% [50 mg/mL] (250 mL, 500 mL) [contains potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AlbuRx&reg; 25: 25% [250 mg/mL] (50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Albutein&reg;: 5% [50 mg/mL] (250 mL, 500 mL); 25% [250 mg/mL] (50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Human Albumin Grifols&reg; 25%: 25% [250 mg/mL] (50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Kedbumin&trade;: 25% [250 mg/mL] (50 mL) [contains sodium 130-160 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasbumin&reg;-5: 5% [50 mg/mL] (50 mL, 250 mL) [contains potassium &le;2 mEq/L, sodium ~145 mEq/L]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Plasbumin&reg;-25: 25% [250 mg/mL] (20 mL, 50 mL, 100 mL) [contains potassium &le;2 mEq/L, sodium ~145 mEq/L]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F130876\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Excludes low aluminum formulation",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F130892\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     For I.V. administration only. Use within 4 hours after opening vial; discard unused portion. In emergencies, may administer as rapidly as necessary to improve clinical condition. After initial volume replacement:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5%: Do not exceed 2-4 mL/minute in patients with normal plasma volume; 5-10 mL/minute in patients with hypoproteinemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25%: Do not exceed 1 mL/minute in patients with normal plasma volume; 2-3 mL/minute in patients with hypoproteinemia",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Rapid infusion may cause vascular overload. Albumin 25% may be given undiluted or diluted in normal saline. May give in combination or through the same administration set as saline or carbohydrates. Do not use with ethanol or protein hydrolysates, precipitation may form.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F130927\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in dextran 6% in D",
"     <sub>",
"      5",
"     </sub>",
"     W, dextran 6% in NS, D",
"     <sub>",
"      5",
"     </sub>",
"     LR, D",
"     <sub>",
"      5",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      4",
"     </sub>",
"     NS, D",
"     <sub>",
"      5",
"     </sub>",
"     W, D",
"     <sub>",
"      10",
"     </sub>",
"     W, LR, NS,",
"     <sup>",
"      1",
"     </sup>",
"     /",
"     <sub>",
"      2",
"     </sub>",
"     NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with sterile water.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Diltiazem, lorazepam.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Drotrecogin alfa, fat emulsion (Intralipid&reg;), micafungin, midazolam, vancomycin, verapamil.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F130891\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Plasma volume expansion and maintenance of cardiac output in the treatment of certain types of shock or impending shock; may be useful for burn patients, ARDS, and cardiopulmonary bypass; other uses considered by some investigators (but not proven) are retroperitoneal surgery, peritonitis, and ascites; unless the condition responsible for hypoproteinemia can be corrected, albumin can provide only symptomatic relief or supportive treatment",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Note:",
"     </b>",
"     Nutritional supplementation is not an appropriate indication.",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F130918\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     In patients with cirrhosis, administered with diuretics to help facilitate diuresis; large volume paracentesis; volume expansion in dehydrated, mildly hypotensive patients with cirrhosis; to prevent renal impairment and reduce mortality associated with spontaneous bacterial peritonitis (SBP) in patients with cirrhosis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F130929\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Albutein&reg; may be confused with albuterol",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Buminate&reg; may be confused with bumetanide",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F130919\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: CHF precipitation, edema, hyper-/hypotension, hypervolemia, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Chills, fever, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Pruritus, rash, urticaria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Nausea, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchospasm, pulmonary edema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Anaphylaxis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F130894\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to albumin or any component of the formulation; patients with severe anemia or cardiac failure",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F130880\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hypervolemia: All patients should be observed for signs of hypervolemia such as pulmonary edema; monitor closely with rapid infusions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use with caution in patients with hepatic impairment; protein load may exacerbate or precipitate encephalopathy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; protein load may precipitate azotemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Preterm infants: Avoid 25% concentration in preterm infants due to risk of intraventricular hemorrhage.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Sodium restricted patients: Use with caution in those patients for whom sodium restriction is necessary.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Latex: Packaging may contain natural latex rubber.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298693\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F130884\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no known significant interactions.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F130886\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F13334387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have not been conducted. Albumin is used for the treatment of ovarian hyperstimulation syndrome (ASRM, 2008). Use for other indications may be considered in pregnant women when contraindications to nonprotein colloids exist (Liumbruno, 2009).",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13334388\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Endogenous albumin is found in breast milk.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F2885289\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Some products may contain potassium and/or sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albuked 25 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $120.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albuked 5 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (250 mL): $60.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albumin Human Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (250 mL): $75.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $64.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albuminar-25 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $112.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albuminar-5 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (250 mL): $112.50",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Albutein Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (250 mL): $108.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $108.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Buminate Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (250 mL): $111.10",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (20 mL): $44.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Flexbumin Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $122.33",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Human Albumin Grifols Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $108.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Plasbumin-25 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     25% (50 mL): $51.79",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Plasbumin-5 Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     5% (50 mL): $29.63",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F130888\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Blood pressure, pulmonary edema, hematocrit",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F130897\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Acebumin (PE);",
"     </li>",
"     <li>",
"      Alba (IN);",
"     </li>",
"     <li>",
"      Albapure (ID, TW);",
"     </li>",
"     <li>",
"      Albiomin (TH);",
"     </li>",
"     <li>",
"      Albotein (IT);",
"     </li>",
"     <li>",
"      Albumer (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);",
"     </li>",
"     <li>",
"      Albumex (AU, NZ);",
"     </li>",
"     <li>",
"      Albumex 20 (HK);",
"     </li>",
"     <li>",
"      Albumin 5% (CH);",
"     </li>",
"     <li>",
"      Albumin 5% Human (DE);",
"     </li>",
"     <li>",
"      Albumin Human Salzarm 25% (DE);",
"     </li>",
"     <li>",
"      Albumina Humana (BR);",
"     </li>",
"     <li>",
"      Albuminar (BR, ID, IL);",
"     </li>",
"     <li>",
"      Albuminativ (AT, NO, SE);",
"     </li>",
"     <li>",
"      Albunorm (BG);",
"     </li>",
"     <li>",
"      Alburel (PH);",
"     </li>",
"     <li>",
"      Alburex (CO);",
"     </li>",
"     <li>",
"      Albusol (ZA);",
"     </li>",
"     <li>",
"      Albutein 25% (BR, CL, HK);",
"     </li>",
"     <li>",
"      Biseko (PL);",
"     </li>",
"     <li>",
"      Buminate 25% (HK, PH);",
"     </li>",
"     <li>",
"      Flexbumin (CZ);",
"     </li>",
"     <li>",
"      Flexbumin 25% (PH);",
"     </li>",
"     <li>",
"      Human Albumin 25% (DE);",
"     </li>",
"     <li>",
"      Human Albumin 5% (DE);",
"     </li>",
"     <li>",
"      Kedrialb (PH);",
"     </li>",
"     <li>",
"      Octalbin (DK, FI, ID, MX);",
"     </li>",
"     <li>",
"      Plasbumin (ID, SG);",
"     </li>",
"     <li>",
"      Seralbumin (CR, DO, GT, HN, PA, SV);",
"     </li>",
"     <li>",
"      SRK (CH);",
"     </li>",
"     <li>",
"      Vialebex (FR);",
"     </li>",
"     <li>",
"      Volumin (IN);",
"     </li>",
"     <li>",
"      Zenalb (GR, ID, SG, TH);",
"     </li>",
"     <li>",
"      Zenalb 20 (CO)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F130879\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Provides increase in intravascular oncotic pressure and causes mobilization of fluids from interstitial into intravascular space",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      American Thoracic Society (ATS), &ldquo;Evidence-Based Colloid Use in the Critically Ill: American Thoracic Society Consensus Statement,&rdquo;",
"      <i>",
"       Am J Respir Crit Care Med",
"      </i>",
"      , 2004, 170(11):1247-59.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/15563641/pubmed\" id=\"15563641\" target=\"_blank\">",
"        15563641",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brierley J, Carcillo JA, Choong K, et al, &ldquo;Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock: 2007 Update from the American College of Critical Care Medicine,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 2009, 37(2):666-88.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/19325359/pubmed\" id=\"19325359\" target=\"_blank\">",
"        19325359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention, &ldquo;Hemolysis Associated With 25% Human Albumin Diluted With Sterile Water - United States, 1994-1998,&rdquo;",
"      <i>",
"       MMWR",
"      </i>",
"      , March 5, 1999, 48(8):157-9. Available at",
"      <a href=\"file://www.cdc.gov/mmwr/preview/mmwrhtml/00056596.htm\" target=\"_blank\">",
"       file://www.cdc.gov/mmwr/preview/mmwrhtml/00056596.htm",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/10079061/pubmed\" id=\"10079061\" target=\"_blank\">",
"        10079061",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Finfer S, Bellomo R, Boyce N, et al, &ldquo;A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. SAFE Study Investigators,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2004, 350(22):2247-56.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/15163774/pubmed\" id=\"15163774\" target=\"_blank\">",
"        15163774",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garcia-Compe&aacute;n D, Zacar&iacute;as Villarreal J, Bahena Cuevas H, et al, &ldquo;Total Therapeutic Paracentesis (TTP) With and Without Intravenous Albumin in the Treatment of Cirrhotic Tense Ascites: A Randomized Controlled Trial,&rdquo;",
"      <i>",
"       Liver",
"      </i>",
"      , 1993, 13(5):233-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/8259034/pubmed\" id=\"8259034\" target=\"_blank\">",
"        8259034",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Liumbruno GM, Bennardello F, Lattanzio A, et al, \"Recommendations for the Use of Albumin and Immunoglobulins,\"",
"      <i>",
"       Blood Transfus",
"      </i>",
"      , 2009, 7(3):216-34.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/19657486/pubmed\" id=\"19657486\" target=\"_blank\">",
"        19657486",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Maitland K, Kiguli S, Opoka RO, et al, \"Mortality After Fluid Bolus in African Children With Severe Infection,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 364(26):2483-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/21615299/pubmed\" id=\"21615299\" target=\"_blank\">",
"        21615299",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Moore KP, Wong F, Gines P, et al, &ldquo;The Management of Ascites in Cirrhosis: Report on the Consensus Conference of the International Ascites Club,&rdquo;",
"      <i>",
"       Hepatology",
"      </i>",
"      , 2003, 38(1):258-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/12830009/pubmed\" id=\"12830009\" target=\"_blank\">",
"        12830009",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Practice Committee of American Society for Reproductive Medicine, \"Ovarian Hyperstimulation Syndrome,\"",
"      <i>",
"       Fertil Steril",
"      </i>",
"      , 2008, 90(5 Suppl):188-93.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/19007627/pubmed\" id=\"19007627\" target=\"_blank\">",
"        19007627",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sort P, Navasa M, Arroyo V, et al, &ldquo;Effect of Intravenous Albumin on Renal Impairment and Mortality in Patients With Cirrhosis and Spontaneous Bacterial Peritonitis,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1999, 341(6):403-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?26/59/27574/abstract-text/10432325/pubmed\" id=\"10432325\" target=\"_blank\">",
"        10432325",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9376 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-EF0CD76C64-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27574=[""].join("\n");
var outline_f26_59_27574=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130903\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130904\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130921\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130906\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130915\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130907\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671332\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15671333\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130890\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130876\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130892\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130927\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130891\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130918\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130929\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130919\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130894\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130880\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298693\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130884\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130886\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13334387\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13334388\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2885289\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322967\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130888\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130897\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F130879\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9376\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9376|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/2/30755?source=related_link\">",
"      Albumin: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?19/40/20101?source=related_link\">",
"      Albumin: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_59_27575="Mitral regurgitation";
var content_f26_59_27575=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Patient information: Mitral regurgitation (Beyond the Basics)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27575/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27575/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27575/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27575/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27575/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27575/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/59/27575/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION OVERVIEW",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mitral regurgitation (MR), which is also known as mitral insufficiency, is a common heart valve disorder. When mitral regurgitation is present, blood flows backwards through the mitral valve when the heart contracts. This reduces the amount of blood that is pumped out to the body.",
"   </p>",
"   <p>",
"    This topic review discusses the causes, signs and symptoms, diagnosis, and treatment options for people with mitral regurgitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HEART FUNCTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Normal heart",
"    </span>",
"    &nbsp;&mdash;&nbsp;The heart is a pump that contains four chambers: the right atrium, right ventricle, left atrium, and left ventricle (",
"    <a class=\"graphic graphic_figure graphicRef58389 \" href=\"UTD.htm?35/42/36516\">",
"     figure 1",
"    </a>",
"    ). Blood returning to the heart flows into the right atrium, and then the right ventricle. Blood is pumped out of the right ventricle into the lungs, where oxygen is added. Blood then returns to the heart through the left atrium. Blood in the left atrium flows into the left ventricle, which pumps the blood to the rest of the body through the aorta.",
"   </p>",
"   <p>",
"    The heart normally contracts and relaxes in a rhythmic fashion. This action causes changes in pressure within the heart that allow the heart to fill with blood (during relaxation) and to pump blood forward to the body (during contraction).",
"   </p>",
"   <p>",
"    There are four valves in the heart:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two valves separate the upper and lower chambers: one on the right (tricuspid valve) and one on the left side of the heart (mitral valve) (",
"      <a class=\"graphic graphic_figure graphicRef58389 \" href=\"UTD.htm?35/42/36516\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Two valves separate the heart from the blood vessels: one is between the heart and the lungs (pulmonic valve) and other is between the heart and the aorta (aortic valve).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These valves consist of flaps called leaflets or cusps that open and close to help ensure the continued forward flow of blood through the heart.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Mitral regurgitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When mitral regurgitation (MR) is present, blood leaks backwards through the mitral valve and into the left atrium when the heart contracts. This means that less blood is pumped out of the heart to supply the body. If the amount of MR is small and does not progress, the backward leak has no significant consequences.",
"   </p>",
"   <p>",
"    If significant (moderate to severe) MR is present, the left ventricle must work harder to keep up with the body's demands for oxygenated blood. Over time, the heart muscle (the myocardium) and circulatory system undergo a series of changes to maintain this increased demand. These changes generally occur in phases over many years, even decades, depending upon the amount of blood that is regurgitated and how the heart responds to the regurgitated blood. The cause of mitral regurgitation also determines how quickly the heart begins to fail.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Compensated phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;The major change during this phase is enlargement of the left ventricle. This is known as the compensated phase, which does not usually cause symptoms, the heart rhythm is usually normal, and surgical treatment is generally not required.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Transitional phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mitral regurgitation progresses, the heart muscle (myocardium) begins to weaken, and the ventricle can no longer compensate for the regurgitation. This phase is called the transitional phase. The reason that you might progress from the compensated to the transitional phase is not completely clear, although changes in heart or heart pumping function may occur as progressively greater volumes of blood are regurgitated",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the size of the left ventricle increases.",
"   </p>",
"   <p>",
"    You may experience fatigue, have a decreased ability to exercise or be active, or feel short of breath in the transitional phase. However, some people have no symptoms. Surgical treatment is usually recommended when you enter the transitional phase. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Surgical treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Decompensated phase",
"    </span>",
"    &nbsp;&mdash;&nbsp;As the left ventricle enlarges and functions less efficiently, the left atrium progressively enlarges, abnormal heart rhythms occur, and the blood pressure in the pulmonary artery (the blood vessel from the heart to the lungs) increases; this is called pulmonary hypertension. Over time, these changes become irreversible as the signs and symptoms of heart failure develop. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"     \"Patient information: Heart failure (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION CAUSES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A trivial amount of MR is present in up to 70 percent of adults. Significant (moderate to severe) mitral regurgitation is much less common. For example, significant MR was found in only about 2 percent of people in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/1\">",
"     1",
"    </a>",
"    ]. Significant mitral regurgitation can develop as a result of an abnormality in a heart valve or another cardiac disease, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mitral valve prolapse &mdash; Mitral valve prolapse occurs when the mitral valve leaflet tissue is deformed and elongated so that the leaflets do not come together normally. This abnormal valve motion may allow blood to leak backwards from the left ventricle into the left atrium. Although most people with mitral valve prolapse have only trace or mild MR, some develop significant MR.",
"     </li>",
"     <li>",
"      Infective endocarditis &mdash; Infective endocarditis (IE) is an infection of the heart valves caused by bacteria, fungi, or other organisms that invade the bloodstream. As the microorganisms adhere to the valves and grow, abnormal structures (known as vegetations) develop on the heart valves. The vegetation can prevent the mitral valve from closing normally, allowing blood to regurgitate. A heart valve that is already abnormal is more likely to develop endocarditis compared to a valve that is normal.",
"     </li>",
"     <li>",
"      Rheumatic fever &mdash; Rheumatic fever is a body-wide illness that occurs when the bacterium that causes Strep throat (group A Streptococcus) is not treated. Rheumatic fever causes inflammation of the valves of the heart, as well as other complications. Rheumatic fever is now uncommon in developed countries, although it still occurs commonly in developing countries.",
"     </li>",
"     <li>",
"      Congenital heart abnormality &mdash; Children who are born with certain types of heart abnormalities can develop MR.",
"     </li>",
"     <li>",
"      Other types of heart disease &mdash; MR can develop as a result of other types of heart diseases, such as after a heart attack or other cause of heart muscle injury.",
"     </li>",
"     <li>",
"      Trauma &mdash; Chest trauma can rarely cause breakage of the chords that hold the mitral leaflets in their normal position. Untethered leaflets swing widely, allowing valve leakage.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION SIGNS AND SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most people with MR have no symptoms. People with mild to moderate MR may never develop symptoms or serious complications.",
"   </p>",
"   <p>",
"    Even in people with severe MR, there may be no signs or symptoms until the left ventricle fails, an abnormal heart rhythm develops (atrial fibrillation), or pulmonary hypertension occurs. Pulmonary hypertension occurs when the blood pressure in the pulmonary artery is increased. This increases the workload of the right side of the heart, making it difficult to provide an adequate amount of oxygenated blood to the body.",
"   </p>",
"   <p>",
"    People with severe MR and left ventricular enlargement may eventually develop signs and symptoms of heart failure, which include weakness and fatigue, shortness of breath with exertion",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    at rest, or edema (abnormal fluid collection in the lower legs or abdomen). (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"     \"Patient information: Heart failure (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;You may be diagnosed with MR after your healthcare provider listens to your heart with a stethoscope and hears a heart murmur. The murmur is caused by the sound of turbulent blood flowing backwards through the mitral valve.",
"   </p>",
"   <p>",
"    A heart murmur may occur as a result of one or more conditions; to determine the cause of the murmur, one or more diagnostic tests may be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Electrocardiogram (ECG)",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ECG provides a picture of the electrical activity that causes the heart to beat. An ECG may detect rhythm disturbances or evidence of coronary artery disease or other conditions that can cause MR. It can also show evidence of other associated cardiac abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Chest x-ray",
"    </span>",
"    &nbsp;&mdash;&nbsp;A chest x-ray shows the size and shape of the heart and the large blood vessels in the chest. It also can identify fluid accumulation in the lungs. Many people with significant MR have an enlarged heart.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Echocardiogram",
"    </span>",
"    &nbsp;&mdash;&nbsp;An echocardiogram uses ultrasound (high-frequency sound waves) to assess the size of the heart's chambers, the movement of the heart valves, and the motion of the heart wall. It can also measure the cardiac output (the volume of blood pumped in one minute) and some of the pressures within the heart.",
"   </p>",
"   <p>",
"    In most cases, the echocardiogram is done by pressing a smooth probe against the skin of the chest or abdomen. Gel is applied to the chest to help the wand glide against the skin and allow the sound waves to travel through the chest more easily. This type of echocardiogram is called a transthoracic echocardiogram.",
"   </p>",
"   <p>",
"    If the images of the heart are not clear with transthoracic echocardiography, a transesophageal echocardiogram (TEE) may be recommended. With TEE, you are given sedative medication and the probe is inserted into your mouth and passed down the esophagus. This allows the physician to have a closer and clear view of your heart valves and other structures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     LIVING WITH SIGNIFICANT MITRAL REGURGITATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Monitoring over time",
"    </span>",
"    &nbsp;&mdash;&nbsp;People with trivial or mild MR do not require routine monitoring of their condition. People with significant (moderate to severe) mitral regurgitation should have routine monitoring to determine if and when treatment is needed [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/2\">",
"     2",
"    </a>",
"    ]. The frequency of monitoring depends upon several factors, including the severity of the mitral regurgitation, the size and function of the left ventricle, and the presence of symptoms.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      People with moderate mitral regurgitation are usually seen by their health care provider once a year, or sooner if symptoms develop.",
"     </li>",
"     <li>",
"      People with severe mitral regurgitation are usually seen every 6 to 12 months, or sooner if symptoms develop.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Physical exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association guidelines concluded that no exercise restrictions are needed for people who have the following [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      No symptoms of mitral regurgitation",
"     </li>",
"     <li>",
"      A normal heart rhythm",
"     </li>",
"     <li>",
"      Normal size left ventricle and left atrium",
"     </li>",
"     <li>",
"      Normal pulmonary artery pressure",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Your healthcare provider can help to determine if you should exercise or participate in sports if you have one or more of the above [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Mitral regurgitation and pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with chronic MR usually have no increased risks as a result of pregnancy, especially if mitral regurgitation is mild or moderate and there are mild or no symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, women with moderate to severe symptoms and other complications of MR can have a high risk of developing complications during pregnancy. Women with mitral MR should talk to their cardiologist about the risks and benefits of pregnancy and the possibility of having valve repair or replacement surgery before trying to become pregnant. Valve repair or replacement surgery is not recommended during pregnancy except in emergency situations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Presence of atrial fibrillation",
"    </span>",
"    &nbsp;&mdash;&nbsp;People with chronic mitral regurgitation often develop an abnormal heart rhythm called atrial fibrillation (AF). In AF, rapid, chaotic electrical impulses cause the heart to beat irregularly rather than in a coordinated fashion. As a result, the patient may sense an irregular pulse. AF can reduce the amount of blood being pumped out to the body; this is of particular concern in people with mitral regurgitation because the heart already has a decreased ability to pump blood out. In addition, atrial fibrillation increases the risk of experiencing a stroke.",
"   </p>",
"   <p>",
"    People with MR who develop atrial fibrillation are usually treated with a medication to prevent blood clots and may be given a treatment to normalize the heart rhythm. This is discussed in a separate article. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=see_link\">",
"     \"Patient information: Atrial fibrillation (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    After the initial treatment of atrial fibrillation, people with mitral regurgitation are often encouraged to have surgical valve repair or replacement before the left atrium enlarges substantially. Delaying surgical repair may make it more difficult to reverse atrial fibrillation to a normal heart rhythm. In people with mitral regurgitation, chronic atrial fibrillation significantly increases the chance of developing a blood clot (thrombus) that can break off (embolus) and lodge in an artery in the brain (causing a stroke) or somewhere else in the body. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=see_link\">",
"     \"Patient information: Stroke symptoms and diagnosis (Beyond the Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"     \"Patient information: Pulmonary embolism (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MITRAL REGURGITATION TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The need for treatment of MR depends upon the presence and severity of symptoms, the cause of the MR, and the presence of other underlying medical conditions. People with mild or moderate MR may not require any specific treatment.",
"   </p>",
"   <p>",
"    Medical and surgical therapies are available to treat people with MR. The treatment of choice for most people with severe chronic MR is surgical repair or replacement of the mitral valve. However, in some cases, surgical treatment may be delayed or deferred due to the presence of other medical conditions that increase the risk of surgery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Surgical treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgery is required only for people with severe mitral regurgitation. Guidelines from the American Heart Association and European Society of Cardiology define a person as having severe chronic MR based upon echocardiogram measurements of the heart, heart valves, and blood flow [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/2,5\">",
"     2,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Surgical treatment may include either repair of your own mitral valve or replacement of the valve. The choice of procedure depends, at least in part, upon the cause of the mitral regurgitation, the anatomy of your mitral valve, and the performance of the left ventricle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     The procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Valve repair or replacement surgery is done in an operating room after you are given general anesthesia. With the traditional approach, the surgeon makes an incision in the breastbone (sternum), called a median sternotomy, to open the chest and gain access to the heart. Other approaches, which do not involve cutting the sternum, are available, although there are fewer data regarding the safety and efficacy of these newer techniques.",
"   </p>",
"   <p>",
"    To repair or replace the valve, the heart must be stopped temporarily. While the heart is stopped, a heart-lung machine (cardiopulmonary bypass machine) functions like the heart and lungs, circulating blood and providing oxygen to the body. Fluids, nutrients, and medications may be added to the blood while it passes through the cardiopulmonary bypass machine. The procedure generally lasts between two and four hours.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Valve repair",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the mitral valve can be repaired, this is generally preferred to mitral valve replacement. Advantages of repair include better ventricular function compared to valve replacement surgery. In addition, people who have valve repair do not require lifelong treatment with an anticoagulant (blood thinner).",
"   </p>",
"   <p>",
"    During valve repair, the surgeon will reshape the valve to prevent or reduce the backwards flow of blood (",
"    <a class=\"graphic graphic_figure graphicRef58389 \" href=\"UTD.htm?35/42/36516\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Valve replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;If valve replacement is necessary, the replacement valve may be mechanical (made from metal) or bioprosthetic (made from biologic materials such as a pig valve). Mechanical valves have the disadvantage of requiring lifelong treatment with a medication to prevent blood clots (",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"     warfarin",
"    </a>",
"    [Coumadin&reg;]), while bioprosthetic valves have the disadvantage of potentially wearing out and requiring replacement earlier, particularly in people under age 65. People who are in atrial fibrillation often need lifelong anticoagulation, regardless of which valve type is used.",
"   </p>",
"   <p>",
"    When deciding between a mechanical and bioprosthetic heart valve, it is important for you and your physician to consider the risks of",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"     warfarin",
"    </a>",
"    therapy compared to the potential need for a repeat valve replacement. The use of warfarin is discussed in detail in a separate article. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?21/15/21747?source=see_link\">",
"     \"Patient information: Warfarin (Coumadin) (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Guidelines from the American College of Cardiology and American Heart Association in 2006 recommend the following [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bioprosthetic valves are recommended for people who cannot or will not take",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"       warfarin",
"      </a>",
"      .",
"     </li>",
"     <li>",
"      A mechanical valve is usually recommended for people under age 65 who have long-standing atrial fibrillation.",
"     </li>",
"     <li>",
"      A bioprosthetic valve is usually recommended for people who are 65 years or older.",
"     </li>",
"     <li>",
"      A bioprosthetic valve is a reasonable option for people under age 65 who have a normal heart rhythm. However, the patient and physician must have a detailed discussion of the risks of",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"       warfarin",
"      </a>",
"      compared to the likely need for repeat valve replacement in the future.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h3\">",
"     Maze procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;When people with MR and atrial fibrillation have valve surgery, an additional procedure (called the maze procedure) is often done to reduce the likelihood of long term atrial fibrillation. During the procedure, several small incisions are made in the left atria to interrupt the electrical pathways that allow atrial fibrillation to occur. The decision to perform a maze procedure is based upon the person's age and other factors because it does increase the length of the operation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Recovery from surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients are able to leave the hospital within five to six days after surgery. Some people are able to be discharged after four days, while others may require a longer stay, especially if complications (eg, bleeding, infection) develop.",
"   </p>",
"   <p>",
"    Depending upon your occupation, you will probably be able to return to work within two months after discharge from the hospital. Some people are able to return to work after one month, while others may require up to three months to feel well enough to return.",
"   </p>",
"   <p>",
"    You will generally see your surgeon approximately one week after surgery and your cardiologist one to two weeks later. A postoperative echocardiogram (and sometimes an EKG) is usually performed at that time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Treatment with medications",
"    </span>",
"    &nbsp;&mdash;&nbsp;One or more medications may be recommended for some people with mitral regurgitation to relieve the signs and symptoms of heart failure, reduce the workload of the heart, or prevent complications such as blood clots or infections. Treatment of heart failure is discussed in detail in a separate topic review. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"     \"Patient information: Heart failure (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Vasodilators",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasodilators such as",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?33/36/34371?source=see_link\">",
"     nitroprusside",
"    </a>",
"    ,",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?8/40/8837?source=see_link\">",
"     hydralazine",
"    </a>",
"    , and angiotensin converting enzyme (ACE) inhibitors enlarge (dilate) the blood vessels, which can improve circulation. However, it is not clear that there is a benefit of long-term treatment of chronic MR with vasodilators.",
"   </p>",
"   <p>",
"    As a result, vasodilators are usually reserved as a short-term treatment of people with severe MR who are hospitalized. Vasodilators may also be recommended as a long-term treatment if you cannot have valve repair or replacement surgery (eg, due to a serious underlying medical condition).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Anticoagulants",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anticoagulants such as",
"    <a class=\"drug drug_patient\" href=\"UTD.htm?33/2/33830?source=see_link\">",
"     warfarin",
"    </a>",
"    are used to prevent blood clots. Lifelong treatment with warfarin (Coumadin&reg;) is recommended for certain people with chronic mitral regurgitation, including those with atrial fibrillation or a mechanical heart valve. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?21/15/21747?source=see_link\">",
"     \"Patient information: Warfarin (Coumadin) (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Preventive antibiotic treatments",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infective endocarditis is a bacterial infection that causes the heart valves to become inflamed. The guidelines for preventing infective endocarditis with antibiotics have been updated [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/6\">",
"     6",
"    </a>",
"    ]. As a result, most people with MR who have",
"    <strong>",
"     not",
"    </strong>",
"    undergone heart valve surgery do",
"    <strong>",
"     NOT",
"    </strong>",
"    require preventive antibiotic treatment before dental and surgical procedures.",
"   </p>",
"   <p>",
"    In contrast, people who",
"    <strong>",
"     have",
"    </strong>",
"    a mechanical or bioprosthetic replacement mitral valve or who have prosthetic material used to repair the mitral valve",
"    <strong>",
"     should",
"    </strong>",
"    have antibiotic treatment before dental, oral, or upper respiratory tract procedures to reduce the risk of developing infective endocarditis. This is discussed in detail in a separate article. (See",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?30/37/31314?source=see_link\">",
"     \"Patient information: Antibiotics before procedures (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     WHERE TO GET MORE INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"   </p>",
"   <p>",
"    This article will be updated as needed on our web site (",
"    <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"     www.uptodate.com/patients",
"    </a>",
"    ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2287276642\">",
"    <span class=\"h2\">",
"     Patient level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5516408\">",
"    <span class=\"h3\">",
"     The Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?18/60/19394?source=see_link\">",
"     Patient information: Mitral regurgitation (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?21/4/21571?source=see_link\">",
"     Patient information: Mitral valve prolapse (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?32/2/32803?source=see_link\">",
"     Patient information: What can go wrong after a heart attack? (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=see_link\">",
"     Patient information: Heart murmurs (The Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_basics\" href=\"UTD.htm?11/23/11635?source=see_link\">",
"     Patient information: Prosthetic valves (The Basics)",
"    </a>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5516416\">",
"    <span class=\"h3\">",
"     Beyond the Basics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=see_link\">",
"     Patient information: Heart failure (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=see_link\">",
"     Patient information: Atrial fibrillation (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=see_link\">",
"     Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=see_link\">",
"     Patient information: Pulmonary embolism (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?21/15/21747?source=see_link\">",
"     Patient information: Warfarin (Coumadin) (Beyond the Basics)",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_patient\" href=\"UTD.htm?30/37/31314?source=see_link\">",
"     Patient information: Antibiotics before procedures (Beyond the Basics)",
"    </a>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Professional level information",
"    </span>",
"    &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"   </p>",
"   <p>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=see_link\">",
"     Arrhythmic complications of mitral valve prolapse",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=see_link\">",
"     Echocardiographic evaluation of the mitral valve",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=see_link\">",
"     Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9799?source=see_link\">",
"     Functional mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25096?source=see_link\">",
"     Indications for corrective surgery in severe chronic primary mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=see_link\">",
"     Ischemic mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=see_link\">",
"     Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=see_link\">",
"     Overview of the management of chronic mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=see_link\">",
"     Pathophysiology and stages of chronic mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28376?source=see_link\">",
"     Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42040?source=see_link\">",
"     Transesophageal echocardiography in the evaluation of mitral valve disease",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=see_link\">",
"     Valvular heart disease in elderly adults",
"    </a>",
"    <br/>",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29109?source=see_link\">",
"     Vasodilator therapy in chronic mitral regurgitation",
"    </a>",
"    <br/>",
"    <br/>",
"    The following organizations also provide reliable health information.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Library of Medicine",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/ency/article/000176.htm\">",
"     www.nlm.nih.gov/medlineplus/ency/article/000176.htm",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      National Heart, Lung, and Blood Institute",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.nhlbi.nih.gov/\">",
"     www.nhlbi.nih.gov",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      American Heart Association",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;(",
"    <a class=\"external\" href=\"file://www.americanheart.org/\">",
"     www.americanheart.org",
"    </a>",
"    )",
"   </p>",
"   <p>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27575/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27575/abstract/1\">",
"      Jones EC, Devereux RB, Roman MJ, et al. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study). Am J Cardiol 2001; 87:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27575/abstract/2\">",
"      American College of Cardiology, American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease), Society of Cardiovascular Anesthesiologists, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006; 48:e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27575/abstract/3\">",
"      Bonow RO, Cheitlin MD, Crawford MH, Douglas PS. Task Force 3: valvular heart disease. J Am Coll Cardiol 2005; 45:1334.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Cardiac disease in pregnancy. ACOG technical bulletin 168. 1992; Washington, DC.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27575/abstract/5\">",
"      Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27575/abstract/6\">",
"      Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007; 116:1736.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3437 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-213.134.24.46-F1BE05E961-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27575=[""].join("\n");
var outline_f26_59_27575=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      MITRAL REGURGITATION OVERVIEW",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HEART FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Normal heart",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Compensated phase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Transitional phase",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Decompensated phase",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MITRAL REGURGITATION CAUSES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MITRAL REGURGITATION SIGNS AND SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MITRAL REGURGITATION DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Electrocardiogram (ECG)",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Chest x-ray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Echocardiogram",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      LIVING WITH SIGNIFICANT MITRAL REGURGITATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Monitoring over time",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Physical exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Mitral regurgitation and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Presence of atrial fibrillation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MITRAL REGURGITATION TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - The procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Valve repair",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Valve replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      - Maze procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Recovery from surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Treatment with medications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Vasodilators",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Anticoagulants",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Preventive antibiotic treatments",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      WHERE TO GET MORE INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2287276642\">",
"      Patient level information",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5516408\">",
"      - The Basics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5516416\">",
"      - Beyond the Basics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Professional level information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/3437\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PI/3437|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/42/36516\" title=\"figure 1\">",
"      Heart chamber anatomy PI",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/19/17719?source=related_link\">",
"      Arrhythmic complications of mitral valve prolapse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/41/32409?source=related_link\">",
"      Echocardiographic evaluation of the mitral valve",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/30/9705?source=related_link\">",
"      Etiology, clinical features, and evaluation of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/36/9799?source=related_link\">",
"      Functional mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/32/25096?source=related_link\">",
"      Indications for corrective surgery in severe chronic primary mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/55/18297?source=related_link\">",
"      Ischemic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/31/6649?source=related_link\">",
"      Natural history of chronic mitral regurgitation in mitral valve prolapse and flail mitral leaflet",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/51/33593?source=related_link\">",
"      Overview of the management of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/2/36901?source=related_link\">",
"      Pathophysiology and stages of chronic mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/45/28376?source=related_link\">",
"      Pathophysiology, clinical features, evaluation, and management of acute mitral regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?30/37/31314?source=related_link\">",
"      Patient information: Antibiotics before procedures (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?0/16/261?source=related_link\">",
"      Patient information: Atrial fibrillation (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?33/5/33877?source=related_link\">",
"      Patient information: Heart failure (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/42/36514?source=related_link\">",
"      Patient information: Heart murmurs (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/60/19394?source=related_link\">",
"      Patient information: Mitral regurgitation (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?21/4/21571?source=related_link\">",
"      Patient information: Mitral valve prolapse (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/23/11635?source=related_link\">",
"      Patient information: Prosthetic valves (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2517?source=related_link\">",
"      Patient information: Pulmonary embolism (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/37/38484?source=related_link\">",
"      Patient information: Stroke symptoms and diagnosis (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?21/15/21747?source=related_link\">",
"      Patient information: Warfarin (Coumadin) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?32/2/32803?source=related_link\">",
"      Patient information: What can go wrong after a heart attack? (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/3/42040?source=related_link\">",
"      Transesophageal echocardiography in the evaluation of mitral valve disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/36/34377?source=related_link\">",
"      Valvular heart disease in elderly adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/27/29109?source=related_link\">",
"      Vasodilator therapy in chronic mitral regurgitation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_59_27576="Acute palmoplantar eczema (dyshidrotic eczema)";
var content_f26_59_27576=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute palmoplantar eczema (dyshidrotic eczema)",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27576/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27576/contributors\">",
"     David R Adams, MD, PharmD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27576/contributors\">",
"     James G Marks, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27576/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27576/contributors\">",
"     Joseph Fowler, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?26/59/27576/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?26/59/27576/contributors\">",
"     Rosamaria Corona, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?26/59/27576/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 9, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H26544681\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute palmoplantar eczema (more popularly known as dyshidrotic eczema or pompholyx) is an intensely pruritic, vesicular eruption affecting the palms, soles, or both [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. It is characterized by deep-seated lesions ranging from small vesicles to large tense bullae clinically and by spongiotic vesicles histologically. Recurrence is common and patients typically experience frequent episodes for months or years.",
"   </p>",
"   <p>",
"    This topic will discuss the pathogenesis, clinical presentation, diagnosis, and management of dyshidrotic eczema. Other forms of eczema involving the hands, including irritant and allergic contact dermatitis and atopic dermatitis, are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=see_link\">",
"     \"Irritant contact dermatitis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link\">",
"     \"Clinical features and diagnosis of allergic contact dermatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=see_link\">",
"     \"Management of allergic contact dermatitis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link\">",
"     \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10842?source=see_link\">",
"     \"Treatment of atopic dermatitis (eczema)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26006232\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The terminology for acute palmoplantar eczema is confusing. The term &ldquo;dyshidrosis&rdquo; was coined in 1873 to describe a blistering disease of the palms and soles that was believed to be a disorder of the sweat glands [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/3\">",
"     3",
"    </a>",
"    ]. It is now accepted that the sweat glands are not involved in the pathogenesis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. However, the term &ldquo;dyshidrotic eczema&rdquo; continues to be used.",
"   </p>",
"   <p>",
"    Other terms for acute palmoplantar eczema include pompholyx, dyshidrosis, vesicular palmoplantar eczema, acute and recurrent vesicular hand dermatitis, cheiropompholyx (affecting the hands), or podopompholyx (affecting the feet). These terms do",
"    <strong>",
"     not",
"    </strong>",
"    represent a specific diagnosis, but rather a morphologic pattern of",
"    <span class=\"nowrap\">",
"     hand/foot",
"    </span>",
"    eczema that can occur with irritant contact, allergic contact, or endogenous eczema.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544689\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of dyshidrotic eczema, including mild and severe forms of dyshidrotic eczema, in the general population is unknown. In occupational or clinical settings, dyshidrotic eczema accounts for 5 to 20 percent of all cases of hand dermatitis [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/6\">",
"     6",
"    </a>",
"    ]. It occurs most commonly in young adults and equally among males and females. Risk factors for dyshidrotic eczema include history of atopic dermatitis and exposure to contact allergens or irritants [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/7-9\">",
"     7-9",
"    </a>",
"    ]. A rare autosomal dominant form of dyshidrotic eczema has been described [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544705\">",
"    <span class=\"h1\">",
"     ETIOLOGY AND PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cause of dyshidrotic eczema is unknown, but it is probably multifactorial. Although in most cases, a causative or predisposing factor cannot be identified, factors that have been associated with the development of dyshidrotic eczema include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      History of atopic dermatitis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/9,11\">",
"       9,11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Exposure to contact allergens, particularly metals [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/8,9,12\">",
"       8,9,12",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Exposure to contact irritants (eg, metalworking fluids) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/7\">",
"       7",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Systemic exposure to contact allergens (eg, ingestion of nickel or cobalt) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/13\">",
"       13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Dermatophyte infection at a distant site (id reaction) [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/11\">",
"       11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Intravenous immunoglobulin [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/12,14-18\">",
"       12,14-18",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hyperhidrosis [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Smoking [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/19\">",
"       19",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Exposure to UV radiation [",
"      <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/20\">",
"       20",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544713\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Episodes of dyshidrotic eczema often start with pruritus followed by a sudden eruption of intensely pruritic vesicles on the palms, lateral aspects of the fingers, or soles (",
"    <a class=\"graphic graphic_picture graphicRef82782 \" href=\"UTD.htm?6/45/6869\">",
"     picture 1",
"    </a>",
"    ). In 70 to 80 percent of patients, only the hands are involved [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/12\">",
"     12",
"    </a>",
"    ]. The palms and soles are usually symmetrically involved, but in mild cases vesicles develop only on the lateral aspect of fingers (",
"    <a class=\"graphic graphic_picture graphicRef55722 graphicRef75738 graphicRef82781 graphicRef82783 \" href=\"UTD.htm?40/18/41258\">",
"     picture 2A-D",
"    </a>",
"    ). The vesicles are typically deep-seated and multilocular (&ldquo;tapioca or sago pudding&rdquo; lesions); they may coalesce into large bullae (",
"    <a class=\"graphic graphic_picture graphicRef83007 \" href=\"UTD.htm?5/32/5636\">",
"     picture 3A",
"    </a>",
"    ). In some patients, symptoms may be severe enough to interfere with occupational duties and daily activities (",
"    <a class=\"graphic graphic_picture graphicRef83006 \" href=\"UTD.htm?43/6/44133\">",
"     picture 3B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Vesicles and bullae persist for several weeks, desiccate, and resolve with desquamation [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. Frequent relapses may result in chronic hand dermatitis, characterized by red, lichenified, and scaling patches or plaques with fissures. Severe episodes can affect the nail matrix and produce dystrophic nail changes such as horizontal ridging and color changes (",
"    <a class=\"graphic graphic_picture graphicRef82784 \" href=\"UTD.htm?42/63/44021\">",
"     picture 2E",
"    </a>",
"    ). Secondary infection, usually with",
"    <em>",
"     Staphylococcus aureus",
"    </em>",
"    , may occur.",
"   </p>",
"   <p>",
"    Episodes may recur at intervals of three to four weeks for months or years and are more common in warm weather. In some patients, flares may be associated with emotional or physical stress but most often they occur in the absence of an identifiable trigger.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544729\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18792269\">",
"    <span class=\"h2\">",
"     Clinical diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of dyshidrotic dermatitis is usually made based upon clinical findings, symptoms, and history:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Tense, deep-seated vesicles or bullae localized on the palms and soles and often on the lateral aspect of the fingers (",
"      <a class=\"graphic graphic_picture graphicRef83007 \" href=\"UTD.htm?5/32/5636\">",
"       picture 3A",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Intense pruritus",
"     </li>",
"     <li>",
"      Acute onset",
"     </li>",
"     <li>",
"      History of recurrence",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In mild cases, tiny vesicles may be seen only on the lateral aspect of fingers (",
"    <a class=\"graphic graphic_picture graphicRef83010 \" href=\"UTD.htm?12/56/13190\">",
"     picture 2H",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18792277\">",
"    <span class=\"h2\">",
"     Histopathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;A skin biopsy for histopathologic examination is rarely needed. Potential indications for skin biopsy include lack of response to treatment and exclusion of other conditions in the differential diagnosis (eg, psoriasis or palmoplantar pustulosis). If a skin biopsy is performed, periodic acid-Schiff (PAS) staining for fungal elements may be useful in excluding a fungal infection. (See",
"    <a class=\"local\" href=\"#H26544737\">",
"     'Differential diagnosis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    The histologic features of dyshidrotic eczema depend upon the stage (acute or chronic) of the disease:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The acute form is characterized by intraepidermal spongiotic vesicles or bullae that do not involve the intraepidermal portion of the eccrine sweat duct (acrosyringium). A sparse, superficial perivascular infiltrate of lymphocytes is usually present. The epidermal thickness is normal and the thick stratum corneum of acral skin is intact.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      In chronic cases, there is a predominance of parakeratosis and acanthosis with minimal or no spongiosis and a dermal lymphocytic infiltrate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18792310\">",
"    <span class=\"h2\">",
"     Patch testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patch testing is not helpful in making the diagnosis of dyshidrotic eczema. However, it is often performed by dermatologists to determine whether there is a component of allergic contact dermatitis, in which case avoidance of the allergen is an important part of management, and may be warranted in patients who do not respond to initial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"     \"Patch testing\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=see_link&amp;anchor=H6508906#H6508906\">",
"     \"Management of allergic contact dermatitis\", section on 'Avoidance'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544737\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of dyshidrotic eczema includes the following inflammatory and infectious vesicobullous skin diseases [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Allergic contact dermatitis",
"      </strong>",
"      &minus; Allergic contact dermatitis may be clinically indistinguishable from dyshidrotic eczema (",
"      <a class=\"graphic graphic_picture graphicRef82993 graphicRef83192 \" href=\"UTD.htm?8/21/8537\">",
"       picture 4A-B",
"      </a>",
"      ). The correct diagnosis is based upon the assessment of allergen exposure and results of patch testing. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link&amp;anchor=H1646554#H1646554\">",
"       \"Clinical features and diagnosis of allergic contact dermatitis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Bullous tinea",
"      </strong>",
"      &minus; Bullous tinea occurs more often on the feet than on the hands and is usually unilateral (",
"      <a class=\"graphic graphic_picture graphicRef54214 graphicRef62902 graphicRef82787 \" href=\"UTD.htm?11/63/12281\">",
"       picture 5A-C",
"      </a>",
"      ). Potassium hydroxide (KOH) microscopic examination of scrapings from the lesions reveals fungal elements. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link&amp;anchor=H16#H16\">",
"       \"Dermatophyte (tinea) infections\", section on 'Acute tinea pedis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Irritant contact dermatitis",
"      </strong>",
"      &minus; Irritant contact dermatitis usually involves the dorsal aspect of the hands and web spaces (",
"      <a class=\"graphic graphic_picture graphicRef50299 graphicRef59959 \" href=\"UTD.htm?13/55/14199\">",
"       picture 6A-B",
"      </a>",
"      ). Patients often report a history of irritant exposure. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=see_link\">",
"       \"Irritant contact dermatitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Atopic hand dermatitis",
"      </strong>",
"      &minus; Atopic hand dermatitis commonly involves the dorsum of the hands. Patients report a history of atopic dermatitis, seasonal allergies, or asthma and may present with eczema lesions or lichenification involving flexural areas (ie, antecubital and popliteal fossae) (",
"      <a class=\"graphic graphic_picture graphicRef82881 \" href=\"UTD.htm?1/31/1524\">",
"       picture 7",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=see_link&amp;anchor=H12#H12\">",
"       \"Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Dermatophytid (id) reaction",
"      </strong>",
"      &minus; A dermatophytid reaction is a secondary pruritic, papulovesicular eruption that may occur on the palms in association with a dermatophyte infection at a distant site (eg, on the scalp or foot) (",
"      <a class=\"graphic graphic_picture graphicRef52664 \" href=\"UTD.htm?7/8/7300\">",
"       picture 8",
"      </a>",
"      ). A complete skin examination and a KOH preparation of scrapings from suspicious lesions are necessary to confirm the diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=see_link&amp;anchor=H4733135#H4733135\">",
"       \"Dermatophyte (tinea) infections\", section on 'Dermatophytid (id) reactions'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Herpetic infection",
"      </strong>",
"      &minus; Herpetic lesions present as grouped vesicles on a red base, are more often painful than pruritic and usually monolateral (",
"      <a class=\"graphic graphic_picture graphicRef52029 \" href=\"UTD.htm?9/30/9696\">",
"       picture 9",
"      </a>",
"      ). The diagnosis can be made by viral culture, immunofluorescence staining, polymerase chain reaction, or Tzank smear. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=see_link&amp;anchor=H25#H25\">",
"       \"Clinical manifestations and diagnosis of herpes simplex virus type 1 infection\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Palmoplantar pustulosis",
"      </strong>",
"      &minus; Palmoplantar pustulosis may have an early vesicular stage, but pustules usually develop in a few days (",
"      <a class=\"graphic graphic_picture graphicRef62582 graphicRef82843 \" href=\"UTD.htm?0/57/920\">",
"       picture 10A-B",
"      </a>",
"      ). In 8 to 10 days the pustules change their color to dark brown, become dry, and desquamate (",
"      <a class=\"graphic graphic_picture graphicRef82842 \" href=\"UTD.htm?21/39/22133\">",
"       picture 11",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30393?source=see_link&amp;anchor=H25#H25\">",
"       \"Neutrophilic dermatoses\", section on 'Palmoplantar pustulosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <strong>",
"       Autoimmune bullous diseases",
"      </strong>",
"      &minus; Bullous pemphigoid and pemphigus vulgaris may rarely present as localized disease involving the hands or feet (",
"      <a class=\"graphic graphic_picture graphicRef50357 \" href=\"UTD.htm?26/23/26997\">",
"       picture 12",
"      </a>",
"      ). The history reflects a longer and unremitting course. Biopsy for routine histology, direct immunofluorescence, and serologic testing for specific autoantibodies provide the correct diagnosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=see_link&amp;anchor=H20007006#H20007006\">",
"       \"Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid\", section on 'Diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19146?source=see_link&amp;anchor=H458196#H458196\">",
"       \"Pathogenesis, clinical manifestations, and diagnosis of pemphigus\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20269882\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyshidrotic eczema is a recurrent disease. Patients typically experience frequent attacks of vesicular dermatitis for many years. Episodes tend to occur less frequently with age and most patients eventually go into complete remission [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544808\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of dyshidrotic eczema involves the identification and avoidance of causative or exacerbating factors, treatment of skin inflammation, and adoption of skin care measures to reduce skin irritation. Dyshidrotic eczema has a tendency to spontaneously resolve over several weeks. However, treatment is required for most patients who present with complaints of pruritus or other symptoms. The approach to treatment is guided by the severity of the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20269116\">",
"    <span class=\"h2\">",
"     Assessment of severity",
"    </span>",
"    &nbsp;&mdash;&nbsp;The severity of dyshidrotic eczema is generally assessed subjectively. A scoring tool called the dyshidrotic eczema area and severity index (DASI), based upon the number of vesicles, intensity of erythema, desquamation, and itch, was designed for use in clinical trials but is not routinely used in clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We consider dyshidrotic eczema to be mild to moderate if it does not involve the entire palmar or plantar surface, presents as a few crops of vesicles or scattered small vesicles with absent or modest erythema (",
"    <a class=\"graphic graphic_picture graphicRef82784 graphicRef83056 graphicRef83053 graphicRef82781 \" href=\"UTD.htm?39/38/40554\">",
"     picture 2C, 2E-G",
"    </a>",
"    ), and the patient does not complain of intolerable pruritus, burning, or pain.",
"   </p>",
"   <p>",
"    We consider dyshidrotic eczema to be severe if large vesicles or bullae are disabling (",
"    <a class=\"graphic graphic_picture graphicRef83007 graphicRef83006 graphicRef83055 \" href=\"UTD.htm?28/13/28890\">",
"     picture 3A-C",
"    </a>",
"    ) (ie, prevent walking or use of the hands) or if&nbsp;it is intensely painful or pruritic (regardless of the size of the lesions).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212203\">",
"    <span class=\"h2\">",
"     General measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;In clinical experience, avoidance of irritants or exacerbating factors is beneficial for most patients with dyshidrotic eczema. General skin care measures aimed at reducing skin irritation and restoring the skin barrier include [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/23\">",
"     23",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Using lukewarm water and soap-free cleansers to wash hands",
"     </li>",
"     <li>",
"      Drying hands thoroughly after washing",
"     </li>",
"     <li>",
"      Applying emollients (eg, petroleum jelly) immediately after hand drying and as often as possible",
"     </li>",
"     <li>",
"      Wearing cotton gloves under vinyl or other nonlatex gloves when performing wet work",
"     </li>",
"     <li>",
"      Removing rings and watches and bracelets before wet work",
"     </li>",
"     <li>",
"      Wearing protective gloves in cold weather",
"     </li>",
"     <li>",
"      Wearing task-specific gloves for frictional exposures (eg, gardening, carpentry)",
"     </li>",
"     <li>",
"      Avoiding exposure to irritants (eg, detergents, solvents, hair lotions or dyes, acidic foods [eg, citrus fruit])",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In clinical practice, astringent solutions such as aluminum subacetate (Burow&rsquo;s solution) or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/34/14882?source=see_link\">",
"     witch hazel",
"    </a>",
"    are used for wet, weeping skin. Hands or feet are soaked in the solution for 15 minutes two to four times per day. Large bullae may be drained or aspirated using a sterile syringe to reduce pain and prevent spontaneous rupture with risk of local infection.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212111\">",
"    <span class=\"h2\">",
"     Mild to moderate disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15309892\">",
"    <span class=\"h3\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;For patients with mild to moderate dyshidrotic eczema (",
"    <a class=\"graphic graphic_picture graphicRef82784 graphicRef83056 graphicRef83053 graphicRef82781 \" href=\"UTD.htm?39/38/40554\">",
"     picture 2C, 2E-G",
"    </a>",
"    ) that has not responded to general measures, we suggest super high potency or high potency topical corticosteroids (group one to three (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    )) rather than calcineurin inhibitors, which are approximately equivalent to moderate potency corticosteroids. (See",
"    <a class=\"local\" href=\"#H20269116\">",
"     'Assessment of severity'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16212203\">",
"     'General measures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Topical corticosteroids are applied twice daily for two to four weeks. Ointments generally are preferred to other vehicles (creams, solutions, or foams) because they contain fewer potential irritants such as additives or preservatives [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,3,23\">",
"     1,3,23",
"    </a>",
"    ]. However, some patients prefer other vehicles because ointments make their hands too greasy for performing tasks.",
"   </p>",
"   <p>",
"    The efficacy of topical corticosteroids versus placebo or no treatment for dyshidrotic eczema has not been adequately evaluated in randomized trials. However, they are used in clinical practice because of their antiinflammatory properties and their efficacy in other forms of hand eczema. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10842?source=see_link&amp;anchor=H7#H7\">",
"     \"Treatment of atopic dermatitis (eczema)\", section on 'Corticosteroids'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The long-term use of topical corticosteroids is limited by their side effects, which include skin atrophy, striae, and telangiectasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15309899\">",
"    <span class=\"h3\">",
"     Topical calcineurin inhibitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;We generally do not suggest topical calcineurin inhibitors as the first-line antiinflammatory treatment for dyshidrotic eczema. The antiinflammatory effect of topical calcineurin inhibitors is approximately equivalent to moderate potency topical corticosteroids [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/24\">",
"     24",
"    </a>",
"    ]. In addition, topical calcineurin inhibitors are more expensive than topical corticosteroids.",
"   </p>",
"   <p>",
"    However, when patients",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    clinicians prefer to avoid long-term use of topical corticosteroids for the treatment of mild to moderate dyshidrotic eczema (",
"    <a class=\"graphic graphic_picture graphicRef83053 graphicRef83056 graphicRef83010 \" href=\"UTD.htm?30/39/31354\">",
"     picture 2F-H",
"    </a>",
"    ), the topical calcineurin inhibitor",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    is an alternative [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Tacrolimus 0.1% ointment is applied twice daily until resolution.",
"   </p>",
"   <p>",
"    In a randomized trial including 16 patients with moderate to severe dyshidrotic eczema, topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    was compared with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?35/15/36080?source=see_link\">",
"     mometasone",
"    </a>",
"    furoate, a high-potency (group three) topical corticosteroid [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/27\">",
"     27",
"    </a>",
"    ]. After four weeks of treatment with either topical tacrolimus 0.1% or mometasone furoate 0.1% ointment, the dyshidrotic eczema area and severity index (DASI) was reduced by more than 50 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212295\">",
"    <span class=\"h2\">",
"     Severe disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15309876\">",
"    <span class=\"h3\">",
"     Systemic corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the general measures described above, we suggest oral rather than topical corticosteroids for the treatment of severe dyshidrotic eczema (",
"    <a class=\"graphic graphic_picture graphicRef83007 graphicRef83006 graphicRef83055 \" href=\"UTD.htm?28/13/28890\">",
"     picture 3A-C",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H20269116\">",
"     'Assessment of severity'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H16212203\">",
"     'General measures'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    We generally start with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"     prednisone",
"    </a>",
"    40 to 60 mg once per day in the morning for one week. If there is an adequate response, the dose is then reduced by 50 percent in the next five to seven days and finally tapered and discontinued over the following two weeks.",
"   </p>",
"   <p>",
"    Oral corticosteroids for dyshidrotic eczema have not been evaluated in clinical trials. However, in clinical experience they have been beneficial for the short-term treatment of dyshidrotic eczema and other forms of severe eczematous dermatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44457?source=see_link&amp;anchor=H22#H22\">",
"     \"Management of severe refractory atopic dermatitis (eczema)\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15309884\">",
"    <span class=\"h3\">",
"     Topical corticosteroids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Superpotent topical corticosteroids (group one, (",
"    <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"     table 1",
"    </a>",
"    )) are a treatment option for severe dyshidrotic eczema in patients for whom systemic glucocorticoids are contraindicated or patients who prefer to avoid systemic corticosteroids.",
"   </p>",
"   <p>",
"    Topical corticosteroids are applied twice daily for two to four weeks. Ointments generally are preferred to other vehicles (creams, solutions, or foams) because they contain fewer potential irritants such as additives or preservatives [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/1,3,23\">",
"     1,3,23",
"    </a>",
"    ]. However, some patients prefer other vehicles because ointments make their hands too greasy for performing tasks.",
"   </p>",
"   <p>",
"    Application of topical corticosteroids under occlusive dressings (eg, polyethylene gloves for the hands or plastic wrap for the feet) may be helpful in patients with severe disease. Occlusive dressings enhance the corticosteroid penetration into the skin and may lead to a more rapid response. To limit the inconvenience of occlusive dressings, they are usually used at nighttime for three to seven days. However, some patients prefer open application of topical corticosteroids because they find occlusive dressings uncomfortable.",
"   </p>",
"   <p>",
"    The risk of systemic absorption of topical corticosteroids applied on palms or soles is low because of the limited area involved and greater thickness of volar skin [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/28\">",
"     28",
"    </a>",
"    ]. However, a prolonged use of superpotent topical corticosteroids is associated with cutaneous side effects including skin atrophy, striae, and telangiectasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=see_link&amp;anchor=H16#H16\">",
"     \"General principles of dermatologic therapy and topical corticosteroid use\", section on 'Side effects'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20269006\">",
"    <span class=\"h2\">",
"     Treatment response",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical criteria to evaluate the response to treatment include cessation of vesiculation, clearance of preexisting vesicles, and reduction of erythema, pruritus, and pain. Resolution is usually associated with increased skin dryness and desquamation. Emollients can be liberally used multiple times per day to reduce dryness and scaling.",
"   </p>",
"   <p>",
"    If there is no",
"    <span class=\"nowrap\">",
"     improvement/resolution",
"    </span>",
"    in two to four weeks, additional evaluation is necessary. (See",
"    <a class=\"local\" href=\"#H16212520\">",
"     'Refractory disease'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212520\">",
"    <span class=\"h2\">",
"     Refractory disease",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212528\">",
"    <span class=\"h3\">",
"     Evaluation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with clinical features of dyshidrotic eczema who do not respond or are not adequately controlled after two to four weeks of topical or systemic corticosteroids or topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    may need further evaluation to confirm or rule out the diagnosis.",
"   </p>",
"   <p>",
"    Additional testing may include (see",
"    <a class=\"local\" href=\"#H26544737\">",
"     'Differential diagnosis'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Potassium hydroxide (KOH) preparation to rule out a fungal infection.",
"     </li>",
"     <li>",
"      Bacterial culture to rule out bacterial superinfection &ndash; Superinfection with",
"      <em>",
"       S. aureus",
"      </em>",
"      is a common cause of inadequate response to treatment in patients with hand eczema, especially with severe disease and wet, weeping lesions. Bacterial superinfection is treated with oral antibiotics. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=see_link&amp;anchor=H13#H13\">",
"       \"Impetigo\", section on 'Oral antibiotics'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Skin biopsy and histopathologic examination to confirm the diagnosis of dyshidrotic eczema and exclude other conditions. Periodic acid-Schiff (PAS)&nbsp;staining for fungal elements should be included. (See",
"      <a class=\"local\" href=\"#H26544729\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patch testing and detailed history of household- or work-related exposures to exclude an allergic or irritant contact dermatitis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=see_link\">",
"       \"Patch testing\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=see_link&amp;anchor=H111504337#H111504337\">",
"       \"Clinical features and diagnosis of allergic contact dermatitis\", section on 'History'",
"      </a>",
"      .) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16212550\">",
"    <span class=\"h3\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest oral or topical PUVA (psoralen plus UVA therapy) for patients with confirmed diagnosis of dyshidrotic eczema who have frequent or severe episodes that are not adequately controlled with topical or systemic corticosteroids or topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"     tacrolimus",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The use of PUVA for patients with dyshidrotic eczema is largely supported by its use in the treatment of other inflammatory dermatoses. However, there are a few small clinical trials that have demonstrated clinical improvement with PUVA in patients with dyshidrotic eczema [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/29-32\">",
"     29-32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44457?source=see_link&amp;anchor=H14#H14\">",
"     \"Management of severe refractory atopic dermatitis (eczema)\", section on 'Psoralen plus UVA'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Phototherapy may not be available in all communities. Phototherapy treatments are usually delivered two or three times per week. Several weeks of treatment are required to induce clinical improvement and several months are required for resolution. Thus, the potential benefits of phototherapy should be weighed against the inconvenience of prolonged therapy on a case by case basis. Phototherapy that is limited to the palms and soles has few adverse effects. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33160?source=see_link&amp;anchor=H1941672#H1941672\">",
"     \"Psoralen plus ultraviolet A (PUVA) photochemotherapy\", section on 'Topical PUVA'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Systemic immunosuppressive agents such as low-dose",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/38/24170?source=see_link\">",
"     methotrexate",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/29/4569?source=see_link\">",
"     mycophenolate",
"    </a>",
"    mofetil, and cyclosporin, have been occasionally used in the management of patients with severe dyshidrotic eczema [",
"    <a class=\"abstract\" href=\"UTD.htm?26/59/27576/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. Their use has not been evaluated in randomized trials and there is insufficient evidence of benefit to suggest their use in refractory cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26544941\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute palmoplantar eczema (also known as dyshidrotic eczema or pompholyx) is a recurrent, pruritic vesicular eruption affecting the palms, soles, or both. It occurs most commonly in young adults with equal frequency in males and females. (See",
"      <a class=\"local\" href=\"#H26544681\">",
"       'Introduction'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H26544689\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dyshidrotic eczema is characterized by the sudden eruption of intensely pruritic vesicles on the palms, soles, or lateral aspects of the fingers (",
"      <a class=\"graphic graphic_picture graphicRef55722 graphicRef75738 graphicRef82781 graphicRef82783 \" href=\"UTD.htm?40/18/41258\">",
"       picture 2A-D",
"      </a>",
"      ). The vesicles persist for several weeks, desiccate, and resolve with desquamation. Episodes may recur at intervals of three to four weeks for months or years. (See",
"      <a class=\"local\" href=\"#H26544713\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of dyshidrotic eczema is usually based upon the clinical appearance and location of lesions, symptoms, and history. In most patients, patch testing is useful to determine whether there is a component of allergic contact dermatitis. (See",
"      <a class=\"local\" href=\"#H26544729\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of dyshidrotic eczema includes bullous tinea (",
"      <a class=\"graphic graphic_picture graphicRef82787 \" href=\"UTD.htm?10/2/10274\">",
"       picture 5C",
"      </a>",
"      ), dermatophytid reaction (",
"      <a class=\"graphic graphic_picture graphicRef52664 \" href=\"UTD.htm?7/8/7300\">",
"       picture 8",
"      </a>",
"      ), bullous impetigo, herpes simplex infection (",
"      <a class=\"graphic graphic_picture graphicRef52029 \" href=\"UTD.htm?9/30/9696\">",
"       picture 9",
"      </a>",
"      ), allergic contact dermatitis (",
"      <a class=\"graphic graphic_picture graphicRef82993 \" href=\"UTD.htm?32/35/33331\">",
"       picture 4A",
"      </a>",
"      ), and palmoplantar pustulosis (",
"      <a class=\"graphic graphic_picture graphicRef62582 graphicRef82843 \" href=\"UTD.htm?0/57/920\">",
"       picture 10A-B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26544737\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Avoidance of irritants or exacerbating factors is important for most patients with dyshidrotic eczema. (See",
"      <a class=\"local\" href=\"#H16212203\">",
"       'General measures'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with mild to moderate dyshidrotic eczema (",
"      <a class=\"graphic graphic_picture graphicRef82784 graphicRef83056 graphicRef83053 graphicRef82781 \" href=\"UTD.htm?39/38/40554\">",
"       picture 2C, 2E-G",
"      </a>",
"      ) that has not responded to general measures, we suggest super high potency or high potency topical corticosteroids (group one to three (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      )) rather than calcineurin inhibitors (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Topical corticosteroids are applied twice daily for two to four weeks. Ointments are preferred to other vehicles. (See",
"      <a class=\"local\" href=\"#H15309892\">",
"       'Topical corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest oral corticosteroids for the treatment of severe dyshidrotic eczema (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). For patients in whom oral corticosteroids are contraindicated or who prefer to avoid systemic corticosteroids, superpotent topical corticosteroids (group one, (",
"      <a class=\"graphic graphic_table graphicRef62402 \" href=\"UTD.htm?38/56/39809\">",
"       table 1",
"      </a>",
"      )) are an alternative. Treatment is started with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?37/43/38585?source=see_link\">",
"       prednisone",
"      </a>",
"      40 to 60 mg per day for one week. The dose may be reduced by 50 percent in the next five to seven days and then tapered and discontinued over the following two weeks. (See",
"      <a class=\"local\" href=\"#H15309876\">",
"       'Systemic corticosteroids'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H15309884\">",
"       'Topical corticosteroids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with clinical features of dyshidrotic eczema who do not respond or are not adequately controlled after two to four weeks of topical or systemic corticosteroids may need further evaluation to confirm or rule out the diagnosis. (See",
"      <a class=\"local\" href=\"#H16212528\">",
"       'Evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest phototherapy with oral or topical PUVA for patients with confirmed diagnosis of dyshidrotic eczema who have frequent or severe episodes that are not adequately controlled with topical or systemic corticosteroids or topical",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/14/32992?source=see_link\">",
"       tacrolimus",
"      </a>",
"      (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16212520\">",
"       'Refractory disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/1\">",
"      Veien NK. Acute and recurrent vesicular hand dermatitis. Dermatol Clin 2009; 27:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/2\">",
"      Wollina U. Pompholyx: a review of clinical features, differential diagnosis, and management. Am J Clin Dermatol 2010; 11:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/3\">",
"      Lofgren SM, Warshaw EM. Dyshidrosis: epidemiology, clinical characteristics, and therapy. Dermatitis 2006; 17:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/4\">",
"      SHELLEY WB. Dysidrosis (pompholyx). AMA Arch Derm Syphilol 1953; 68:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/5\">",
"      Kutzner H, Wurzel RM, Wolff HH. Are acrosyringia involved in the pathogenesis of \"dyshidrosis\"? Am J Dermatopathol 1986; 8:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/6\">",
"      Meding B, Swanbeck G. Epidemiology of different types of hand eczema in an industrial city. Acta Derm Venereol 1989; 69:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/7\">",
"      de Boer EM, Bruynzeel DP, van Ketel WG. Dyshidrotic eczema as an occupational dermatitis in metal workers. Contact Dermatitis 1988; 19:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/8\">",
"      Jain VK, Aggarwal K, Passi S, Gupta S. Role of contact allergens in pompholyx. J Dermatol 2004; 31:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/9\">",
"      Lodi A, Betti R, Chiarelli G, et al. Epidemiological, clinical and allergological observations on pompholyx. Contact Dermatitis 1992; 26:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/10\">",
"      Chen JJ, Liang YH, Zhou FS, et al. The gene for a rare autosomal dominant form of pompholyx maps to chromosome 18q22.1-18q22.3. J Invest Dermatol 2006; 126:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/11\">",
"      Pitch&eacute; P, Boukari M, Tchangai-Walla K. [Factors associated with palmoplantar or plantar pompholyx: a case-control study]. Ann Dermatol Venereol 2006; 133:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/12\">",
"      Guillet MH, Wierzbicka E, Guillet S, et al. A 3-year causative study of pompholyx in 120 patients. Arch Dermatol 2007; 143:1504.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/13\">",
"      Veien NK, Hattel T, Justesen O, N&oslash;rholm A. Oral challenge with metal salts. (I). Vesicular patch-test-negative hand eczema. Contact Dermatitis 1983; 9:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/14\">",
"      Lehucher-Michel MP, Koeppel MC, Lanteaume A, Sayag J. Dyshidrotic eczema and occupation: a descriptive study. Contact Dermatitis 2000; 43:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/15\">",
"      Uyttendaele H, Obadiah J, Grossman M. Dyshidrotic-like spongiotic dermatitis after intravenous immunoglobulin therapy. J Drugs Dermatol 2003; 2:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/16\">",
"      Iannaccone S, Sferrazza B, Quattrini A, et al. Pompholyx (vesicular eczema) after i.v. immunoglobulin therapy for neurologic disease. Neurology 1999; 53:1154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/17\">",
"      Gerstenblith MR, Antony AK, Junkins-Hopkins JM, Abuav R. Pompholyx and eczematous reactions associated with intravenous immunoglobulin therapy. J Am Acad Dermatol 2012; 66:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/18\">",
"      Shiraishi T, Yamamoto T. SEVERE DYSHIDROTIC ECZEMA AFTER INTRAVENOUS IMMUNOGLOBULIN THERAPY FOR KAWASAKI SYNDROME. Pediatr Dermatol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/19\">",
"      Douwes KE, Karrer S, Abels C, et al. Does smoking influence the efficacy of bath-PUVA therapy in chronic palmoplantar eczema? Photodermatol Photoimmunol Photomed 2000; 16:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/20\">",
"      Man I, Ibbotson SH, Ferguson J. Photoinduced pompholyx: a report of 5 cases. J Am Acad Dermatol 2004; 50:55.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/21\">",
"      Hald M, Agner T, Blands J, et al. Clinical severity and prognosis of hand eczema. Br J Dermatol 2009; 160:1229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/22\">",
"      Vocks E, Pl&ouml;tz SG, Ring J. The Dyshidrotic Eczema Area and Severity Index - A score developed for the assessment of dyshidrotic eczema. Dermatology 1999; 198:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/23\">",
"      Warshaw EM. Therapeutic options for chronic hand dermatitis. Dermatol Ther 2004; 17:240.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/24\">",
"      Ashcroft DM, Dimmock P, Garside R, et al. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials. BMJ 2005; 330:516.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/25\">",
"      Belsito DV, Fowler JF Jr, Marks JG Jr, et al. Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis 2004; 73:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/26\">",
"      Thelmo MC, Lang W, Brooke E, et al. An open-label pilot study to evaluate the safety and efficacy of topically applied tacrolimus ointment for the treatment of hand and/or foot eczema. J Dermatolog Treat 2003; 14:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/27\">",
"      Schnopp C, Remling R, M&ouml;hrenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial. J Am Acad Dermatol 2002; 46:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/28\">",
"      Pariser D. Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption. Am J Ther 2009; 16:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/29\">",
"      Tzaneva S, Kittler H, Thallinger C, et al. Oral vs. bath PUVA using 8-methoxypsoralen for chronic palmoplantar eczema. Photodermatol Photoimmunol Photomed 2009; 25:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/30\">",
"      Polderman MC, Govaert JC, le Cessie S, Pavel S. A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema. Clin Exp Dermatol 2003; 28:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/31\">",
"      Sezer E, Etikan I. Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema. Photodermatol Photoimmunol Photomed 2007; 23:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/32\">",
"      Petering H, Breuer C, Herbst R, et al. Comparison of localized high-dose UVA1 irradiation versus topical cream psoralen-UVA for treatment of chronic vesicular dyshidrotic eczema. J Am Acad Dermatol 2004; 50:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/33\">",
"      Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999; 40:612.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?26/59/27576/abstract/34\">",
"      Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76:371.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13657 Version 2.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-221.179.173.170-4115C7D097-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27576=[""].join("\n");
var outline_f26_59_27576=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26544941\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544681\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26006232\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544689\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544705\">",
"      ETIOLOGY AND PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544713\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544729\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18792269\">",
"      Clinical diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18792277\">",
"      Histopathology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18792310\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544737\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20269882\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544808\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20269116\">",
"      Assessment of severity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16212203\">",
"      General measures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16212111\">",
"      Mild to moderate disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15309892\">",
"      - Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15309899\">",
"      - Topical calcineurin inhibitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16212295\">",
"      Severe disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15309876\">",
"      - Systemic corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15309884\">",
"      - Topical corticosteroids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20269006\">",
"      Treatment response",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16212520\">",
"      Refractory disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16212528\">",
"      - Evaluation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16212550\">",
"      - Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26544941\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DERM/13657\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13657|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?6/45/6869\" title=\"picture 1\">",
"      Dyshidrotic eczema foot 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/57/43925\" title=\"picture 2A\">",
"      Dyshidrotic eczema hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/4/27715\" title=\"picture 2B\">",
"      Dyshidrotic eczema foot",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/49/10004\" title=\"picture 2C\">",
"      Dyshidrotic eczema mild 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?25/4/25669\" title=\"picture 2D\">",
"      Dyshidrotic eczema fingers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/63/44021\" title=\"picture 2E\">",
"      Dyshidrotic eczema nail dystrophy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?16/11/16563\" title=\"picture 2F\">",
"      Dyshidrotic eczema moderate",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?22/12/22724\" title=\"picture 2G\">",
"      Dyshidrotic eczema mild 3",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?12/56/13190\" title=\"picture 2H\">",
"      Dyshidrotic eczema mild",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?5/32/5636\" title=\"picture 3A\">",
"      Dyshidrotic eczema large bullae",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?43/6/44133\" title=\"picture 3B\">",
"      Dyshidrotic eczema severe",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/30/11747\" title=\"picture 3C\">",
"      Dyshidrotic eczema severe 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?32/35/33331\" title=\"picture 4A\">",
"      Allergic contact dermatitis hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?4/43/4789\" title=\"picture 4B\">",
"      Allergic contact dermatitis hand 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?38/11/39103\" title=\"picture 5A\">",
"      Acute tinea pedis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?30/49/31506\" title=\"picture 5B\">",
"      Acute tinea pedis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?10/2/10274\" title=\"picture 5C\">",
"      Tinea pedis bullous",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?28/17/28958\" title=\"picture 6A\">",
"      Chronic irritant contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?36/12/37061\" title=\"picture 6B\">",
"      Chronic irritant contact dermatitis 2",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?1/31/1524\" title=\"picture 7\">",
"      Atopic dermatitis hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?7/8/7300\" title=\"picture 8\">",
"      Autoeczematization on hand",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/30/9696\" title=\"picture 9\">",
"      Herpetic whitlow finger",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?23/22/23904\" title=\"picture 10A\">",
"      Palmoplantar pustulosis - heel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?3/39/3701\" title=\"picture 10B\">",
"      Palmoplantar pustulosis hands",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/39/22133\" title=\"picture 11\">",
"      Palmoplantar pustulosis old lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?26/23/26997\" title=\"picture 12\">",
"      Dyshidrosiform bullous pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DERM/13657|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/56/39809\" title=\"table 1\">",
"      Topical corticosteroids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/42/11943?source=related_link\">",
"      Clinical features and diagnosis of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/11/22714?source=related_link\">",
"      Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/20/40265?source=related_link\">",
"      Clinical manifestations and diagnosis of herpes simplex virus type 1 infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/58/7082?source=related_link\">",
"      Dermatophyte (tinea) infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/40/42631?source=related_link\">",
"      Epidemiology, clinical manifestations, and diagnosis of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/6/27752?source=related_link\">",
"      General principles of dermatologic therapy and topical corticosteroid use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/21/21846?source=related_link\">",
"      Impetigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/20/29001?source=related_link\">",
"      Irritant contact dermatitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/63/32758?source=related_link\">",
"      Management of allergic contact dermatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/26/44457?source=related_link\">",
"      Management of severe refractory atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/43/30393?source=related_link\">",
"      Neutrophilic dermatoses",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/31/28150?source=related_link\">",
"      Patch testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/44/19146?source=related_link\">",
"      Pathogenesis, clinical manifestations, and diagnosis of pemphigus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/24/33160?source=related_link\">",
"      Psoralen plus ultraviolet A (PUVA) photochemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/37/10842?source=related_link\">",
"      Treatment of atopic dermatitis (eczema)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f26_59_27577="Laparoscopic cystectomy a";
var content_f26_59_27577=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F61558%7EOBGYN%2F73354%7EOBGYN%2F52353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F61558%7EOBGYN%2F73354%7EOBGYN%2F52353&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 483px\">",
"   <div class=\"ttl\">",
"    Laparoscopic ovarian cystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 463px; height: 259px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The ovarian cortex is incised in the direction of the ovarian axis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 495px\">",
"   <div class=\"ttl\">",
"    Laparoscopic ovarian cystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 475px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The cyst wall is grasped and blunt dissection used to separate the cyst wall from the ovarian cortex.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Laparoscopic ovarian cystectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 431px; height: 267px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAELAa8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKjuJ4raCSe4kSKGNS7yO2FUDqST0FAElUNS1jTdLGdRv7a14yBLKFJ+gNcVfeJ9Q1+5ltdFc6bpJJhGoMMzzsPvmJD91VH8bckkAAda3tG8H6bpm6SykuVkmw00xlJmnb1kkPzE9uvHagCzH4t0OVd0N+sqZxujjdhn6gVjal8TfDdtqVlpdjdjUdYvW2wWVuQGJ9WLYCD6nPoDXQ3GnWKxvFePNOJnLBJZXf8FGeg9qg1Xwxpms6Xcafq0LX1lMPuXDb2jPqrH5gR1BzwelAGY114pmtDNciy0xgxzHDEbo47Dezx5P/Aagk1jWrGASTzCdT/ENOA/QT07QLvUtHtk0i8llu/sQ+z/bbw5luGzlCTkbsoVyRzkGovEk1/eNapNp/mIX2HyyQIwQcuxI6cY6HrTEGneMdTO9rzRmuIOqG03LM3/bGQD/AMdZj7VsWfjTw3dM6JrenxzxtskgnnWKWNv7rI2GU+xFZWiaQfsyLrQlghDMoiiASN1JwBI6nLZyD/CPY1NqHhG1neRI9E8PGzUfu45LJHPQDuMUgOtiljmjWSF1kjYZDKcg/Q0+vLP7OTQNkMGnjRZd/mIdIcQJJ/vRZKHPptP1Fb+n+LJrGJ314K2nxkK+orGYvJP/AE3jJOwf7YJX120Bc7SimQyxzxrJDIkkbchkOQfxFPoGFFFFABRRRQAUUUUAFFFc5f63c3t/LpfhtEluYm2XN7KpaC0PcHBG+T/YBGP4iOMgG493bpeR2rzxLcyqXSIsN7KOpA6kDIqeuNkuNH8Gx3dxcXJuL9lEl9f3cgBVeSplfoidQqAf7oPNavg3xBB4l0ODUbNmkgk3ASmMx7sEj7hJK9Oh59eeKAN2iiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKzPEOmyapprQ21zLaXSMJYJ4zzG69DjoQeQQeCCa06RiFUsegGTQByTeLX0gKvia0ktogQpvIlLRKcfxjqo9xlfcV09ld21/axXVjcRXFtKu6OWJw6OPUEcGkmhtr6DEipLGQffrXFz+Cjpepz6hoM91ayTMrSfZpNpOP7yEFGHuVz70CO8orhoPFGs6ZIkOsaal/ErlHurE7JE6Y3Qv8AUZKsfYdq1I/HHh0w+ZPqK2gBwy3cbQFD6MHAwaBnS0VzknjrwnHE0snibRFjXqxvogB/49VDVPG0bW+7QIBdIQSb6fMdtGoUsX3EZkAA6JwfUUAdDrus2Wh2X2nUJSqswSONRukmc9ERRyzH0FcV4plvXtnvdYjHmpG0trpauGSDC5DzHo8m7GONq84yRurR0WOaCf8AtHUZf7Q1OZA8dw6hVhiY/KkaD7oIAJ5JJOCTgVUdo7k37XlwsbhlMkshGEUZG7BIyAccUCKXg/SptJ8OaHo8bpe3MumxlZi+d7MHaaZm5ON0i89yR747Dw293BDPBqI2yRFm65H3j90+mNv61g2d2bXxEEis/slpDa20VpHJ8pdMyjhOq9gAeeBnHSum0rUU1iyP7vaWjw46gE8Ef1+hoAk0eEFZLt5GkuLg5fL5CY6Io7Afz61Lqd/HYQB2G9yQFQHBbkD9M1gW1y8QlslmWCZTudHXmMuBtb3HmAj0wwrD8T6qI9O1x7Zy1za2st0YyG/c4ViSxx8rcsAD1KL65oGdP4Wu5dQ+1XEsi794DIjhwvyhgMjPZunoRS+IbTaitaFbdnLPJJtAAA5LMx6D3z+Bq5o0NlpmiWsdq4+zBAwfOS5I3Fvcnk1xHjrxFJPf3GgSR4s7iz89XUHfN28tcdTuIJx/CrZoEbdldaxPpLjRIba3h5Md5fK7iTJ5ZYl2synqCWXPpjmsW+/4SsBmm1uXCn5THbLao3tl43x+tdj4XvftWl2yHOY4E5LZJ5Zcn67c1U1/W9D0ieSTW5ba2hZdhmnbl2xnYi9WwDk46ZFAzj5rnxVbK9/c2B16FsBIbSZIpo1xyWBASTnuAp9q1PDVjoGuw3U2pAXsoCyTWmoBj9lDg4QoxKYwCMgYOOprT0fxr4SuVaPStWtZmUjdHHkuM+q43YrQjg0q/wBRW6t50MxTDIpGJFJB5BHIyP8AJpiKV74Q02GINo9pHpuyPZ/xL820mB0ClCB+DAiqKa1qmkyBZCdTthGGMcoWO6UDqd2FR/oQnf5jXXanv+wTiKdbeQodsrLuCe+K5oaDesYne4hu0YFdyjbwQfmJOcj6dc0hnQaNq1prFp9osZNyqxSRGBV4nHVHU8qwz0NXq8zufCniOw1UanpeuWNjcvtV4xp8s8ciKPuyESDPfDYBHY9c9LpnikB4oNeijspZXEcNykm+1uW7BJP4WJ/gfDem7rQB09FFFABUV1cQ2ltLcXUqQwRKXkkkYKqKBkkk9BVXWtWs9FsTdahKUj3BEVVLPI5+6iKOWY9gK5W6ia/8rVvGY+zWiOHs9H3BsMvIeXHDycZ2/cTHcjcAC09xe+KI2eOSfSfDgBZrgkxXF2o7qesURH8X3iOm0cnA8S+MbLQtOOnaDbGOCCPiG1wkrKemwH7mc5BILNztX+KsTUPG7+Kb9Us3ePSIbgRNNGu/fIM/u4V/5aOMZ3kFBg7QxBYa3hDwe2ozx32oIYrIZZI95YuTn5g3XJycvznOFx94sRj+DPCup+K7sal4mKJZRSbobWNP3cbAnLKGyTJnq5JIx13fd9ntoIrWBIbeNYokGFRRgAUsMSQxJFCipGgCqqjAA9AKfSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAU2RS0bBWCkjgkZ/SnUUAcFd3eqeG5pzdafM2n4GLuyBmHU43xj5029yNwweoxWxoviZL63ldWiufLwM27Bue4PJGeldLWPq3hvS9TdZJ7cx3Ckss9u7QyAkYJ3KQT9DkUCLaT2t9GwcIwBxhsUr6ZZvu3QL83XBI/L0/CuN1Pw14ht7iGWwvodRt0DCRJ/3E7g9t6goT77V+tLF4ka3vp7HUI7vTb67i82NLhRjzQv3UcZR8heik+4FMZ0U/hTQrjUYb+60y3uLyFdsUky+YUGc8bsgH3603XtEsrrSJ4ZAygxsoPUklSoGO+c02x8QRNLFHduEMq/KSNuGDYIPoeV/Or19J5lzpZU5heUncOh/dsV/wA/SkBX0S3luNPjm1OFYrhwB5KvuEQXgAEd+5+uOlZdtb283itrOKKRoLEeadygqZW+bJbqdu4ED1cn+HjS0e9t7Owt7aeUIwOxSxzk9eT+dY/gi6N7rfiKaZh5kN9JbKM9gQR+ahTQI29e0G31V4pziO9hR0il54DYODjtuVT6grWV8Mp7ifwpBcanCltqU7yyXEKggRlZGTaM84AQAZ9K6xiQp2jJxwM4zXBXesWejzyyXbvZ28rNIZrgjZCJcF0b0G8Fsnj7wyOMgzc1q+tpbyGGK2hubtX2qsidzlevYA4J9qvWukQRaTPYFvMM6MJ3wAXLDBJA6ccAdgAO1ecWuvXniDxkLDwzJDeR6dbSfbJNuYEuWVUTdKpIOU5Kr8w56Z46m60PxDbWUlzYalZzakhDhDbMiyhcER58w7cneNxz988cUCOcsrm5Fo1mYDbXaRiCeINzvXA2LnoHDFQ4zgsprs/Btjb2tlIQoe7WRo5pGk8w5zkqCeQoJOB+Pesq2vo9WvLSa9sxb38UscSuxKsdr5ZcEDIyMjj3qSzNzpVzdyhh5co84IGyDl1wfxXNMDbvlh0WK4v4gqQrCQY+gLFsrj6lj+deRfEeXU5dUstS0a4jg1i11L7Bp1zt8weYybrhSvRhgsmP+mXXPNej69rjxac94IzIIUBW1Rd5lnL7Yk/Ftp+mTXmuqWk154y0vw7ptw8a+H4Cbu6iXcTczAPIyDnMrZ4B6b2J6YIgZkjx74tls9RXxR4X0rU1sbn7JO7WbD7yb1PBJUFcc4ODV7wvr3hDWtN0+e2vdS8GyzSPDEktys9s7jrGxfcqk9Qp2EjBFesaVpTHQNWm1W1WK41NpLieA4YxqV2ohIJBIVVyRxnOK80t/h3p+rfDzVbTfC0LyxGC5jwxZkXbyevfBzzxQBsatZeIdBheS+afU9I8s4utPLysg7F4CWbHfMZbHPygV6D4a1exvtBs7m2uoJIHQYkjbKt75/A/jx1rxHQx4i+Gv9mtot62o6HqVt9pt9LutzIjBVdljkwWQ7S+AflGMnrx3Ph650LxxE+p+Fbp9I1pH8y6spVAy/TMsQPIPTzEIz/eOMUAd299LNJJHaSQrcRx73tZQDKBkgNgN0ODj+ded6ve3EF1dSa3FDZxtgS/alCQzKyjcvzEqw6Z9OeeKZ4kkjjZIPEtpc6ZcWg329/A67QxPLxScDHqhwfVG4NaOma54jMEh0ubSPFVmACIvPW2u9p7nqjD3O2jYC54Q1yLT7m307zzNo902yxnaXzfIkxxblxnKkAlCTngrz8uep8Ra5b6JbRtIklxdzt5draQ8y3D/wB1R+pJ4A5JAryDxRqVlqV/9juvBjW2pTuLeG3jujaXczZDAqVGHVSNxb5kGMk8Vr3Wr/8ACHsn9r6nFqXi+6iEdxqFxhLewi6hMgBUHHoC7YJBJVaAubNzKNIv01rxCUvvE0ibbWxhJaKxRuqpgZJOPmcjLYONqggeeaxrE/i6aXZdx3Ibhvs8ilThiCoIyBGpzlsnORjcSrEs7i6124228cl5Hc4Ek8yMHnYkHlchgvRljHJHMhUDC+q+B/BVroMJmmiQ3UknnFeOJMY3tgAF8dwAB0UDkk2DcyvAvgZbUfa9TU7XwUtypUbeMDb/AArwPlPzHA3k/dHo4GBgdKKKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACq2oWNpqVq9tf20Nzbv96OVAyn8DVmigDz7V/Dl34ftBPo0Muq2EJ8x7GRt9yq9T5MjHLf7rknjAPQGn4f1OfVY9Untr1xZebG1u7A4hVEUAEdQQ5yR14INem1534x05/DOqt4h0u2MmnXsoXWbdWAC8AJcqD0KkLvx1U5PIoEaH2VtXtZZ7a3i+0EgzQCTGJMclfQHHfHrWToseo6T4y1VNQa3eymjS8sxE4LNtYiQ46nCn9ai1NDalxAJHZXAgiEQk5dvkHupLDgkDrXTXXhURafo/9mGFb7SozHC0oOx1YDeh6kA7R64xTA3ZtQghcqxb5WVWIHA3Zwc+mRj615941MA8Oa7qMdtJdRfZ5PKG0jzWcArGM9SXbbx0zW1Y213d6xFY3NnNb2sUZlmLyAlhkKkYKk5U4JOf7g9TiX4iYW20BcDyzq9vuXtgbj+hAP4UAT/DTwzY+EvBOl6Vp1uYESFXl3Y3vKwBdmI6kn+Q9K6esjSLvaxgmk3BvmiYnHy7EOP1NLrespp1rI8aedMQqwqDxJIxAROOmSQSewye1IZyE1u978QreGGSGWG0hlM7Hl/PdtoHHGREN3T+7611/iBYjprWqoDNMPLhUA8HseOgHFZnhbTRZag5mPmXTweY8zKA0ju7F3IHqQMDsoUdqg8W37DUF0XSJH/tvUEAeZSN1nbZIMg9CTkL/tc9FOADI1XUbCzhvdfvpFbRPDUbOJAM/ab0KUZuPvbc7AMffZu6iqXwO8N3dtY3ev65J5mpahNJOIznMG9tzBucFiSM9cABc9aXxJp1p4l1jTvBFgjLomkGOfUApJDuBmKFu5wSJGJPPy5ySRXTeNtfbR7ey0zTY2uNVvm8m2t0wGbAz9FGByegGT1wKYizrnia0t5xp1u5lv7lSsEcQ3s/YkAdlyMkkAdzRqcf9n6TZ6dYmBpJmKkPiMPwT+BLbR361T8H6BDZyXv20NPq3yJc3YG1GGAfKiGcrGOMjjd1Oc1Y1/xHY6V9qmfG2AAPMecNnaqIvJLZOMAdT3NICtLohub3QNPbCrpNoWd9hKFniaIAHpnqcelcT8SPACpd20/huU6Xqcz5t9QiYq0E+7Pb+BskMOhBGc4r1jTIXtYHN1KZLiVjI+Wz+A4HAGO3em6k0Nxp8RkX5ZyiKSOULEY/XFMD548G/tF3USSaV490CZ7+F2hkns9iq+0lW3o7AA5B6HB9BXaw+NvhTeIJ00uyOpMMJaf2T/pDuThUGFxuLYA+bGe9cB8a/h7Y2uk6r4v07zIZpNTmj1FQSwO6ciOVQSApDFQexBz1HPHeHNdvdE8T6X9j02G/1+7je00ona0cVwzqiyyYJI2oWIX3B96APaYvM0zUL6PSoLc+LXhM1yd7SWugW5XIQZJAcgAkLjcecbQK8t+H6674912Sw1IpFFpzLNPawZIuJGTcLiZ2zxzkZzjOEXOWHt2vaZbeCfhhJpEEqyapqp+zTXTjMl3cS582Vj1J2729gAOgrZ8MxwaRpuuQwCNAL8wRkALvIijXH5gj2xQBB8LLaxht7+KPyJLu0m8pZEUgCB1WSPapJ2gqwycksykkk813lcb4Sjjh8SXAhVR5ulWru4XbvIknAJH0rsqQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKZNFHPDJDOiyRSKUdGGQykYII7in0UAeSX2mXvhDxP4es4JDcaHJclbYyN+8j2xSMsDOeSBj5D6DB+6CfVbm5SC2aZmAQYGT0GTgZ9uazPFuj/ANt6NJbxssd3E63FrKRny5kO5G+mRg+xIrmdO1F761MmFUBij275HluPlZGJ6EHK8f3ie1Ahmga/PHr2tfarSQzmSJGDP9xREpX8CzsPrmun2Lr1rfQTGVbSaPyS8blSDzyh6g4PX6VyGsW11pf2nXbWC+u2uEWGRI48bNoc+ay/e/i6r0PBBHI7Tw/ss9AtEnuFd44VeaQjaCxG4nHYZJ46AcUAczdWV3aWoTUwjtBJthMJYCWMbhk54DFGAK88pVG3kV7tHeGVI7IYCFiPNmcsBHjpwpI3DtKv4db4lvIZNKu7aOdkd4jiaMnCcZzkdMYzXP6cNPtIku55IrfT1v5Zi7sAkYRVVACe3yLTA39b1KLwzoc2oXa+fdsVRUThp5mIVI19ASQPYcnvXDeIp/8AhXHgzWPE2rT2z+KL390k2TtknkwI0weqoen+yhPc0aT450Txhr82vQ3EieHvDpeFHlTH2m7f5cooJLYQ7V4yTIQBXhX7RPiLVdf8dw2OqmO0023tgYrFMzSQeYD88ygELKVx8ozgEDOc0gPpf4eaRbeHbK9gklEl2rmS4mfHmTORueRvdjk/p2qj4DsZNfS68VXYkEmqy4hSQ4MVojYAXHI3lQxHpgdq818K+PdM1nSoV1DWLHS/EFnapbSm8k8tZyq4SRWb5cOp5BIKnPWvUfA2qRW/hCO6iPmoLO1aNVIIYmMKAD0+8CPwpgaPj/xC+jabCtnIBdTybBtALAAZIUd2PAA9Wql4T8LiKWHVdbIa5t1CW1qWDJaAAZLYOHlJBJbnBYhe5NbRdMutfK67I8DTWzPFppZf3anfiS4xyCzYYJ6KP9o1L4v1WfVNSh8O6YZYWmy1zOvBiiBw7+wHYnqcAdzQBu6dcPriXVzGdtqxNvHwVbZxvbPcntjjjrWjqbLDbQRgYDTRovoPmH+FP021tba2iFlAsEIjVERV2gKOgx26n865jx9qF0rWVjpZBu5XIX5SVWTACbsdBls/QH0pDK3iFLfWfhDrskKmSK6sbq4Tz4wpLfO6kqOOoBrxT9mPS5Nd8bS+IJ1D2thZh42AAAuJflI/BAw9s17Z8S9QtvDHwt1eEHmOw+xwjpueQeUn6nJ9ga5v9nLR4fC/wzurm6kjUSXU800in5FWL93x7DyyfxNMRd8TiXxH8U9Pso5QLDQwss69P3r4diT6BAg/7aGpPDcj3OkzB41kku7ie/RVOQUmdpI2x/u7VyP7/wBRWT8NrGfXNE8Qa1cXUrvrckyxv5ZYxJMwVQoHZUCDPtmr/iaF/B+uaZp+hIUttWiay0+1RTstrkEHdkfdQLl8dMof71AFjwNqlzN8UfE8N1AYrOe1gXT5D92b7OWS42+wkkx+vSvTK83TS7fw9428M2lqmy1iWS3hJYszB4mY5Pc7oif+BV6RSGFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVxHizSv7O1U6/DNKloy7b6IfMinGBPt6cDCt/s89jnt6QgMCGAIPBBoAwDqUV1oUsaoWLxbNoP8LjAOeT3H0yKxtBuzNpkCz5a5tgLSY4C+eyL8pAPaRGyPfArP16KDwJI92ZQ+hzvhbUAGSDJ+ZEXq0fOcA/J2yMY8/wDEPibUvElwdI0GW+iZXYGyQ5klU8O0jDCpjgjPTdnGOQxHX654ltdGeayt3hvbmH7pDbIIUII3TN0B+XGB/d69QfBtQufEvjJ10nQrVtSt1Do0iSlUjbjIj4+XO0Z4yST0zmvSfDXhGNZZghh1CVCJrm5uG/0C0wvLHP8ArDtYn06n5h0vxs9naONDuPJ0KWYf2lq5XZfXxccNCMDZB0Xf1x0wBuoAwvhnp3/CGppehyXdlca+kjwyai6ZsdIkkJJQN0muWyF5IA4XI6NU8cfAzxJplzea3pGqP4hnnma4uRIgjuWLHnAGQ468ZHYAcAV6pYaDFDpv2Ke0trjTufJEEe1AmfTHB4wffr2Fa9ppWr+GLUT6ZdfabFeX025yQq46RPz5eMZwcr/u9aAPl6axtrW5kunnaNJH8pw5Pl52ttLA/wAXDptPIJx7Dt/h54lgt/hzqfh+OUyXWigXNqpbBmtnbcVGepjkYr16Eetej+OvB2kfE/RJb3RGFjr8GCVmUod5GQkyD1HRxng5BZTg/MPid9XivDGzvZ63psjRtEWw6sOPmGMYZTj3znpTuI+yzdQ+GPh1p4skVoYLGOKL5sAKsWd2fouag+GOntHov9qXO+W41hVuXeUYKRYHlR49ApLfVmrzXSfFcni74HwC1cC+0yJNO1KHIJUlAiyj1Vgcj13H0r2+3kjtLa4muGSKJXZV54CrwB+mce9IY3X9R/szTnlTYZSMIHYAD/aPsOprkvh5p1xeyz+ItTbKT3Ek1irKVOxgF8056bgPlHZT/tHGdbLN4/194rnzU0W0dZLmMDCy5GVhJPqCC6+gUfxV0HjzVpLRLPS9KKPq14THaW+3I34yGbHREALE+g+goA81+PSzeLtH15NJucW3huJbyUL0uZgrN5fUHKRl3+rL2q7Z3/8AZ/7Mtm/KyapbLAgJyc3c23P1xKT+FanxNez8G/CnU7CSQ3E5sJzLcP8AfmnkQxhjjqWd8D0Ax2qO50qFtP8Aht4MuWQTW1vHdzQN3MEIVcj03tn/AID7UAdnomh/YNA0SO3mNlb2MhuJo1T/AFqbHAQ4PAG5T3+6Kw4mPijxVoyxzFk0HULieRyuGZPJ2Rg/UzfiIya7nU51tbFhuCsylI8jqdpP8ga8n0TWRoeueJJrSEy3N9PbW47BQolXf9AB+ooA6q4uLS88e6PYw4eaGSa/bHVFVGTn6vNXd15/8OLOefX/ABDrV4FLyNHZxDugRd0g/FmAPutegUhhRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVV1PULXS7Ga8v50gt4lLO7Hp/ifagC1Xn/jb4jWejpPbaU0NzfR8SSyNiC393focegPY+mK4/4g+P77UtJi/s5pNP0+8kaC3UDNze8EZUfwJ0+Y8c8nFZ2heCZtTurZtVsxNJAqvbaUoBht2/56y7gQZOc7pBz/DGfvU7CuZkCX3iy9Gs3l1OlhKpxdyDEk3PW3jOAkeBgStgenXB7Oz0a30fQhcXcMthpOQ0djbqXu79wAVXDYZ3JB4IGeyr949LHbQ2eqeRZwrq+uht5XJFvZE4+eRjn5ucjJLn+EKvTo9I0JbS7fUL+c3+rSAqbl1wI1/uRL/AntyT3JoA8809v+EmsImWNbLSYSfI0gLnayk4efvI+RnYM7SPmD9Rb1XTC+mpJcL5pivULjAdJI2Vlxn0DMeORnHHWuu1fwzHcXj3unukFw+TNG65imOMbjjlWA/iU/UNgVz+pxlrW40/xDFPaCfKxXhQypGy4aN/MXjhgCPMCnqORQBX02+ufD0m5zNNpS4/eohlkt1GBiVPvOgHSRfmUYDbgAx9FtLmC9tY7iznjmt5V3JLEwZWHqCODXnXhDXhdQi6glgufs8ptrn7NKr+XIv3lyMg5zkdyOR3rQutFv8ARtUl1jwrfxPHduXm0qZgsNy/dkP8EmBjI4OPmBPNAC6np0kl0L7S5orPV4GMaToh2S5OTHInBwcfdPX7ykGuP+Ivg+1+I2jyatpdolr4ssNsdzbMfmcDnbkdSRykmOQcd+O3tJ11JZL6CB4JfuXNpKuHhY4yHHcd8jg9Rg/NVvXNNngS11eymjTVLRdmTkR3MJP+qkOOB0If+EjPQsCAfHUtve6Vps97oFxd21yIjFeWew5ni8zJSTj72OcdVO7pjA+lNe8VRaroulf2Zif+0kFxZQucCVpsCNHPUYLOD6bSe1ZfjjwND4sefxD4TYw6mfl1HS5Nql27kjosgHI/hfg56NXB/s+6rLF8QJfDV7EU07RI7q/txcQlZrdyFR4+eijezbexJoA9+X7H4I8MRwu4CRo0txcbfmeQ8s5UDLMzHgD1Aqv4U0yTTrW78TeI0I1m5i3SAncbaEcrCvv3J7sfQCsnw0f+E08TS6tc7X0rS5f3AyfmuRkjI9I0Kn/ef/Zq1r2pX3iPVRomjN5cLLma4HzKkRP3yPfGFHc57A0Aef8AxHgvvFM1tf3Yli0yx17T4Xh28Shp0XZ+AYE/7R9jXdaVFHf/ABR1rW7tc/2dALO2K/woPvH6l2kH/AfasH4vZt/hle6V4daS3ubXU7G2tJmO5jcm5jfcSc7jlgx9TmvQ9D0T7FoK2In3z7wZ5ydzSsGyzN7sckjtuNAFTW7pZrd7m6c29rEDJICdxCKXUkAdSwYYA55FeUweJtEs9Lh1mS8+0a1LeNH/AGNDAfMSYsIYoZiSfL2sFyWwCc4zxn0jU7S53m51aW3WKwxPBaQglWKkASSsfvEbWIQDAPJ3EAjz/wAC6I3iC78Ny3UMRiTULnW93OSFkZUbAwDliuM9RkjpQB7N4a0xtH0S1s5JfPnQFp5sY82ViWd8dssSa06KKQwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAKGv6nFoug6lqtwjyQ2NtJcuiY3MqKWIGe+BXJeFviZpmtyXKXlpdaR5Onx6oXvGj8s20gyr7kYgcEcNg811XifS/wC3PDeraT53kfb7SW183bu2b0K7sZGcZzjIrzbS/gtaadpeqaXb6syaXqmnQ2t5ClsAWuIgMXCNuO3JGSmCDk89MAHZQ/EDwtLZG7XWbcQidbY7wyMJGUsq7SAclQSOOccUs3j7wzDpVvqTarGbK4LrHIkbvyn38gKSu3jOQMZrgNU+GWtWK6TJpN3ZXV+NZs7qa5SyEIijhjmXzHVpSZMGQfKCPYDmtG9+Ek1xpkNuPETGV7i6u77zbTdBczT4y4iDqFK4+XJYD0oA61/G+kRXVy095ZppkNjFf/bBPuzHI21TtA4U8YOec1uaPqthrVit5pN3DeWjMyLNC25SVODg9+RXmk/wf83QbvTf7cx9o0a20jzPsn3fJk3+Zjfznptzx6mvWBx0oAKKKKACiiigAooooAKKKKACiiigDnvFni3TvDcSLcv517MQsNrGQXcngZ/urnueK8tvotT8XhL/AFdh5DhhDFJn7PC/G0RoPmmfAb7oIOcZr1fX/DOm6xNDdT2dq97Ccxyyx7h0IwwBG8YJwp4zzioE+y6ddGKxjfU9X4UkkfuRgdT92JcYO0DJ7A0COZ0Xwba6Yx1bVZmt2SNUa8uXAn2DgIuCVgTpwnzknlga6KzgutQhjh06J9I0Y/MXA2XM/ToDygPOWb5z7HmtC10lpLiK81iUXd2nKIBiGA/7C9z/ALRyfTHStegZW0+xttOtlt7KFYYgc4Xue5J6knuTyas0UUAFFFFAHMeIvCUN/O2oaTO2l6yF2i5iXKTKOQk0f3ZF+vI7EVlWWt3Wmkad4wt1td4ws6827njlJTwuT0V8Nzxmu8qOeGK4heG4jSWGQFXR1DKwPUEHqKAOXKo0vmWc5knjjGGC4uI055KnkjPYgg9gOtbejX3263IdV3p8pZPut2yPT3B6e4wTlS+ELaKUy6RdT6c2f9WmJIQPRUbOwf7hWua1PWfFPh3XobO7XS302Y5gumkeETsQf3bZVgsmcYy3zA8cgimI29Z0CSC9F9Y3DW84OI5YgA4Gc7CvR17BcfQZ5rzv4lakNCil8V3mlwpqEdrcWMup2WAjo6HYkoJyG3KoAJbBPUZrsrbxdfy3Gp2viTQ/sVtEFNvIG80S8EuxwOCDtxx681ia/bHxR4I1nRTOkr6hpzxxuyqSJQNyF2PzYyAMc4zQBf0R30TwZovh2zMdzr06K0sTZw0jjzGaQjnaNwZiOcYA5YVP4z1/T/hj4IuZftCveYy88mN0kpwMkDvj7qjgAAcAVg/Bq7m8QeNvFevuS9nbw21lbndkeYYxJNj0OTGD3+UA9Kx/DFlp3j/4r3766z6ppenWYW2huV/cvcsP3p2n7xVHTHoGyPWgDgr3xbqOv+BNC8QTXdubbRNehubqKzyxuJTMGLSAj+FWAHqdx6YFfRklzcJNNfW9x5lndpm3MByrIwyHHqeVOfSvA9B8NXuhfE/SNMvrxGtPtMunynOTcMkcj2rS5zltruo6Z2LXoPwt8Swf8K70TR7O1vtc1rS2e3kt7eIqiNHIyqJJXwiAAKepOBwD0oYGj8Qr7yNDOkxyML/WHNnaLGN8jTEEudvcANJyeORzjmuy8BeHn0LSVN5sN/LGiSbPuxogxHEvbCjqR1Yse9c1aaRcQeKrS81mWC68YXsTRRpa8waVZg/OYw2DycKXIyzMMAKCK9JjRY41RM7VGBk5pAOooooGFFFV9Puhe2qzCGeHJYGOZNrqQSOR+H4jmgCxRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWX4qvbzTPDWq32mW32u+trWSWCDBPmOqkgYHJ57Dk9q1KKAPEf8AhPNSXQbSe38WWl4txc2keoXi6eFGkLIshfcOn3lVfn5X+L7wpr+OPFl7p3hyK2vbezmv49Vc3jWW77RHbBTFKqEjbuGfbnOOle4UUAeCRfEbxVb6LqN3dXlnPLJ4Yh1y3C2oQQSNKYyn3juHGcnv0xUGseK9T1yCaFtSi1TTLfWdJMN/bw+Sokd8yQgg4YLx3JGcEmvdNc0qy1zSbrTNUh8+xuU8uWPey7l9MqQR+Bq5FGsUaRxjCIAoHoBQB4fpfjnxXqnjC70uW8srJ3mu7X+z3jAngCo/kyIv33OQGJPykHjFYel+PvEdl4C8L+Vrscv2kzx3mp3SBjayoqFLeR3JAYliSzckEAYxX0dRQBieCtRutW8J6XfagbdrueBWla3JMbN0JXPY4zW3RRQAUUUUAFFFFABRRRQAUUUUAFMihjh3+VGib2LttGNzHqT6mn0UAFFFFABRRRQAUUUUAFFFFABUN5a299ayW17BFcW8g2vFKgZWHoQeDU1FAHISeFbqxYf2PeJLaKpCWWobpFXPZZQd6jHGDvx2xWLq76xaXkCweGJo1hQgywyeckgPUKV+bP8AvIK9JooA8q+CKRWN74w0z7O9kZNS/tGKzliaN0jmjUEjcBld6OMj0riPg1PL4e8T+JvD2rSwyX2mXiakJW4PlnNvLz3ARY2/EV7f4m0KTVGtb3Tbs2GsWRJt7nZvUq2N0ciZG5GwMjIIIBBBFeKa/wCFfFOk/FqDx9rdtpEGh+WllqaW928gaOX900mGRSANysRzjaTk0xHUfG/Sp13XmmSxW1/PEJraQJ85u7c+ZEQe5ONmD2Y11Oh6lp/hP4V6LdMwmjWygESw/eu55FGFQd2d2/NsnvU+vo914Fne4mht7rTgZHlkG5UaEnLH6gE+vIrhPgpIPFGoSXl68iWWisX0fT5IjHsinBZbk5+9kF0TphF6ZJpAel+EdKurSGfUda8t9cvyJLkpysSj7kKH+6gOM9zubvXQUUUDCiiigCE3UAn8gzIJsgbN3PIJHH0B/KquqQXfltPpTQreAZ2SjCTYBwjMASoyc5HT0PSszxHo0kt0mpacCt2oAkEeA0oGduMkDIyevYn2pmheJ7e7jkjuJCZLctHNJsI2uhwysMZB7++eM0Aaej6xBqUlxb4aC/tSFuLaThoyRkEf3lPZhwfrkDTrL1jSLXVhFIXeC8gO6C7gbbLEfY91PdTlT3BrOGt3miRMviiHNunA1O1QmJhxzIgy0R9eq99w6AA6Wio7eeK5hSa2ljmhcZV42DKw9QR1qSgAoorn/Evi/SPD08NrezSS6hcAmCytozLNLj0UdB7tge9AG+7KiM7sFVRkknAArzy++Kumy3txZ+FtPvvElxb5Ez2QVYEYfw+a5AY8fwbq5zVYdY8ciW78SK1l4etNk39jxPu8wlvl+0MOH45aMfKOnzZzXp2nafY2v2ODTo44rVA0gRFA3EYH/wBf8BQI5+HXfGF1brM2jaPpm59ixXN7LPKT3+WOPHHTgnpUbah49nmMBsdKsojn/S1jkuPxEe5CPxNdcGL6jIttGAVx50zc/wDAF98cnsM9zV+gZxOn6Drd5u/tDxvqUpU/NFa2cFrt9sFGYfnWPrvgu7SaSc654i2HISWPV5g0Z7MQMKMnttIrvG869vHER8m3hJRpQPnkPdVPZRxz1yD0xmm3ui21xZyQxr5cjKQsxy7qfXJOf1oA810bRb67iWDVfEXii+iX5cR3wgIYdi0SqzfjgV1UvgCIoEt/Eviq3QY+VdVduR7tk/rVq2uLvw8BHq8CXURKpHf26YycHPmqfuH/AGskHPOK0LbVP7W1G5tLFpoUs9gnlMWMuy7gi7v9kgkgEcjBoA5dfCmt6ZHM6+IdWukXlC962/8AEFHH6VlT654r0idr20uv7WsEbbJY6gkUTkcD91cRgKGzxiVVB6ZHWu91VdQ+WH7Mt5YEfvGSbZN/3zjaw69x9DVa0sdNuNSsrlLkSYR/Lt5AAdwwCcccr05BxntQBl2Hj2SW2judR8M61Y2jjJmxFOI/95Y3Zx/3yc11Oj6tp+tWSXelXkN3bP0eJsj6H0PsalvbNLmEphVfGFfbyv8AX8iK4PW/D8Sas93aSS6dqsYDfa7NipZQOrrjEg9mDDjqKAPRaK4/RPFM8F1b6b4lRIriZhFbX8XEF0xGVBH/ACzkIz8pJU/wseldhQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHgPjXxr4s0fxL4j8P6ddyS3ltdDVbd2jXAsFgaWSMcdNyhOecmtXSfiFqr+HdR8QR3UM6aprj2ejW9xCxBgUEDaFx8xKnO5gBjr2PodxqXhQ+Lbq1uW0weIIrMec0sSiQW7EnaZCOV4J259yKsTaZ4Y/sf+y57HRf7Ltir/AGR4ovJiLElTsI2qSSSDjnJoA8dk+IGs69aSagksmnSf8Ixq0rQW8p8sTwuVWRfcYyD2z1r0PUvFV1oHwu0XV9i3d7cQWUO+4chBJKEXzJG67QWyf/r1fs18Ix6ZLPNpmk6ZZo01gftMMESsrMfMQdtrnJK9+4q5Bq/hnUbq48NRTWE7QW8ZksdgMfksuVABG1lwOgzgY6UAeYeKfGPiXWtKsbCwmtbK8HiZdEubmzmdUn+QuNjgFlU9GxkggeprvvGfiS90LUfDmiaUtobvVGlRbvUZG8qMRIGO7HLO2RgZHetOzj8Kf2RE1mmh/wBl6dL50ZiEXk2sgz84x8qMMnng8modM1Hw949sdRi+yW+pWVjevaSC6hSWJ5EVTuXOQRhxg0AchdfEjVbTxJZeH5bDT59T1E2jWMtrK0kEsb7vPk3eibGI9QRWPqvxQ19x4jtI7ew025gsr2ex3q8hcQqT5iSANE5wCduAAcA5rv4NH8Ny+J7fXLa9tzLoto1jHbQyxCCzUnltoGUbA28nGO1O1R/BfhOC91W7t9HsBMqrczRWyeZKsjBRuCKWYMT7jqexoAueAb+/1TwdpN7q0ttLez26SO9ucq2VBBPAw2DyAMA9K0PEOk2+u6FqGk3oJtr2B7eTHUKykZHvzT9Gs9OsdOig0W2tLaw5aOO0RUi5OSQF45JzxXG/GrxHc6F4QFnpEuzXdanTS9PIOCssp2lx/ujJz64oA4Lwi158TbmLSdR3W2g6eyrrUZP/ACFL2DCNGhzzCNsbP6kge9bOs6taeA/Fr65qsrpaxeZp8wEWGeN182FIlH32DrgAdPNboBxY0XR9L+HeuT2MJEOnWemxamskjHGIw0N03uSvlOfU/hXJjStR8f3EHjbxIHgsb4vbeH7NkyLBWH7m6f0dmCtnsMc44AI3dZ+KfjLSdI/4SW/8DrY+FUuESQ3V3i9WFnCiQxAYXqPlJ/xr2lGDoGU5UjINeI+PPEX/AAnWl+EvBloFbU9bmjm1aNQSLWC3kzPu9P3kZQZ64Ne3gADA4FAwooooAK5vxT4SttbcXdtcTaZrCLtjv7b7+B0V16SLk52np2IPNdJRQB582r6t4ciMevxeUAMnU4UL20gAABcD5ozhRw3GScMa6bRfEVlqagxTxFWAZHVvlcHuD+n1yO1bdcdqvgHTZb5tS0Rjo2qHcTLbIDFKT/z1iPyvzznhs96ANGfwxarcm70e4uNJuHcyyGzIEczEcl4yCjH3wD70otvE0SnbqelXB7ebYuh/ErIf5VyX/CS6h4VvHh8U2xt8oqrqEQJsbhuMYJOY32rja3U9Ca7eLW4Gk2SAjKCQMDlSNpY8+wFAHN+KNZ8S6NZRKs2hPqV5ILeygMcuJJCMkk7xhVUMzHsF9xVHQPBJ0xtW1G+nlvtTvpQk1xcqAXJZVLAdlwAAo4A4+ufAx8TXGqeKGjWeAJJp9irjHlpER5rA9tziTPtGtepTRx3VvJGSCrjaSD0oEZjWim2OlWjCIbMzShQSuemM8Fvr0AqTRbee1Rre6VpPKJaOc4wQeoHceuPeqnh/UGaS/S9BjmN7LGrHo4BCqR6ZAHFbruqIWdgqjqSelAyh4el+0aPb3ByTcAzHIwfmJP8AXFaNc1otw+m2yW0iHy7cmEhTwOTtx+PHsGWtuHULaWB5UlHlou4k+mP/ANY+oNAENrJHp9ukV5LHHJJK5UFuWLOSMfnWhVCwVN4nl/4+rld+D1VBjCj0AyPxJp+qSyQwxtCHL7wNq4+bg5H5dPfFAE91AtzbSQyZ2yKVOK5yCwMkeraHLPNam4gBS4tB5LrlNhdGHRgVzx0rUtb92CmQB0VRvZewP3ZP90j8j+NWdQI8qOQKx2tkSJyY/wDax3Hr7UAeYeG9X8R/D/XIPD/jm8fVtBvJPL07xA4O5JCflguewJ/hYnnp9O5120t7a8t710zHJMiM27HkOchZl44PO0+oI9Ob80VvrFhPYanbQ3VpcxFXGN8MyHgj/wCt/OsDSZWs5W8KeJF+0QyIUsbqblbyHB/dsT/y1VRyP4h8w7gAHQWOob52tbvZHdoSMA8MOxH5jinayAbUbsEZ5Dfdx78H+n1FYFzYyWUSWj/aJFhRFhunbIIXgbzjhhxz3wDxzW7Yz3MbNHextjI/ejlcn+n8unoSActqOmWmtW0unXkf2izumCyIXwyc/wCsVskhlIBBBPQc9Ki0fxLf+H7e3tfFTJc2SHyRrER5TBKg3KHlMkY8wZUk87c4rp722t7u9RzdXdncKdi7DsDn8QQ361De23kWgtrlBOoJ8mQR5Yk5yrAY5IJ5GAfTsQRuqwZQykFSMgjoRS1514WvG8Ka3Hodw5OhX0hTTXJJFpNyTbEnopwSnTGCvHyivRaBhRRRQAUUUUAFcTpfjxtY1qa30fQNSvNJguzYy6ojRiNZAcMQpbeyAnlgPWu2rg9B8D6n4e1af+xvEjwaBPetevpr2SOwLHLosxbIQn/ZyB370Ad5RRRQAUUUUAFFFFABRRRQB51rvgB9T8f6jqrwaZLpmqaUdPuWkBFxC2113x/KQSQyqSWBwO+K5TRfhJ4givdEudX1WxnJnifWERnInS22C2VMqM8J82cdTjNe4V598Q/G9/4f1j+ztMg08PFpk+qyy38jIjpEQPKTH8ZznnoOxoA5XWPhXrdzpcMVtJpv22LUr+8inN1JGYlnYFcfumVuB8ylfTDDnNqb4V6lJc6kpn0jZqOixadLeRw+VLBMkbIWjjVduxsgEBl+XjHSrPg/Wta8T/FKS5muJLbRoNKtbyKxEzLt8+Nj864w7Ak5z0wMVY8Q/Ei+03xTqFpDZWTafp19Z2M0ckjC6na4AIeNemBuHBznB5FAzAt/hNrC6Tcoy6PHdtPZTmL7TLJb3n2didko8sbVIOMAMfeu3+H3hTUND0jxHbam1lbzarqM94g09mKQLJGigAsq8gqe3pWHZ/E28l16/wBJuLK1t59JF/Nqkjs+yCGFVMUgwCSH3j3wDgGsSD4w6vHpOu3FzpllLNZ29pd2zIWjSWOeZY+QSxHDZB4PqBQBNpXwm1WPTbu0urjSbUDQpdGhks1fNyXbcJpgQMEYHA3cknPaotV+F/ibXbHVBq8ugLdzaZZ2dt5LSsivBMHy25MgMuRkc/MRj12/FfxC17wrfWmm6ppFhJqWowD+z1tZpHjluTcCPyixVTwjo5OB3Hpn1JN2xd+N2OcdM0AVdIhkt9LtYZre1tpEjVWhtTmKM4+6mQPlHbgfQV4v+0fqC6D4q+Gmv3ySHR9P1RzdSKhYR7tmCffAYge1e51l+JdA0zxPotxpOu2cd5YXAw8T/oQRyCOxHIoEeLfH/XtP13UPCfh+3QXemX2zUNSvbbDNHpvmICVcdEY4LEdkFes32njUPB81hErxy2yGKMRMAytGcLg9sgD8DXhHhz4caT8S/H/jqTUrq/ttL0eWLRLGGym8sLFEm0qcg5X5VOPUnNey/DO9nl0m3hvAGu0Rra6fdnNxbt5LkjsWVUb6GgDD+G1jpNv471nVIbPy9U1u0iuzOUKk7D5c6Y6A+YFc46+YDXqVeaanG2i6/JKhuAmnXS36HghrabEc6f7q5V+f7ntXpdABRRRQAUUUUAFFFFAEF/Z22oWc1pfW8VxazKUkilUMrqeoIPBFebavYy+CE3TNJc+FvmT7U7lpdNVs/wCsJOXhBYgMOUHByOR6hTZY0mieKVFeN1KsrDIYHqCKAPP/AIQvbal8N7CGCSBpoJJw6qQwDefIOfZhn6gmtO3NzpsEli32geSCqtuJMkajAZT67duSf4k5xurC+HNjZeCdW13w5bwvBp9vKstszZIEUmXUZ7gM0q59E5rrvEmo27afdWSTbbiaFwh6AkDJGfXFMRkW9hqMfm31zEVjulE5hgBLwuQNwA55OFbjIDLjvmpNOvprmZ4bEC5R1AYZGwDnhv7o7YPOCB1XnatNaidWWfYkqMchXBG3IG76YOfwNLqOsw2tq8sGxyqeaVY7cqOp/LJ/4CfSkBQutIuiUSwuCt4ifPPcL5kRBAGxlG3dwMdQcYyTxVd9Cu4y1xNLAWwqnbubjIzjJxk/3iDwPXmtfwtdrqGh22oKCDeL9oIPUbuQD9BgfhWtQMz9ZiLW3nI7RvFk7l7KRg5+nX8K5cX2r6nrM9rbaeZLdFXfdFwkSvgHAOSx4KsCoP3RzzXcVQ0ZSLeffu8z7RLuz/vnH4Yxj2oAp2WiypIJ7i6xcDOFgXbGuTk7Qcnk8kEkZ6VdW2uLZ3eCYyocnyHAA/4CQOPxzV6igDmJwy60jW7ywRXWYpB90xybWI74z09j2zVzW9Ki8S+HRbXDNGZUWVHAIKPjIbsRg+hBHYg81e1Bo7do7mTaAGVH3HjBPB/AnP50mlN5ay2jgh4HOMtuLITlW/p9QaAOd8Ba7c3rahoOujGuaU4jl3D/AI+IW5jmHY5HBx3B6ZxWq12dIv0tbnnT5yFt3xkxsTjY3P3ckYPbOKwviJoWqzXWn+I/DF0YdX0tJFaHZuW7hYAtGwxk8qCAOfQgnNW9N1rT/F3hKa/Ee2SKNhLErB3gcANgEdf4WBHUEfSgDpL8JJZSAvhfUYI4Pfg8fhWTaZuLY2VycpLGdpj+6fQrzxjjocfTpUFnK2o3MltLM6QrAZC0f8RJGSeMHkMMVdi0eyuoVffJLaSIpVFcqrcfeODyT/KgDitT8PXuveH54mtnFlNFvhUTmV45F5RlYkMpDAEDnGMV1vgXW31zw9BLdlBqcH+j30agrsnUfNweQD94exFV/wCxj4Wtmn8NQv8AYkJebTQxZWBOWMW4/I3U4HB9ATmsl/I0z4i2GsadcQJp+v2oiu42O3zpFI8mVM9WwxQjuGU9qYjv6KKKQwooooAKKKKACiiigAooooAKKKKACiiigAqhqujaZq4hGradZXwhbfGLmBZdjeq7gcH6VfooArxWNpFezXkVrAl3MqpJOsYDuq52hm6kDJwD0zUE+jaXcanDqVxptlLqMIxHdPArSoPRXIyPwNX6KAKa6Xp6Xt1eLY2q3d0oS4mEKh5lAwA7YywA4waz4PCPhu3glht/D2jxQyhVkjSyiVXCtuUEBeQG+Yeh5rcooAw9Z8M2WseINE1a9edpdIaSS3hBXyi7qF3MMZJGOORg1uUUUAFY/jDTbnV/C2qWFhdS2l5PbusFxE5VopMZRgRyMNitiigD4s/Zin8Q698WZYNRvrySzglm1TUIi5CyXGNis+Op3MDg+lfRyn+wPiRqtuqEwalEmtREnADptguFH/ADE/1zVf4ZeAB4U+IPj3VhCI7fVLqJ7XHTYVLvj/gbsP8AgNavxTjW0tNI19oxImlXi/aVPe1mHkzZ9grh/wDgFAFrxxYQG50/UJo2eAk2N2FPDwSgqQ3qAT+tX/BE8raEtldBhdabI1jLuOS3l8K5P+0mx/8AgVLPYLrHhW70qZTu8t7U7yfvLwrZ98K2fesDwffBdWs7iceXLq1v9muQzZJvLbKn2JZNxz6RigDvaKKKACiiigAooooAKKKKAOS8d6VMfs2u6Zbvcajp4ZXgjbBubdsb4x23DAdfdcfxGuYub6CeTQLmzMdwl7fwQb3DYeJstnJ6nCgYOO30r1SvOPHujy6KsetadB9o06C9gvbu0RCZIQsoZ5YsexYsvfkjByCAbepaXcWO1ra3a6toySixgFol/u7cjcMcdegxjvUOm2moXFxaGGCWC0HzmeRtrjJGU2EEn68Dk+vHR6LNHLZKsT+Ykfyq+7cHTqrA9wVIOav0Acb4cvH0kLYSQKsYLKQG5SQdAe2Gxwfaui1F2vdBu2s2/eS27iM+jFSB+Rpt/o9re3BlkWRJCuC8chXPpkdD+NUNMt9V0+5FvPd2kySsSHKtvYDHzbRwDjrzjODjJ5ANTR7pLrTrV1ZdzQo5VTnGR/iCPwp0itbTtNFGXjk/1qr1BA4YDvwAMfSsQI+n3UtuCyEbmhfaPmjPJUepU/Nj2b1q5Y38xBSQlpQxcDGd46lB9M5HquPegDZRg6KwzgjIyMH8qWsf+1Sl0oYNJG65RY1yWXswHU+jDtweBWwKAMTxJZiaNZVmWNuFwzAA88Hn0547g/Sq18L9dMtL6yAmu7b70duwbendefvdOnH5810TIrEFlUkdCR0qpdW1rHh9pgd22iWFcEMehOP68UAS2F3De26SwSxyBgCdhzj29uQR+FcFYRReFvi1HptlA8Wm67YyzgDlFuo5WdsDtlZGOOny1fMEmm+JrW+t4jmedra/EONrFlykm3ryRz6HPqTTPidp10JfD/iLTzMZNDvlnuIolLtLauNkwCjkkKd2Bz8pxzQBPrTyWuo3MkylBGG2TL0WFgN3yjuCSc/j2ra8M3qzaRCknlxy26KkgU4Xpww/2WGCPr7Uk6wazZW2o6XLBcoyb43UhllQ/wAOemDyPxNc/pmn6dq2tzQBmEVhGuxY3ZGy5J2tg4+TGNvTJyetAHcKQwBUgg9CK8l+KkMul+E7+MPNPNZzLf2lww5h+bzGGfQMvA7A47V6LBb3emQENezXsAzkyqgkRcdiqgHHuM/yryn4um6l+H+oslxI08xUEN1UmRVcey8cdv3lAHtgOQCO9FAGAB6UUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVT1rToNY0e+027BNveQPbyAf3XUqf0NXKKAOC+FOo3Fxo8Nveq/2u3V7K6Zmzm4tm8liQem5RG4+tMu9KuI9f1azs0USl49Z03ecoJl+WVfbdnB9pCa1rLQ7ux8XateQrEdPvXhu0w2GScL5UoxjoyBDn1Bz2NdTgZzgZHegAU5UHBGR0PaloooAKKKKACiiigAooooAKRgGUhgCCMEHvS0UAcCkUvhHUo9NjPl6RcnZpsgH+qbJY2p6DA5Meeo3J/dz1dvq8ToDIrKRjJHI9yPbofofY4s6nYW2p2E1lfwpPazLskjccMP6HvkciuF1KbUvCMTnUYbrUtKiVmW+gXfJGg5AmUZO4f89ACDglgpJLAHcxahBNDJJC2/ZkbRjccen1yPzFYlnrEc3ihY2RcPZBvMU5UYdsgfgAfxHpXOW+p2V9HFdWNzbvbyqCsyzx7drc8HPBHoT3x9b5sbm2kW+vbcRXpZ/Nkj3FChYBGPYNlVJUY+9z3oEdpNFFdQgN8ynDKynkHsQaqro9n5jO0bOxGBucnbzngdv8jpxVC0vJEgR1b92Qfl67PVQO5Xr7r9KvpqO4hdmWbIXnAZgM7c+45HqKBlpFgglCIqRvKS2AMbj3P1pYpleSVOjRsFOT14B/rXN3z3OsXlra24KpDI0jXaDIiIHyjGR8xDYI/3geCDWlc2UsUERWQMwjWOSTbg71+6/wBM5yPQ+1AGvXP6vK88fyKwSUbCrNgBgcYOOnPBx2Oe1NXUJDA0U6uwP7tl3fOuDjqO/bPY4PRqnaUXlsIptsgGA528EH7smPQ8gj6+lAGbDDJf29w8bjzJ4lZhGed8bjp7kH8zXT2UwntY5Q6vuH3lGB+Xb6VFptt5EJ3ZLuSSSMH0/pXP2sp0rxNDEkrPaahuUhmztkXO1+e5AKHHdVPUmgCLQzNpHjrVNJW2MWlXsQv7V92VE2QJkUY4ySr49Sx710UNqtvqc0scaBbkbnIHO8DH6j+Vcd8Ry2leJ/Bevid1hi1H+zp4tx2ulypjVsdMq+38Ca6u6M0WrwbTiKQ7uT3xtK4/FT/wE0AWNV81bNpYMmSIiQLuwGA6g/UZ/HFeY+K9KXUvHWj+HbYEW0sovbtCMr9niKuee2XES478+lej61dmFVhUjMikt9Mgf1rmfBsBv/G/iXW3AKQrBpED56+UpeU/9/JNv/bOgDuaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACqurX9vpWl3mo3rlLW0he4mYKSVRFLMcDk8A1arI8YaZNrXhHW9LtWjS4vrGe2jaQkKGeNlBYgE4yewNAFDwx440PxJcrbadPOl08Auo4bq2kgaWE4xIm9RvU56jNdNXmXgzwPrdrrPhu/8AEcumxr4e0z+zrWKwd5DMSio0kjOq44XhQDyetem0AFFFFABRRRQB5b4i8DwaLqTarpWk2d3pgLTvZpaI01tLncZIuMsrc7o88dVBOVPQ+HvE9vqOmxuD9rs7iMNDJjh06Mp4+8B2PJ6deK7GuX1rwsJZ577RphaX0nzPG+TBMwOcso+6x6b15wec8UARrb20d5bDTr2SMXDH9xKhkQ7RwQQQVIxwc9COxFO0q2/tZ7h3vZBaJI9uYFTYXKsfmJ6jkErjGBzntWDpWpT2erLDr1q2k3Ko2JpwGtmkIIXypcYJwTnO09RjBAGhot0gdmS5MqyqkyzBg69ACVx12sDn23+lMR2dvBFbQiKBFjjXoB/OqzXnl3SRzsqKYyTkdTuAz9P8aoy6pMgZWVQSDnIztOORx1H8Q9Vz6VVngW4sUkibzDbsVMQ5MaHscfewR+Kk0hmpfaSlxjy38vjBBXcpGMdPpx7jj0xJBZ28E8aJI4mClsbslh/FnPXJxn3rETWjDbs/2gPBgDeWDMMcEem7+uP73GdaXN/q2u2Btt6w2hLyzkHa8Zxwp759D6D3wAdySAMkgD3rk7i0F9r9lOHikS2uA5ifhlcq3zr9QB+IPvVm61SSR51DIyAbkA5WRCMkfiBnP+8Oq1HolvHqOppqEbGS3h+aKYjBkYqy9e4AZsjpuJP0AMj4x263el+G7bJ8yTxDp/lgdysoY/8AjqsfwrZ8W6mLa80y2hBN35yT7ccGIMEc5+rrx7isbVJTrHxm0nS3YfZNF059WKgZ3Tys0KZ+ieYR7n2qXx1qEVhq1hdXas8cLYhto2DTXkn8McadTliMnoNuegJoAqeKtavLe/lazj8+/uXNpptmW5mlxncf7qLguxPYepArrvCeip4f0C005ZmuJI1LTXDjDTysS0kje7MWP41m+FPD1xbXkmta20T6xcR+WIYR+5soydxii9cnBZ+rEA4AAA6mgAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAIDAggEHqDXGax4Qltna68JywWE24ytZuuLaRzklgF5jYnGWAIOOVJ5rs6KAPOB4nis1ht/E0LaDdfc23R2wnHOEmHysO6kcjoQK6LQiYGlkt0W6NwAIzFFsRVXOMyZwRzwBnHQZrobiCG5haK4ijlibhkdQwP1Brn5vB2nDnTJb7SG3bv+JfctEmfePlD/AN80AGr6bb+ZBNe2FpdyHG52hUlmzyvPqD8ue4A71qaffW8kKJEixKpCbVwAufun6Ht+XWqc+jX8wKtr975ZGGQwW5BH/fusm78M61BMJdJ1uGVGyJbbUbRXSQHqA0ewrng8huee5yAaOt20drIJ98Plbt/lSDPzZycDuCcHtg/NnsYvB19F/wAI0ii4El1FJJG6zvtYS72IVvT246dM1zmr+DvEGrXHmXM2iqwiEKTATmVV5OCwZdw5OO+CQSc1o23gATxQjX9Wur4JkNDbj7LFKCMbXCku647MxoEYOl+IZP7b1a20K1/tzxfdOg1CaLMVnpyrkJE0rLkbRuIUAszFjgA4HZeHfDb2t62r65cJqGvyKUNwE2x26H/llCpztXgZPVjyewGvpGlWGj2a2ulWcFpbr0jhQKM+px1PvV2gYUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAH/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (C) Alternatively, the cyst wall can be grasped and rotated to separate it from the ovarian cortex. (D) The cyst is removed and the ovary is left to heal by secondary intention.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William J Mann, Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27577=[""].join("\n");
var outline_f26_59_27577=null;
var title_f26_59_27578="Neuroendocrine chromogranin";
var content_f26_59_27578=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F70724%7EPULM%2F66047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F70724%7EPULM%2F66047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large cell neuroendocrine carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 262px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEGAYEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDubSOGz8yCC0URupYAxjHHbnjOMYFdHo2nbPJd02Ku7EaqAX9yo4GOeetZ0NlLaxwyWEc966tvCvKY4VxkAFRywzzgnsM9KSTxBqImhj1JIbf7SdgRIA0kqgctwflXjoc9K9Rxc7qnt+L+R7Tba93Yw9S8QiLx1d6fdRy3OlRRBLqCO1Z2bPfOMAfN1BH3Tiotcm8I6RfbJptSsFGUWKOV5WkTryvJK56DOcjjHStyzuJLwTiK4kkuJJAyl5cqQAc4Pb1xgZqK6spBqQ3t8soBWEIrxliV+YE8Ar8+eOhqI0mrwcrdf6/zKWj3NDwv4ksddtI00Rp3jjjKpJJG6hcHAZsjrxnB61paM99Ne3S6haW8MUcu62ljOSV55IP3T/PNci2/RboXUflo+DlLbIEnIH70DhmOcg9cHua7nSpYZ7OWWIlbg/u5sncQcZAP4dPrUSpunHun1IkuX5mdDq/9q6Hf32nzW0cNg8ouPPBEiFR1Kkf3R+OcVw/gjWL26OpXDafaJBdECANGwliUZ5DHqD1PTt1zW3488Pyy2EzaGYNP1PUR9mNwwO2UkjJIxywUcHHWszT9Bm0fSbbTIZzI8JkW7LSnIck5decEZxgnpW9KUJP2aWj7/l5mkGmrAdI0vWNBj0mSzMOn28xkigKeShdG7qP4cnIHfmoNb0uPWYFtNUN7dw6VJ9ptkkJjMLHBKh8neuDnvgjFbemXTLbq15ETPsG9kJdSR2yev1wKr3t41skVzcJm2ljY42k7QTgj64AP5+hraNNKbilv/Whdrss/2n9uu2ntxHHcsNu5UBZdowF6fMMckH8etZ+p6pFDrmnJqRtkjlRmeaePBRFxlzjsCRnkAA84xmi1gk89miuFWAyeYMIqFcgYJ4yTwcE5znBpvivQp9Qu7G//ALRt1t7WHEkRRmO3eD6d/wC7kA45FZYiCh7tNb9txNKOiGeC766vr2x1vVLq902zVnS10Zb0iG4GMCcBuXznIAOOhHWu18Q2fh/W54ZJzDFqduN0Nw0JWUD0yOSO3fr715t8QdHudX0TT47G8lnbTLb7PFbSqqq64wzAgbvMwq46gY4wau+FDd6zomnMzxyyWk32NZkDeXdbED71k5UsDuQ7T82wkcHFccJuFW1R8rd7PX/g6fMz5NebY828S/FrxFcSXOh+I9KhluZpozBaTW/kSlWcEKSDwCOucnp061674e1ebToda1jWdP0j+ztKhMiS2kKCYHcACduWHy5zn049rmu6dHfw2QvxYXeowtm1hvYgHVyODDM3zAjGeD1xxUHhaK2totS0+8tI7SPcY5RIob7QhIBWQnJ6EgD0x710Q5lRktH8vvaX3dxK/K/wKmn+JNI8TajeR6Rp13ZalCiXSsqnc8b45OPu/e4B5IP4VQutO1LVNWlu9NvTBfPGtob2AsyMgO4iSNvuFW4+UZOWz2rpNDvry88SXmhTeBr3RdIgDLb6opCxybeFLHaCQQOAGOOB7iwbvWE1HXry50+O2t7aNY7G9kUbp2wei91BwMnrRKHLJNRSaSa96+un366210JhUvpY2NKe/tre0tbuKK4ljt1WW4jXy1MgH8K+nHtVTXfElnpFzaRXIllaVgNkQ3SAHJ6Dk/dPT0q9pD3M+mwSatLay3BGxvsyYjx/f556cHHTBrE8Qi1dtrQfZLkKY1uJcnzCFO0KoPIJI6c8e1c8eVT99Xv2HGzepzPivX/DupaVqckdha300J+0/Ypo977lyGBKHgjjLA54qrYfFmIR6dZ/2EvkzRj91E7J9ljXAbzMjJAOceopbDSNN0+eGeT7RdXsga1mY/ufKQ4fGB15UMCT2FQaHp2mjVL6G405ftbI0kMu/a1wind8pU449Pyrthhpe8nrHpe9/VL+uhs4pjpltPEfi+XW9StPsv2Iie2mV3jS6REAwY26smchwBkH2OYP7I8NaldzQ2l7JETEGEL2+6KVM5DDJICAtwq4HtXRJc209vLhZ1jRTcgT9Cr/AHlU9senYGsjTdPkuLpxbufsXmjZEka78NyQW/hX1PP/AAGpVJQve/bfZdhqyWuh0unaVby2sen6xbWdzHZYa1e4jVt3HQDkZHGenXtWd4p1ufw3rg1l7G4WxmVYZYUCmPIGQSV3EKAOuM/hWrqNqUtJFtfLbI+67ZU54IzjPesHw1qNzPqBtXhWC2IxKHB3FuQD8ozyenYA156cVNc767d11M1d3kc38RorzU7XTNY0kXssepXrTRahZEmZFdGDW7DoGBG1T0YKNpDVy3je6v8AwkItM1D7ZazzRDymQqpMJIDSNzw25flPY5Pavcz4fubG6W5s7gRWwBRrWM4Cqe4HYggZI5x0rx/x3oMNtJZ3moI13ItxItyYWMnlE/Migsx2g5J6dT05FRiYzqqUoSta1l5evlpcnmlZqFrnQ+DIZY1tXsrYJaTWsZjaeDl9vSUsR94sSTknrwcV3MVrLCVSySJgg3MCQMsff078VTnY+INAtbXTr97RkCSRyPblQX24KY/iTBIPPXgehs6Wuo2lulhcqj5CxG/izuDfNkiPHCgAAHv6V1QxEHFS0T2svTftr+Zbl3MS403VBrTzz2dnNfR7Xs7qX5o/tDZJL+iqq4BA6kDtVu21PVBqkWsNrs6Wyr/pGiLArRs23BIfAYKCc+vGO5rc8ZWN6v8Awjf/AAjU6hIbzddbgH8yBlw27jv/ADPtRZ6Wn9sHzY4V8rKoFORtPU57jFFKMaSdW6fN007+m9uxnzKS1MTw74hXX/El9ZJpNxpQihWVrneGEuf4TjhQR0HJPPTFXPGSXllBHqGlaPDcy26mKVioYNC3XPt6/SugvJLfTX+ZWaYlzAqD/WyBMhO+0t0B/LrWP4E8Q6r4r8H3OrSRR2Ec+9LMBf3igfK+8nhhkHHHG3vnjGjzR/eVLNJ7Pz6W3JcuqF0u4+1CG1kQvFIY7iNYpNp244DAc8EcDv8ASptV1+xtZr2NL+FZbX5potmWB9OMZHXOOn4V574Z1bUo3utG1GW3S+eeQ2140SiVZF5y56gHA28dCO3FQald+H7fUVuPEdrLNc3UCyTwWZaSJHc4WSRgPl3HGMED195rON5R620tqn69tN9DXkW72PRYrXSY5pPETx+RetAPNPm5VUPX+dc/batH4v12KztBBJJbIXaYLhnTIwDnj6AdevSsbVNPeG6tZZ5HaC6jJlgdeCnQBSOAFIx+X1rNlt7Lw7q8smmXVxazJlysUfmCRgM4YZGBt5znoBx61VjVgo1oO6S122X6ISVtX/wx01/4Um0hrqbSogZ523tI0/lu/ou4Hp+P6Ve02yvbK8ttb1tWm1BEZXaMgmNQBgMRy3QjPPNZT/FbSo9MikuLG6vnLKkhtYgWEgGcBWIzxXU6F4q0bXNMN3bXEUSTRFtk7qrBSdoJAJAweCOferq1pVKa9or9b/8AB7Gbclp1Of1bWdK8UzX2m6deyrqZjEoDDYGXPUHvj09a5m9s5PCOo6epSbO1WN3MM5bpjHTHIH49q9BXwxpstybyxDI7LteePGWU9h7H2rft4oJtPigkV823yrI4zjPueDwOn0zXRTxUKck4r3bar5d+3kPnSZ4/f2beKNUluNEuEspEVBdCR9mx+mc+uBxiumv/ABJDp6vZyXf9pTWyg3snlhdpHIKkD5u4Gam1jwdaOqgPHZqTuLLkhjnqO+RWRoem6ZDq0n/CQeIdOthKBixJCMynueT19M10+0w9RRVm0ulv1S1/DzK5o2E17UF1TQ7bVdIuEWIyjLsvmcKcgYPRhjIPbHGKxdW8XX9jphlt7yG4mDK0iXFqkjIMkK24+mT9PatjXtf8OaZpUllo9k91HNmOKJh5aqefmGDkcY/WvObae5GjXcptsLPi1UkgiQbskc9jiufFKUqLglyq/u33fWxM56Oxm3+sX1xco0kNraz5CC4iiEblc53Z6DGOn06dtddG1vWNNVbLTIb2e5XEqhEAXBz8rHjJySf1rGuPB+q6fbww3rL9kKefbtAdzMCSRGxGeRjp9fSvavhY9hoGkWUkjMlw4xPCvzfeAAH1GP1Nedh6KVB4mCWrtd7/ADT+4iKcou+z/r/gHgX/AAhXib/oWYv/AAFhor6w/wCEni/6B99/3xRXH7N919xyfVP7z/H/ADLNzOthZP5KM7AAlVPbpz71yepQT6pqEFzE1wqQhJXEI3sUH8BHdCeTjkHrx0cNSluri7VBcIi4UmQYRgxwO+GB9uQfxp9mpMyzoXheIFWTOGU5+YNg4ZT+n419JSpujr1/r+v619KMbIzJYbyK9laNUWORgYmVjuEgzge3HGfw6mtvSp7zfM10jQJDFIiwBVUNKSvzkHJzwQDnactxnFVL2KTy5pY5UJ3BmikO1AwH3AeoBySD3yKlMEkc0V15zOnlhWkYhjjGMAd84H5GtKklOOtipajArLrANteATlXCwDIR2zkjpywx0Ge9afhQ3dnrN4LiAJFdRgvIpGC47nB4z/gKrmwjuJVkhmKFlLJtI+Y/3gSO2e3SrLyPDKmZI964VTISSzYx255I6VjVkprlWuhM/eVifxbIrWv2eAol1LGblFkbJRY8ZIx0ySBj3rAuIbu3eC7ubWc6bcL5vnhMmJ+zAdOvY8Gk1ayAupNaVpL3zInEJDeakCkAtxnGCeff07VmXUh08tLLqk8ltdIJrmGSYqjRv0EX90ocYwOcY96mnemlro/zCF0jodOdJzPJZTWhlEfl5yTh+cMVPTHHPNPmWa33oixzoPklaVmAMWBu7H5gQCucZzjIyawdOWy02J3s5IjKcFjMAH6dmPHoP61raoLm4jWNJJGRAhKOrMcHOcdwcYwe1dEqfv76PuVZt7kDXMME0sj3CWtmqCdbuB9qvGc5YjAxtIOUPcY44qq+oS5jubiFHe62xfuiWRyVxlh/dOB6n3q1aRKLKS1vYoGR53Z0kYA+Sy87FPBOQvDccH8GWcMg1HUrGbT5bCK2WFbacAJDcIUJKIOSoXCg8nk9Bjm+aMb3/pf1uHMk9SCws72O1sSzgSKI3zaHMSnqwUMM7GyfcH0PNbNr4Re+/sK50zVbjSbGxLM1taHEU6lzuRk+6M8nPbOeDTzC7Qg25AMQwUB+9GevHcDnp17c4pLqe4soVgtWdVbKnaxwGPK/meCcdOlcs5yqSTi9dfx/r+mRJOfu3L1mmiWlvqtnqMgvNSkUyXfmozFUyRGQT8qqoIwFIx9atHTIbq0t5o5Fv7IqrrIQUkCgDqR1HU4PSuJt9eaLXf7Pk3SWV4pVpJW3IX2nsOgJAB5+orpvCfiC0t9Jjg1BbqS4izvkcAQKCcDbkjC4xwenvWFTC1aMdEyZwlHXcn1jXotM0mG2u/PZJphFDJGu8qw+YZ74O3HfOcVPq9+NV0RkjmMbb0DmNdxQjnj+WPeoNVtdOv7eW5MEV3HA+54kOJopFPyhBjk8nI44zzxXHyXcen3UMejtOxvZnFvJbsPJLRD54dvQOApLbyDjpmuP2rpzTfcIxW6OyuNTsPDmm6Xb63HPbR3J8kSRoWjt2J4DsOQOQuQCOefWub8Qxz6x4g0fVS8g0vS0l+yQqx3CVlCrIWIPy7Nxxjr7V1l/DpupaNaXMrwatbRsJ4ZvLDc45ZQOnPGPoK5yLV1W6MU5mdgu795H82PUg4/QfnXfQiprnitev/A7f15hTSfvGMtlBaXcsZ1Rnkmi3PBdSYO12wSj9DkngEL29q3LOwiItvLVALZv3RAwY2B68ZByCc4OOfyhlnsvLaW6hiw4DKuM7gT8g+Y4DE9Dn8KzNKSXerafcJaxKqlYprhvLPGAOoyD1HA6ccYratKrJcyWn9f13NW20bGo2amyuordmMrKJI42J243AnnGT396x9EtrzS9HnF0VaWWfcio3LIiABT77j09s1oPpGpa94itLG61CbTrSG2kka7spPLld2KgqjDvgZyc+pBqzqGk3Vrdi0heO+W2VfIu7mQBmJHO4gfewDkgYbPSsaGLbvTls3uxRmtmyhaXNyLd2ieQxzThFRVxsCrlvvdCS3/jvFF0hkndbYJFcyg7JQ+xZGUEqG6jBPGQMitNWu4dRtRsD2jQBpJIVPlq/Rx09RnnHGD34mjS3kfIAXZxkAgcdAB+ANVW5J/EtxOSILLxC13Bol/a7rKGa3BawvEaOWWZ1GFJ5CqOcn6GuJv9X1S18Z6lct4VF/ptrlZ3RgEyQqjc+35kXBwzc8tj0rstZthqKrHbOXgcYLKc9CeDketU7FrjTLy4ayYtC0IR45AWR9v3DszjA5/XrXFWwc6sE4y1XS39fiKHurQy9N1a50jTINPe+Nlc3d3JsedwYi7k/u4WH8C4CgNhs9QK6fxSmoJ4IaSG8gj1SIZJzh2I7IePmz0z69RiuKtJLvxHYjTNQBK27R3bXQQDzmeQtuHA2sWyT/Suoub+C4jWN3hfB+zO6xbW3JkYXjjGf19Kxhg6zg4bfPyKkrtNFD4d+Ohrtta2V3HObqUeQ04hxvdc5JI4xgBuOmcV6GlqGv1m+VpDF5W4Lt4znkev+GK820bV38JRanYW9hJPfTCZtPuo4g6QNsJw49MgYIyT3HFdn4bF7puixS6xeT3dzdMLlt4B2fKMxr/s5yR35688ayptK87J6afqYzTuHiWdoYo91vIFdzGbhVPDcbT+fcVzMM3iePSdU0mfUriQkCOzdrWNTFFuAZRgAu6rkBiSDkZFYnjvxPE9+32uDVAryxeXbkbVVcEFVIyrMT0Bxz3rpNL8WJf6VbqkOzdH+4R4y7RnkfvM9wQeM00udezSu1940nbY8ls5Lh7nVNMXxEt0ZQzwPKiQSxyfxh1I3Ddgg7eOdw61Q0XRNVv/ABe1jokRsNNuTGZ7RWaYP5ZVsSE464zx/wDq7r4jaBpM86XLabJPOlwrSG3cQlenzIxzg7jk4xwD3rU8N6bf6ffvbSSXyRyphbi2u9ssfXIyR6EHIxn8a4Pq9enK8Y8qeumunl2XkV8SV+m39djl7668V6BPrE1/BmFLj7PHBI2/Yilj8o4IGCMEdj7V1ls0f9oapFDDDHeSxJKsxjxIqHrGSea0NRaexvheuL3UkDKXRoE+ZAm3aSDnqNxPc+xwKt29nrlokmlSxadqsjnKzggvjgqR1645Ga9OlV5lFyio2e/yS1XyFt1OW1jwvBfaLZ/ZbOa38RSXJWJ0XAdVBOSAQOnfnmjRPhAZ9Aml1h2tNakfdFFDIoSPB4LDAA+g/CtzVBqOp2wtFtntr3R8Ot0rna6Y+Yg9vx7V0eiavB4i0GW1mu445lCxNLE6jJxwRk4yfStsRh06TjbRvW3S/Z9n+hElfVkeq2muaB8P4LfR7mTUNQij8t7hcs+3/Zx1I9+3Xmsf4VnxgjavB4hJvCQs1jNP97dzkEdOSfXjFWPE1jrMb250rxI0CxnBjKmMyEdgRwfpitOLWdQ0m4tLe8F/cmUZ8xoB8g7glfT1rndDlUVDW/3q3TV7fL5jbvdi+HW165iuTq8MSxq5BR1+U4J+Y54p194K0HVbuHUY2gW6BDF4j8jEfzq14uub2a1t/sReSI53sWwMY7jvXC2erS+H9Oma3eZbiQtsfaHSLgk7VPVsdBzVVK0knXjpbotAvpzLQ7ddN0fw5A9zrUUSWiZbzDHlVOTzVFdA8N+JbA6lAsF1Y3JzHIjFN/JGVH61W8A6xea3oj6f4o8id0thM7tJuYZJIz26AdK5Tx6o8P6Wba4kuoE3mW2jgbaA3UKfTPJzVUoOpO9R8rX3ku93dnTxbdKkt7PSrRhDB8m6RTI+Px6cmue1ew264008k9rCF8zzYTgk46cHjJrO0TxzNq88djE32KeGJd7u+7f2yWA69P8A69aurX8HiNF8OTJcQXLRlhMyfLKRnOccitauHjypN211f+Zd9mmcd/wtV/7up/8Afz/69FVf+EHtP+e1x/36NFT9U9PxMP3vdHrcN5DP5dx5MckcivIbktkDjPCkDPXtjp34qe98xWiFpGztLJFuRnKlY2wX/EZ/yKeUjtWBigN6kuFMcmPlZSMN6HA5HtkGntE12mCztCkm7zQ5Ul1IYkjupPBGeR6iu26vzLb+v6/I6/MgnuhLDNGjLuimXfKuc+WGwRxzgMRn/eqSxkeK5dthtyvmRRqG3h1yhDkKMgEZ47fQ4qCyuBca1cl0KRHMu8qNjA8jB/MY9T+NRqLXVEbyJYli35WSBQqAqwOCwPZhjt3puO8WtB26MsLBFcK7Qu0VukxuI3idgdqsSwIUfdJ5984NTXxt9W0u3iSZLpl3CQKdrOmQQ4zjo2Mge31qXT0uraUmN5EjJ3iQjKuSTwccKCT26YqHVNNeC/WSylxHvKSBfnXIH8IHIOTzjg5qE1zrXbb/AIIddxbe38/R7i2WQEvOZWjPAKBssD7/AE9a0rF9P/sx5ZJLZZLFCbO+MKv+7AB3KWB2sDlWBxjgjgg1nqDBcxBZVXeiNIucgKTjJ9AegrastKsY9DvLa3RZ4bjcWjnkwp7cnsOgrlxFtfPX/P8Ar/gETOE0lbfVbZ7y0kCQl3UeYADJg8gduCD+PauiutRMmhy6Zb3J03V7hXhhucOyxt1DK3XBGfxFeVeFhfal4u8Sm8trmzsmuGUp9xEZSQnld8FOc4A4Fei6PbpG9tapcOP3ixly+9tmCOc/xcc5rWNR1aKqvddLdvzNJe8jG1CYy+K7u20rU7S+l06wj+1WZg/evPg/MXPJDZU/X6nO/aat/ZtpbQ3KyWs5t4nu4GKyGJz/AAFiCG54GBz3pbG5kg1aaaSFEtI40lnd4gA7DkHcOhwuMH+8PQ1JqF/ZDUHivoJYZCEl+QrIjrkqh2kDBUjGR7H3reLqStCoua3b9e/57EJa2ZplTfWzWzbY3ypBVQVOMEbf7vbp+lV3vLK4lazWdbqaSEb4j8ocA7RgjkDII9jjJHFMtdStlt5J51uLeztot0soUsYo0yzZG0k5VTnGTjOOcVzXh28v9R0IXeriC0vnUSSwQZMJjZ/lkQEnbnKkjqMk8dKzp0W7uWiT/FiW9mb8y21nfIUeNopHVBDdMVcSdFAY/e6cA8n3qnrNmBpl7JHt2lVYLjOQGztOOcZ49P1q5PJZajdWQlWDfL+9jklJwZUBYBcYwy4bPNXdOuI7iJZFgkjfkshbJxjDH6dfyqnOVNKVtVv/AF8jTma1OZjuGmv7AwvPFcTRofLABQgd2ORzxnP19ajnzbeJdZ1zT7iZkdS9zp8nFtD8ow6gf6zJyRkDBGPTPTzWDyTRPFIfs+wIJVOQNoPX35/ziqFnp7wtdSMkTRGOQFByWDD7pbqcfMfYYrOtGjiLSluv89gck9UA1uXVrG7srOKSxmtZkyrJ5EUqZ+ZgfQjB/H3qG2sjeJPBfMs9qQPK3gfuU/un1HAwfqabpdvZW1lMZ1ktWmQkIGZ2HABI7nBA54zgnrzUsJu7QS3o/wBNiuWaOCJHBUJgM38Ixxk7T2B5NbK0bxp6dv8AhwWmkS7YWMUdmLSbElshMm0AHaQfur14zjB7H8Kggsbprtl8oRRiMElkImY/xEnJBGPxz2rd0mSC400ujkhkDLjoVzkA9OMjnuaxb7SIbeyh06wk+y28AC28YZvL29BgkknrjmsIVW5yjJ2JU7t3L0gjnRGglfZG5O5DjYfQmorh55bFo7PaJmkIHm5G49ACc9zipY42hsvJkmjS7fks2cZIAJHfqM8VTawVrtpZ5LiXyiMPJt+VchiwwR1wOoyPWop8vNr02JTHWXn3lhJbvKkWoBDIkSOxUuByoI7/AP1qlsJbubT91/JCJEG15IzxzjjPcg4BzVP7PLFqUU8cs1vamYvGhVf9YTkO7DknjGavJe6fe3d0ilIpHwGIb7hJ/iHpn+dazSaulfr6Dl5EOi+fFJPb3EZypBDuu1QTwVB7kgA1JdFIWx+7Fy4JjRuDgY3H3xkfnWKdOku9XF3bkOd4YBl+VVOOvucA5rU1C1SZlF8h/d/6uQKMgk/Ngc+gorKzvFpvsN73MGyeDRtUvILa2BjIV54dxMaliOck/Ic5OBwa24re3NxLLHGqO4LvGOWfA+8vqT0z3qnHptrFeRW0MYktlYPES5Jwfvq/PORz/OonaW11L7Zf7lO90ijUfMQPugH06njirhFSiktHYEzF8CeK28Ya3cRw6ZJperacqy7ZpN64JxhlwPYg/wAq7TxXfK06LBcvG4QCWRmxjB5K9geR+VV9NstM0/WTfafaQfbNUcSTOPkkkP8AtH0yPujjqaq6olvbG7ivLuJodQui8QKY2McfIccsAVznj9OYnKFTEJwjZJbfn+pnG99dTGIuNa0+40/UbfzbKQKougAm45ypB6Z3ADgGqcMGp2/iFDPCY7RwypGpyoYnK/N1yRnr+FdBAs1nplmlxGzywq0Rj3fdPJGD6Y/StyWFHRl5YMMkH045H0z0p1Wo1OeOnT7mW3ZmPvt9VieKVF+2gbHDklZOCBkeuKuwQuLeML5hMYC5Y8so/nQzLCXlZwXRTyyjP1zSadqKS21zKMt9nQu6IMlwBnK++eP8KU02uZLQT20I57jbIYZGfc45x/D9TXL69oVxLPHceeggGWKgfvJAcdTjj6joTW9Y3j6lYJqItZIA67kinzuTJwQw9RWXL4g0q8uJNOurtGuVXa6AlQOeOen4VFalTuvaO1vMdrtFuBls7O10y/v5rwSFZY7gvgo4ORHIepGeM+nWs7xV4Xs49NuXtd9vICDNbrGDjnJx/Q1zfjLXdOikgu7C7WW6tmEdwqLvBVmXAfI2npxznPTvns0vr2XSpBqii2hukBtLgsGHPQNjtzj25rKjiPZy5ab1T9b+n6r7iLW1R1GgaxbeIvDcMlkDE8J8srKgJRlOM+/Tg1y3xc8Pa1cavYeJNN1HZDZRootg7K4O75mQjuwIGPbvmotDu7zR9CvbnVWlt7m1mZEynyzoR8oOOuPXvV7WPHVtfw2+lXFhcxpPErz3aYVLcH+LnBOO+KcounU9pSdo3t39fXQhx1utjV8P+L9O8Qx7L+KS0vzuAjYFd6jgH05qbXZvDehWa3WqhIzcfKiMm95MjlVGP1rhrXW7A+I5rC7txcfZVU2epJLhLgtnbkDtwOR3qb4y3N1b6HorS21zHKwZHYIGEZIGc81VWjCU17NNJ9P8gkla8Tt/DWj6fG41nTYQqX0IzuPAXt+g/wA5rk/G+tSWOv3WnPZR3FmLYSyTSw/dck9CeuABWvoNzbrotmguVW2WFUi29WXH86reOdFiihXWLi5VoABm0wB5uMbR+Y/lXPTpJ1rT2136ja11Z58Y9OitYrywiR2dA0iFgvzc9MdfpXYeDNTsobiS5itpW1DYV3vl1XOOASeO/Y1zvifTvtK6ZrGm6W1tbiIRyQebtAG7JY9+f89auaJrkrXMemS2QtftHyLcjGBx0x9DXf7K9Pkitr6J7al3vobe+b/nsfyX/Giov7Gv/wDoMW//AIEj/Ciq5F/Mvu/4BPJDy/r5Go1/LLcNCbYtbRyEpKjl3+XPOAM4xlSfzrQSCOHUkBuGAhUp5YOFYnBy3qRkgfX8KisL+e4jMksRtIAwyWBbac4APb8fepLu3aMiVbVZHB5Cks/oAo6dsf5zUylry2sXdktnYQQB1jLFg29kY9QOn4dqrGVJbhXs15BKhDkbWzz9e/8AkU21u43kuZY5JY5h0aQ8bj1GCf09c9KlVnkf57hlnlQM8CAMqoeM7uw56HPTI9KXLKMrsrZkpmKJFGjYAG0HjHc5PPGSGH4CoY3EsSuNvmAFNyrkDk8fTP8A+uqxhtb3ULBZY5ZBG7CNj9wkZX5iOmc9AeR6VoWV7K8ccHktbImV2BQhUAkDjJGD/KiUXBe6tf8Ahw1XQo35i/tCHz2lDXJCBwCVRsZPzD1UDnvwK39EtY9RXUUuZAuJViicNgjKKfxPH6Vm6qtpGqS3Ek0PmEIxjJBZvcAcDk5Pue1a/h1F+1XU0exoJCHBVsrtwMH6/wCFcted4xkr6ETldaGLN4enUO8jLJbxwiJpDJ8wG47H3H8seo6mnabp1lZCZreBZHnk8yRVGfm7vznn6GnePtWksNJ1C0W0e5nnTfDEjH9/GGXfgAfeXOQvf2zXNNFrWVjtbq28zzFIgnILJyCCWz8uNrYGDnoSOtVCcqlKXvfIpXlHVnT3NxdFzLG0zoMMY2PysuMkbfXGRj8DVCa6s7bVbiFIrhILWVYGZ0KDdgMHhYn5o+cNwBkfjVCa3OrTyT7xDElztki5Zw2w/unXoUHJyCN2Bxwav3enNfZeO6neJo9hLKrKhwSW/wBknB4xg8dxiumHs0k77odkbckqrDBNaSlUUeZHt4zzzx2IPHFYf2MXE0Nxp988FrHctJPbG2VzKWGWjIPTrncOfTBptjFNb6W+ntciW5kiPCARHcP4gAPlPyryeMninWFpDpsdxFdRNDC/zFYlLLGNudqHpxhuOMk9qSgqd7PX818/69BctiDToZImZC0UOMk+SpTOPukge+RjA571tLIsVp5tiIgrxhPMAYk55xzyBnPbB6VgfaLNoibmGGaGJ8yq0gTYVKsAS2B5i8HGcH19ZRaiG+ivIL3yJlLF4goVGUt/GP7vr1AJzWlSDlrLT5FSV2dFbTOJXmiOzccOvG1iB1GO/riq07iPy4yRIqjc4DYKndgEY49M+veqmtaZLcXtre2V1B9sQIkVrdMUj3FyS24dcKSCAMnaORmp9VvIJb4xKhjlC4ljYlSoOQOAcn6e9c0Yxk04/Py/ruQldkWo6dHq8Qfe4CYCvCfvbDnnoQc5yuPxrPthdidtPtY/JUje5nfCiQyAoeOhY4Awe/fNWPBOmRz7rISZ8198UqjlExk49ewyfQfSrPjK0sNT/szSPD+t28Vz55aS2OXluWGR97HBA3njoORjitPaezn7JvRdbbef9dSublfIV9P1pllRC8FwFuI4m3psWNC7IVOOmNo5Pf68Sy3ST3/2V0l8tpDs2KQyAEDGcY5yO9LpN3bLr02n3jRtrCxiO68t8rJIFBl2jr97knAyc1fkWJLgToqQzMwACkj5vQZOB/n1qajUZ/Da60Jur7Fm5hthp0eoOxMEPBCHeYsdgeM88Yql5kPmLdGbeu3AIBAQ9wQfut7HBq9aILmNtLtZUjE6ttYrlY325zjuPauTsBcWetiHUnntbmyBgdFP7mcc4BHcEYIOOmKzowUk77r8hQW6uaEl3ItxbRZU3EjsAigkH2z9B+dN0mwD6i1xH5EcSI7yBVO9AVP3yOMcDH5VG9pcRagl5cwsyxyl/MfBCKpy2Wz+gHpVq90+K9urXUjO8kIUMdoDeYMfKWPcc9MHmt5SUdE7XW/6FNpaIn0SdheiW0uUEcGd8fIwOwxnGeg/GshpbWbWotNjFxbtabURJMsvtuJ4LN6/QnNK0V1HexIZpVjaNo/PjjyI2ABxn8iM9eR1zWdex6hp95BcSA6nay8GKYfNnsyY6E89Oox6VpCKcm1Ldaf1/mNLW6NRYY4tRbzLrdGuBhnYYbPT0/wqLUJ4EuzbXKtHGcOk4/e8HggjqB7iqXiFrSND9ohMNvJjhlI5IJ5bse2PetLw5p8Oq3KQT3FvcTWimMLHLhjkBkDoepAOSByM/kVJxpwVSo32HKy1ZYu7ZZ51mzg2pAQKM7MHK4/z7VVuVj1G/W2SWOO/SL7RFCUJxtONwPbr0/yHpGthrtxFLcITKjAuvKDacHaPUHGR1FF9HKjrIQiiMZjkUHcwB6e1RTmmlZ+hK20ZetoJba0EbfvXQfMMdTmrC7XjLxzD5hgDrt9CawnNxv3W9wWXcVMoLbl7nI/EfWp7uya3nN9p7Brh1CSoekq+47EHJGMfjWdWDT3vcmSK0hvMSPJC3m2+Sd0m0H6E8Ecg/wCRV7Rbu3fdZS+XDqSKHuI1PGexz+P4VR026S4vWivbXySrMojaYOjkD730ye/OalXS7Y63eXeZkuWt1E4X5VZV+bIGOo9vetajU4tNdNPUqWug7xot1Nol4bMsJWjwzRDdKF/iCjpXit/Boc17YxRLNb2TOVuZnRhLvVCFXHPBPBbnkivarTW9J8RWtwulStPtA8wbShweM+/TpXkHis3HhW9kgurZmaW4bZc5Yb7cjghugZeOCO34VzOjNN0pLV9/y+Zm7JXY22tdPmtFu9Ltp7K2g2m7N3KHScB+CB6r2/LvxpaRfbruGJ9XkhtFnc/6XAWhiBVigJ69QB17Zx1rH0zWrfxBGsuu31yXjjDkyr8gB6Dgcnpnj1xVqGRmsdQ0uztoJI2yPPZiNwP8eCOPrnt2rzKVb2lS3NyRV2tN/Ky6dzSNrXTPVvhbdLr2gRzaq/nwSv8AJG7cxkcbfw9Pxq5408MTzXX2zTx5ptAWEEjffTHY+/T2960fCzeHbzRIbDToYINW+xrLLGqEHcAATnowzxkdqtWz6rPpl1bgwRX0SZilkbIZSB+R7EdO/etIVeaSbsvTYxbd9Dz60sJr230HUoNCjhi85vtNsJN5h2tjKnHIIAO2tnxT4kijfUdK1a2guYXj3raOxVpVPcE/X+db9pqL6G9qNfFpbb5NkUkcmRJn+XNV/i/Bo0On6fqGriCIb3ht7l4S+yQrkbsfwnac/nXoOvCU+SUdNUravvp3sDktmcvdapZKbZbzTja2p5hmgU7UwBjeOwz36Cm2irqGqi5jdrl7ceaibcqWA9ehFN1m0S28KbZrh7jUZmHmxxNjAz6HjGKoyarHodn/AGfY5tryWMrJcE4yw7bu55/So5a2vs17v/DX37lvS9iprniPXZporWXSIL1bh2jKJuA9C2e3XGO/Sr/hbwlqN2tyk1jcWqTqVF0t180RHZQyZB9DzXQaKXt9FtpNX8+4djgSHKlTzz7H/Oal1HXmttLW40svIsBxLG/Lfie9KM8Q5KMJckX0W33u/wCFhLS6/r+vmM/4VpB/z6H/AMCTRVT/AIWW/wD0DJf8/hRXX7HM/wCZ/gX73ZE9+lxFDBNDHMziXZCqnacswGSPunAGec/d96uG5/tGN3sIYpZbcBPNaUrvkIZWVkAyPuhs9G3YGMVRu/tV7qovoI7X7Dao0EoBxLE5HQ54H3VIOOans5ytq8VtbtGJmZ5pNo3M5UDdj0A7+1buLaXdf1Zj5b6klxepZ6ebjUdxaPyk3pHvfk4AIIJIz0zzg0X8VjdMStw8c0uHJyxRmIBGBnI47dPbvWNpL6hf6ZfeVGLpDCWHlf8ALQ7+D7EY6HBG38a2PDsn2XyNOXa7LCEaYnJYqvfPGAAe/b3oqQ9ldx3X5FNW1Qo06a2uHdZGjyqsZYwAX4469x3OBirvEiKzEfvceZLuLHaAcEY4HOQTReTxTXMMckbx2+0Mk/OAWBBQjOcEc57D6is3StSjW4exigjtkhZFjbcF+VUx1zyijuPc46GskpTjd7itpqa0EDS2cO/Yskbbd/O2Qdu2ee9aXhlYrXy7eGUyybZQw2BWJzuOB2we3/66w0ltpsxxSyZdiArqVVy3bOfve3v9K0tK2WepwzMFMySeZnJ6Ywxz0yR61zVo+60/UiaumixqbQ3viHypFMd9Z4dYiA6ywsM7uBxxnp0Iwc5FYjSw6vJd3OmzkwpKYJkeEgxS4GDg9V/nmumvImt7O+1WyWV9QTT5YYnAz5rKCRlexyeme1cz4ot5La/sLJIInW8tzcLI0YCTSjZvDYI55GMnv3qKEoRnppe3/B/4HYISVy3JbXDpbXDB1nRSDxgyAcgfToR+NXmV/KE9sYwYvlKO4j4IyQAev86xdCsF04OhZrZHQI0KytKW64Lljy3X5uOta8oHlKskGIjkLzlWXGc/UHgj/wDWaqNKfKtUD3sWbWK5muIZ5L1ILBE3NaMAsjcEMHzztPDDoQRWVqFyloxe1uJFlEgjIMWQueg9AM455H403VNYFjeW0UP7yWUbl4BL5yQMkgbcA8jPWl1DT4Xub5lZTHNEFnRP9YhU5Vgc47eneqgnFqU1ZNfr1BXT1MNLdpm86ZEklQr5flt5sa88xlW6dOBjPp61bsIIbu6kja4tobm1TO6RtrfPzsVsggkcY5BFM8SWElr9gUpEttIpMjRAO0/GAm4fdOMNk8n+cNjdwvPbLbTIsxIdS2R5sYAywLjqcEdBypIrr9pzr3Xr/l/X4murWjLl5ZRasBFcAxzRkNGCMZYcMp9OOM98H8FuFb+0WuUWNLq4jCyzEDeWUE9OgOMDk4pZbJRLMBJGTJHhJopdzc9QRjAwxGD33GlhvtPg1VdLurqGbWo4xJIwBG0E5QSH7oY5Cr3bIPfnKSc42i29On9bX/Em6Rr+FrePTbySaV8q6zSRJkbC7DLL69zxzzmuX0+zbwt4htYNT1ZdQlS5W6iMVsI3G4fKpI4K/wAJ/iOK2vE1nDeNayXd89rLHLvidFyygHJ46DBA5+tWr+9w0V8koZFUbnwCSjDqrY4I9O+KwhFyak23dNPoSld3fUw49DS08Q3+qSFJZ3aRIWwdyRuSxyfxP9TxzrzwLeJDal2WSKRWcqudpXnCnoTio7Jbq6keN1OxEJWZ33MPmBwp6/MPmwc4xirOiW0kd7eXcsrHcp8tBKHVHHBCAdM89ea2nNvWT1Q2/PUz59Qu7fV5oYwizQTCe1AXCleeAc88cE/7Q/HQ8Ry3WoXNveWLMhwpMbAHDcgqynqPTHem6xI1lawapJCf3cS/aVIBYHBxn0PQY6H6itHR7AazKLp52iiZRtEY53Agktn2OKwqz5IxqqO2nzJdlaRztm9lqNhrEHh+/ikvomCSI2V2jcu4/MPouO2CCM021uWgltbO3Plwlfs7W8kTchV+Qg9jgHJPUmtnUtLXTdbV4/mubhH+78ihD3KjgnPPP19ayklk067SWdhLEWWMRj5mYkkFl/3ep44rSjP2qbS+Tte+w4vmNS1ASYJFNG6tkSJuBJ9c8+pqzPF9nll+QyW8cvlO4Tgt1HXgj3HeqMFgto7XEpUvuDZ6AY4Bx647Vqw6ms1o0aHz4XGAj5G0jv8AXvWFTRpx1RnK+6PPL+zubHUZp4rmWK3lJXYyeYpLNjoevXof65rY0hNO+wzWEdrbQ3kkm0XFtbsqBjGscjhs7g7bQSc9e55NWIbMaffTSrcH7NLuZ0PLZOOfw9qjiKx3wgiCSncpLwsQvlk5DcDPTI+op42pGpZvovv20NZPmPP7CGWwvNc0yC5Mj6RCUNwrk7JElKsdrfNvdSOQMERg967TT9dlea1i08QT2x++7AjcvQFcfebOc4xj0q/oHhrS7fUdX1W70uO0ucyW3mSHBa2OCJCM4BPGSOmO3NYmkXEOi6VcWUBiubhJpJ3eIna6MAyOoHBJQr07k1nhJa8kkm356bbk/FpudDPbJGJFtnlRSd5WIDIHsD1/nin6daMwdgrJBJgoXyG6ZJx2+lUZGuNV0iCe1lWG7DebD5+QCcchh6cjj+VSS61dweSl75RmwEdYQdvmd9ncjv8ASule1c3Tt8x67Gd4eg1i01LxDFq2n6db6etwsmmy2wyzpznzOck42k575xxjG7ps1w0Ky3vkPdZZAYUKqFxwTknJqO6sriSBW3lnJV8MT8p9PfiqWoXF1aatbRCPZDKv3iQAqjt781coqq9Gr+WmwoxVrXG3ENtEVmsbaKESkHIGwKRwSR3+tW9a01r+dG/1sLLhlyCqt2b8qjvvJ3eXazeVcD7qyYIzj/6/WnQz7IbV5JJYwoIAKgHI4G6qa0UkU+55R4m0RdP1u5trWLfLITthKEDJBO5SODz+XHatfwP4ettPlhuvtYluHg/0i3lYMd3XgduR0/Wu/uIpJpIx5S7lz7MpznIPaq91JawyuRbW6XMn3pFXaxA9T1JrgpYGMKiaV+3kK+pkzmxvJ1EkjRTxp5kbqMFFBwNwHY/411WjeRezpHbXtvexqu52V1kAYEgfMOhGCD+Rriorea7udSmdJXuZ4TFEoXYpxjbz145PHrUPhK4sbG01awuZ3tdSvI/LYrgLCewU9xwf5+9U7YibptvyVr/1pdktX1R1/jzw8niG2W8ti1ve2LmOf5Mhw3oueenBrzOPxLrWo6oNM1+0kvNAnZYZbC5tmzEq8CUNkEHGTkVq6vc6/Bo91pCzKt1aFXlkt2LtJk5UAnqDzWj4audP8aXFnrt3N5SWYMEyNGVfch4+U9B3xW0I+zhbnTWtvLzXr+DJtf3Zbf1/XzOl8Nw+F7/W4r6y1RVW2Rl8qST5G7AgtzwB79KxPGmjaZrszyaJcQXV0XBjXJB3ZHJBGD359qzvFem6akD3/hi0jmM1xm4h2E/McYAA+6pHHFanii5voLK0bQrSG3ukTe8tuoKRsOChHcVmoackZPa3p6r8u4O/VmLbeMv+EYsbW014fbIQT5jjLvGqnB5Gckcn8K2p/Eel32hyX2kxtLbshKh4iu/Gc5B+hrmtJsrm7tZbiVVuDdErM0KAjPQkDt171Hot9faQtxoUMUF1ZwQOyxzrt8tOSAv4n6CsvYSo3nNJwXrfsU1Ju72Mr/hNp/8AoEWn/fH/ANaisbzbT/nyb/vxRWf9tYX/AJ9P/wACC67/AJHsc0FqjEWbpMl1G4eZWTk7flyemT2yM9u9T6TpqNoix/uk+0RmPEb7QF6jaM+vbNQ3kZs73fbw7mMSnzWXekh6YwOw4PPUEd8VNba1Y3aRRAi2uUZo3VEJXIwBg/w9eh5GK9iTm43jt3Lu7DNAji0+abTGUxxTFpdhbnkAE5B4GBUkdgFmSC1zvTbvJGSTkElR0CleuPzqKSWzj1CKdoChtXKKdxYkkZOQM5Hf14qxqNxNHeqxMgkHMQiXcgRcbm3dtwPTr09KTc3O/dD1uR2CteRzJcrFbBQSqM24Fc8H5T0wBke9MtYInZxPJDJchg8csgCFgDnYSOACMY6e+QRWhM9rpokuJJDLu6+ZiMAHOGPfseeB1rEu1juMy2UkbpbyIZ4C27oM7ee5GMHpg04NzvbRAncuCyv1N3JcGSdDOZkgljCODwdo5+6D0z7c1ft7maS8lfUGW2gYDZ9q/dySHAO4AnkH0AGKy9T1iz0xluLmdpLaYyMXj3eYqKC7bhjkL7EjPPNOuF/tKwa4TzBFO/m+YjpnaRx1yQCCBgYIx15rNzVRuEmvuC19GehaQ63GkeXMwyyFOB04I/SsXxhp82p6TpJ06KC41jTp1nt7V3CNMqrtlRS3G7ae/GQM+tT+FdWW/huBCCJLSQQtg5X5gGUn0PUd6nvP7N166m0e6+0wX9uRMjqCjIxGQUk6N7gHPFeZJcsrS0OfaVzzI+L1i0+/1RreeOC1RwsUqnf5m4r5bofmDAjkHp2ODWr4cm1lR5N46zwXIMsqXEgWVMjlNq9ueARkcc8VZ8QeBbW38T23irVDdXctm3m3C2oz9ocKFSZkyAGTAJwDnk/XIsLsRXHnSzFpTI/lrLwwyxCuFPzAN1Oc+nYAdcJe2bVkrbebN4+8jqF06BkhRGlSRYwEmbkccrn1x198fgatnGbaVXku4jGz79zjtgjy14HB2nlvfrSR3zC03zElZVEfmK2zg5UsOOwwenXHHNQuYLPUIXvJo5XcqIE2lNpboDknPQnjg57dK1gpWcZMavsytomlWWlDWbTSiqXuoT/bZkupGljErgnGDgpn9cYz0q7c2c0l2CxwzxBVxGJdhG7ooORwxAPQk89DVW/1HTbLVVs5xcJJcIHKpbsSwLfLH5mcfeGACcD2zir+mY1mCe5S6+xmDCyichCg52jHI4I5I/PBpc6b9on6vz2Eko67FbR4dPvit6+oRJa2EnmXlpNGSZoiMJlgRtIZc56ZwOB1w9N0PS/F88epw6dq2nXG4arM0uFNyIpNpRWJztBwwGPx5U1t3XlC8vLq48p7ePc9yWw+IyoVgBgh42Xr1HXrWX4Y03SbCyk1rRGuJbJ4ZFgE0jsyKXBKBGOFG8ZAUDOec8VMp101Om3Z2V1pq9bPv5dRNPdPf+v6/wCAdTpM1r4hubi1v0VYnJdF3eWWUngE55z39DxT9QFrBZSSailxbaa5EKWc8OxoyMDr3XHf2681S+1PHZS/aNjQvJ5cjFB0IK4B7fMOp9hzUMySv4cvYHI1CaHZNa28jHzEx83yEnliMkLz0x7VXJZrorr+k+n9ajat6EO6ZNQWa8mMcW1i/l2/+tBGAw6Y4IyO2DnHAqxawrHYT7bmCa6cxzyGJWjDouASu7AVhlflGOvcmqw043V+k0kV3EtzbI8aT8SRKw/iHTd6/wD66p2tgJpb6KUSMjf6MCo3bCnGdpHTOeeecV0+7Jb7W/MvR7MtW0EkOvOJJiyXDkTr5eM7zyjc8kN1ODz37VqzFdLuLb7NJNCyDK+Q5y2c/fXOD68iq39nPHk21wXKIoZGYgxc5JGOD+PpWz4x0q3hs7fWtwH2XDSZwBKh7k9sHBz7muapONSpGMnfp8+hnJptJsxpL66a/Dz7Zo3gKTSKQSxJG0A9RjGcfUetS2tpbw3t1Z7y5hmErpImTjGA6n0OR3zzSafPG1vNMIleTOXBTHOeHGRxnnP4Yrk/GOsva39vNBNZQ63cqvkG4lMcSRIWVnmI+ZkLZRFBBJzk4UA1J2vDZfqN6aI7a/S4kuIVtpE+zsrRypJ65GGX37cmqUNzHBcz20zbiB5jqkZP3h1HoB0rk9D8dq1jcvrQzHFdMsY09vOLwggZDvgMRnn2wRnkV0BZbtIriFHu7OdTGCQY2lUHAcKfmGQO/wDKsKNaE37JvXtoEVda7FDW724Gq6fZWoX7NdW08nnk9CvQZ/EHnsKnsXu0tYIoIo2uLlgJp/utANoJ2+vzAYB6bvyseIYJ7zVtFmtlRooTJHOGUbdrLxlj0/X0461FrOlXsaIbGENIdzFk6o5Od+Pb1xWqcK1P2TdtR3TVrk0aXBhVbzcjQqzgzu37xw2Qu09QRweeax9RvLc3tpc2Ns/2q63RNGhwBgHHYYOBjI7celdJPd21xYEPM3mNKIiZV3eTPtVthx0U5zn6ioNLMtnqZtpbZ5HfO4nlem4srHoMCuNyScZyWsf08/vJUmtWV5bK2uZrWze8kFzsZA+BsJJ6buoweN3Tt71pWF/C8stm8IhS1QKlzIBhyOCQT/XqKq6po6RjUJoJHgnYghgAdm5vmx0OT+lZujW9tf27213JeuYnKq8gVWPOD/8AWJ969G8KtPmu2l/Vx/Er3OsgZPN+VhtIwGJzk+v0rDurKKDWG1O7umWJUdTEzbo2Dd8H7pyAePStG2hlgcxQkNaRxrtYtkhgec1R1SUfbkjeJPJICsG+YHccdPQHmsI0oymRHfRk8JR1FzcbJFHyqZMcfQ/571ZiuleZljRzIGI3cYOfT9a5/wASadOY4/7Pu3ju7WJpEUMPLmJ5Cle4OPbFVND8SnVNOW5jt1TUYG8i7gDFWikA5wp5IPUHsODyKLKcuXvsFr9TqZ54ftCo0u58kHC5yPw6VnaivmXglyHAA+UDkY702a9ttM0w6pfNtV2xHlSfmx0OOnvS2F9Za9bWl9HESJVJBB7g4I4/GtYQlD3rO21/Ma0ZW8WahJbaLeSW6tHMsed+R8vuO/Q9RXP+AtPtfEUj3OqWztlVdFRSoHByW5wSc5GOvt0rqIHMV48rtHNFuO5WHCr/AFFZtlbTReKon0oQrZTptEQ5VWBJLjkDHPTmuPFUbLnS2tsK7Wz3NbxPoT2uiTava3MJjKKbiQDcfLToVPZhya534YrZanpd/NPFcSgXRMsrQhFlA5UnH8XY98Yrs9a0RLy6OkWWotZ2hUSeUW4ZScEA1bi8rQYntRbxWulRpghV4JPUn3rHkhGnzX1f9a9/L5kJtq9zKt7DT7ETzaNbW8cUcRaZWJZjnuGHUgdOvX8ubtp9Qtba01LT5on0cMWkmjAdTGByGHr7f41Ha6zDL4rutS0y5uE0u3BEqo26OZCDhgvb6+nTjNO8b6nYRaZp11p15LbQT8MkaZjYHrvA7nNaYKnXjW5Zr4t/uv8AeXfQveKLvStL8PRanoHlyxXxOxIjgBscnHrWPoemahqtqs8saI6D/j6PUAjlfUkg960PFmvLH4Y0Y2mmy2ojIea4gRSmRkY29SCT3GOtbwvtbbwvo91ZaXamK5lT7YikHameXUfrjk1VScamHdLSzb1b1t5ii2vvOG/sQ/3JP++2/wAaK9fzoH/QQs/++korxvqq7Gntl2PPxd3cNzbppk8ksUMQEloAN2ckcMfuk8gVe1O3t2liLyqsqyK0q7MHDFeWPTcPfn64qxeeXJKkscUci79rlly6MBvw4H3lwOMZJ6AZqC8v4XEErQMsTsoCyMRsY8gMOp69+ntX1XM5NNKxN7alyeETpL5mY2VW8uQKobb26jnt1/Oq8EchkgheM3RjGCFBIKcbeexxz165wKn+1NMu0q24sQqtxwODzzg+3fse1SWV7cTKI4FkDK2TtXAY5BOPz6/WsPfjFoNUPmuRKzWg2SDDGWJ4lG/PA6/4/gM1PGoify/KEeB9zYmDnHJI6njvWTqp3ai6wNbyhZT5wZnGw8ZHAx37/jWlFLElpG7byh+YEjBQdgPT/wDXSnHlirLcT2I9Qiiu7dUSRR5RLiFkDDJGG2nsev4Z96y42jFqqxJGryM8bmJgCcAMv0O0kD16+lag0Z7q7aS13LO4ADKudyDnueAf6Cub134bammq3Go6VeMiTosVxCJsLtTOCrdmAOPl69u9Z+1hTas7jUknua2mS3NxouuHwrBEmuu6rKzkOEwOC7j0HI54+tLdaD4l1bwpALy5tLbXUIxcRE4Y5z94D5W4xn35pvhrQNRsdIu7Sxmij1GWIBbp/mhbaT8pA+YnJ5Y55PfFS+ENL1y38/V/EU8gmJMK28JaeOGPOC2RwScZwBmieJjTk/ZtKzutN/L09SW9W0aVle+JNG0YPqcMV+5YqLeN/mH/AAIgAjvk9Kxr/S7i8uhq2mtbyK4AksLmRY/L9llxgHcM5PHH51PFb+Kr6BLOz8PSywNuInLvHGDwQZBjcxxnpxx05rcbVNM0uKC0vprFLhAvzPEAd5+7nI49Bu6+prCU4Je0um29lt+H/D+YRel0tR9tpbXMVpF5VzpqhNpikcSYG7J/eL8pyQeeD/Kqt9NNp955Xk/vi21mZcnYAflj9xj0rqc2F9MvlQrLcoAjT2zlecZ5A+XPsasBkEi/aU320mPLmK4Ib+6Tzg8fQ04Ym2j1Xb+r/iJVe5wen6vczLdC6nW4tvIO5CqmNSQMAj+JTuC855HXg1NZQ+ZZvZwWMMLR/PKicbj05yevUjnoParPijRLtNLeK1stGTLmWS4mBIDnnKr3PUZKnAJI71LaWt0+hwXFpNAwVVTZaSb4yynLlT1JJPIbJGCPat/b05O8VZ6FqS3RT0uKewgghidWVXEUP2iQKFUjkDPJ5PT1PvVp9Ns7XSpbC2tEitVBKxIcAksG75/iHOc1BrirNe2HmyzW8WPNKCLO/GW2h8ccqCc9uM8irZvYUmhiuI1SONmLz4ZWjBXLHP3SFz0PXnHpRJzlaXz/AK/rqDb3IbKWGW2jtbk27yxja6b88MdykjOeR29QccVX1TSTIEuJrh4FRlVWiTcx6EBcdG6YP1OKq2bm3vZf7Tgh37lC3kCb1C4BXzMj5Qcjb1HOK0ADqMZvLFmULE6iJkMfmEHbuXjKgfNxjHt1rWUXCV07LuVdp6bGxDeC6iWVpty45LHJXkZz6HP+NQC2nL3gBIEh3iRfUg/MfTHA4rK8MQyrJ9n/AHnEAjMsxUmTDLydp7BfToRz1qXw1qug+NJXt9Mv5pP7MvR5jbCn70bhtyeGjYBj68dBmsJU3TcuXZde3Yyk+R2JLky2VrJ5QSS4bCxRAAYUDnnpk4A5p7quq2emTSzLFdwCVY4LhztCv8pyucN93jmo3u7C98TanYRRSj+zAHnV+Nu4/KuCOQTkjBPHeuIuNehm1ZhYQ+dejORPOII0TftLYcgbSVwHVW6fiNNFbm0lv56r8rf1qWtVfqd7a6Slta6mBhLNE+0zKzklBgvnjnGMnHXmsF7/AE+ewt9QtIUjFxCmG2iQqrZ4yRwD6Y75IzmtX4f+Mr640vU4NSitriazuWt/O0mTzFjYKpKfN97buH6jtzQsbDT7XTbqS/E1jLC89wssUbpGykB/3i8gnCsTjgEnGK5VX97mqpvX8tGSpO7bHyafp6Qpb3VtFiN0dI441TbjsAMZ4OMjtkVr+IdQa6aeS30h7d7IK0Esc6MLhGBztx0wAOCBXLeG/FNvrNvGbRZJbeUYVnUod/JwNwyTgE8Zx+VbN3PqFpqKLblHtFwCJDkAdMAdD67u2K3gqdSXNCzfr/l/XzG1doZaMzXlxqF5eyXGn3BUWunm2VPsRA+Ybxy4575rWkMN9AI7iF2kA3ncxIbB4Bwf/wBdZCqstxLaiKWO3lUFH6KrMMgKe3cH8Pemm/0myXTLSLUd9xM3lQHBCyt/dD4256Dr6U6sIKyl/SBpJ2LtxLJeW93YeUuJkAiZUyA/VDj1BGKfYQO3hRbh0kN5CkqrhuQwB+Q9zk8VS1aeW0YSy3IWUfMVDhSo6ZPt69a6DwbrFrrlg0sTxC5WVoLiONtxRwARIo91YH6GpxMWqV47XX3inpG5n2WrQajBbWojuCZoz5jPHgq44Kt6EdvXtVK6FzFqcUMTxR2Pl8R5wxP17knJqCW6S38bLK0jW7XWYJYQ+6PzEPI9N2M+h56emj4lsU+3213GIlLR4jJbox6gEdM+tZ4VqM+S/wDVgWjI7C5Npdi2eOeVpSQZGA2x4yef5ZqG9V1Mj26o8/RQWxkdwfwqvAt9Bp0c13drPOJeJs/MYxwN2OMg/oOals5xdzql0gXf8xO8Dd6dOg6ciu3ls3Na9y/M5rxBq40y8s7rVbS4fSZrUq7xJueKRXyoIHJBHftgetcx4O1G31f4hapfWELxWn2WQjDZyxdNpbsCfnOPc16jqcsENo7vaCSEnDRfeUHpnBrK0K20+3s7hrOyitnZw7vCN/m9QM55OOcD3rm9nWlUjUv7ibduuqf+fkTq2n0NBb2ztLa3t7uJrtQmT5a5AJGCeevU5qSL+y7GxshbYt7JgfJCjHPX61Vto7NPLZNqwR5DnGOeoBP9KsyyQ3cSQyFF2vkKzY69PxrpcIp6X8w0WzK0ksMbNbvBjzmOdqk/Un2pl2if2jZWFhNHBPID5XODnacEeo65FXnTy3G4fuxgDeMk+49PwpbKGO68SQXVx5S/Z13W5X7xJ6n6elRUlaDa7fiDehQ8bCDUZrTTbhmtprWNVeUNg7zgswI7cV0+taXc6tpUdpHMj2csREjtnLYHykEen61V1XwnY65NPqFzcTCeMEmAEFHHUKehwcevrXjWmeO9S8MwXj2c0cr3UrSsqr5piIywXZn5Qemcdh7V5k5+3UKC0+en9MhSSXod7fatpfgzRbDTdQieVp3fcgjDyOvUk47D69O1bS2OlQymdGT7Oq+ZFHglW3dPlrk759H8aaCmt3aXP2+0tw13p6rtLBx29uO1TLruialrvhy8tr6XSZkkaAQSD90W4ARj0Hsa2hQnGl7zaet79+nnr3C+urKHxH0i9urVrmzuhJYuhaVI227FXrgH2B/Ku98CXtj/AMK6T+z9QVgICI/M5YH0x1/rTdc0+0tXuVaIyDBLxliA4b19R16+teM6rpU9zql3p2n3bQ2b8hbZsMDgcHIxx6denSs6dq0eSs7OytZXb/Lb1CSuny7k3/Cwrj/oFaN/3z/9lRWZ/wAIxpf/AED9T/77/wDr0Vxf2R/el/4B/wDbBz1P7v3M9htQstzdiczRSSOmBt24ADLg+53n/IqwsVrHaSWJVZHUea/zB5Ackg4yTg7cc9cVU+JGrt4eXTr2ABRqEoge5fLJbZBAIABxyfw9DisbwpqMd9c6nZx5lu9LRY57jIdnBUlcMPvHjBB78jrXuqvGe7t/macytc6mFoJbnzGR1kRRMkL4IByPmyO4JBI9T6VM12kUMce9wC2126EMT1HfB7VS0WGGG6eRAqsynzAH3IXIGQpPqFBqW9ilUM27bAVDCYEb41PQbe/JHIz15xTko8/LcNLlXUBNHc+Za+Xt8zfI7IxyCCGxjv8AXitCJrv7BNNBp41EqR5MLSiHcScFSW6KeuOvWrGnQF2Vg22PG0OwwM+p/l+FdIqJaIGhjLNsB3AkN16AdjxWFevpypEyn0Ob0VL2zF0J9Rt/7RuJGlvbnb/x6JgBYYl7Ko/iPJPPOa1LaS31T/QUvfNniRT5MjFGxyAwH4dfUc1x3jrxE9nBqMmiR2txPbDF0rsv71dvzJIAfmA4HHQ8gjHPKNO2mGy1BRao10q20aiGUyRqQdxjJY7mBUEhhj05zXLBxlCTldW16W/z+4apX9T0vSfEVqZJ4ILS4upIztGchM/7XcHg8Y/GsxNUg1zWJ5GimfVLf5LWN5JRbWZ5BcAAJvHTHU+tUvDPiu6vXl0lpGW5hjDTXDYChwSCo2n58HA3E/mMGtiO6h+VZIJJ45DsmaUkSxt2OOgz6Yq+RVE3GLt01/HYOWz0X4mfHbeI5bfTk0zxNeaVsG29W4YXcrvyS+enzcZHBHbNReJfD3iZ/B8Wl6bc6bfXNzIft9w8X7ydd3BZ5epAAwc5GBjgVa16e8S7jZJpwrL/AKMIlPl56HOD94n14GKWz1CVHl+zmZU2kuoTAQoeSF75wQDXXThOMItWaWuqX4vcOR7owfCHgrxN4PgbVr6+gSBnT7bHAhO+FTwzY7jJ6A9OvNdinjDQk0m3aTxHpUdvPMwhuvtiDzuTgYJyMnI6djWdp+r6jFqqrLJI9vIHYgYBVuCUAHTHPB69Md6rah8O/Ci36avb6Dowv0O5Vvkk8kOckbUVghyedu3uTXNiYVXUvN3b6kzTvqb+paodDsZri8jlv7faWRYDuKdsEt6+5qa3NrregxywW/2eKZS8auACjDncAORz+dQNrmrWs4+2JpBhMYYSqk0kj8gFcZwWHXaT0FS3WqXcyGOGe2iuQ4WJvJURvzjB6kHP5UKnK6a37/0gin2OW1IfZZliu/MnuYFSNYw2WXen31J+71OW6HByD0qxYvcW92tvdo8yPGVWaVhhUC5WR3zjdwA24cZOPd989xqUG2O8l0+8hm/fEf8ALQHv6jlTg+ueKsW1tdahZ3ZuraKGebCMn3opACGDrx9w8HGOCSOcc98pqMPft5/5r89DVvuZCpAklpNqivDmF4bdIZRmdt25VyCQeSSG4AO1fSt+zu7aezW4t3JtkiMpVlw6ooJIPqcKeAcdvWsDUraOLTNUtRAbryilxnymkaGTOCwz1GCctyTnOMDFaV9d3cbwXNpEI5dqsN5A3Pn5kYepOeTwd35KpH2iWv4/P9QauT+GfEOk69bSNpO3e8Zk+zmRDN5fdsLnbweV/A4rO+HPg7T/AAfrWo6hHq1/evet5xinhWJAc5+6pwTz1GBg9KdYDSdOu77UNJ0yePU7qJiuYwAhIIKAA845PAyduKueFI7mDS7WHUJg8+AFAG0gEcDB6cHp1xWdRckJ+ybUXbR7/wDDIzlAXXdQe81CXdHDGs6gSGKI5Zh91SwGSV46kA5OK5rxF4ZsLy1tbfWY1uYXmUMJowQqsASmVII+6MHPy9uprszbyTSh0lbb5ZxGqcN25P54rJW0Nxq2ozXMImtjP5UaSfdyF++Bng9Rx6964/ZxqRt2KjpsSaJpmnaFbvbaBZw2UBkMggiDbQ54bJJJycevYYq1I0b2jCOcARE5AOdh7duR1/yaoC3ZGm+yToy5xOHcMUHfDDAzjucUunwi0uhJPKGg25kEB3kqfb9TjNdXsIKOn3WHyqxyFtoWmaLqdxdabZNpsogCSvBcSXARWI3bQ3IUEL13YB4xiu2067TV40EkaS3SREygLhTwRuHtnpUdxp62JutSabfcbRFHImQFjLZB9/XmszTbxptNinMcqS8xOYTjMjbcLuHYc+o5Peqp0KSpWoq2v4sdk1oUdU8N6jqWr3sOnX95ax3umtjMh8hblWG0OM/ddWYErgrtGD2rE0fQLabVTpmt2ry6xaI4ijuLkm3SPAIEeMKAcgYPzeuetaNl4+/sjxBqs72L3UDQx27zxkm3ikywiJA/vuQDjAAIJI4rasNHZtQ1Ge4vnkuL0KSwfKIOfkCnO0DqBn07muOMJe0lJ6x7brysTe3Qy4tJs5r6OPUPDNmkUUeGnkDBo2HRdpzuHuDgCt7whdHRdRk+0wbLK/KxwBUCi3cBsA7egIHU+g9qzLmDXoIng1BrW6iBCx3sGRLH/tSxnI9Pu5qC/wBQtPD9rcz6jKq208LwjYSfMkKNt4HG4n06DvXbUhCdFySS0v8Adr8gcVy3Ld5Bb6trsKWMVmivPJeo5yjPcsCu4+u7HJ68Va1Z2JhtzG6yS43yD5o4mH3TnGCM8djg9jWf4VbUL++ElvAq2EMMXk3RRgJiQCWGeyjjPrn616FPZeZZ3pRI2M7iXj5TuBH5AgL+vrXlSp+ykqkJXf8AloKUuWyPHrzWtWs9Sl0uexe6uIbVpYvLQoWKnBGD1zkdOx55raL6kmmBr+yEV0du23jk6Djjf+Z/SukvL5zrNxGbDZeRDiQNuBUjs3U5/TFMFylzazrcIvljgqw6n+7j8ia9SlOdoyetvxuNN7lZJLltJR1mBfcVBJ4JB5zjvjirMVhE0dxMu6OSUB/k/vAdceh71R0y8S7WJTAIDj5lkBUKB3OauHVAmqxWUcZ2zK/7zPB2960mpp2itdwkmtjJtdOjlge0RYpE43BgSNvX+vX6VaNi6SDy1UQABQWO7Zj+fSm6zEHs44oVZWdwCwPBIPCnHbPP4UQXSrayqXMkyEBgg49/5Vo5SkuZMeu6H61ZrNafZXkYRv8AMrgkFRjJH0zWHrmpTaXPpOorEI47YlXdnJjkjICgN/dOT1x3rrZTG8KC4hG0EYJPQehrKnlXxBdan4aW0hl0m4ttsl3jdsIII57568dMVyVG50+XtqQ27adDDmv/ABFq1nJcaQ8n2e5ieC7WPBUI3ClG6kjnkVjeEprDQ/D+qLKAupSlEiuvKEjHGcDnjiu98C+DLnwtpraKt559hqbFYectB8pP3T1U4wRnOTXO+JtH0rRLvUrDUBLLb4DW0itgoxYkcnjgjjNYRdGdVq19rWFG3zK3g68XT7yQaJZ2upSzx+TeIs2XGTngdhzkYGM+4rk9b8JTXXi0C5BtYo3DSgkfMRyOPrjmsi8s38Nz21/pgZY/N8yG8iyJp+f9W3AHY+vHeuq1bxLe+IbzT5/OtrC2kUJKMgvz138cg4z7Vk8bFzUI630vqum2vZdgSv8AEtv6+7+vXv01DUrzQZptQsEaexKxLIp/1i46nBOTXldppkth43ZtEd83X71kcMQGYnJJOQenXuPWvVPDt7YfarnTdIc3GoqglfzOYmBHqK5XxLr2sLOtzFo0dre2tyDKTEHwg7ZwcZ6YrTETVGXLZpu1rf8ABvoCS5r22KWdT/55w/8Aftf8aK3P+Fk2H/QLl/79iinfH/0v+Abc/l+Z6DrGhaT4x8L3GmaiXKeY8kcsMhVlJyUYY4b73Q8GvOvDfw31WxlsbW3uITo1rITKtrCy/aD1UvlhlgcZyTjkDiut0mZ9OhhBeKRZBlVVsowwCApAyRnHb/6/Q2msQSXkMDM1vBcAqjq2EV+6Y7N/MVFfCWndamN5QXKti59jtpbV1eOO2dDskAQ/I2PXnH0ORWDqGm6rBfxyaO+ny2Ziwsd1MY5IiepU9GX2q/q96NMv1S5YRx3O4rLncV24+U/XtWhZzQ6jGzw2vk3C/K8UnXH94c4NOPNBcyV1+BMW0vIp2GjpbyW9xfXc91dhiVC5WEHsVBA7Z/Gry30Usty0LZFqSzMo3fN6e9UtStrm20W/t7ee4kuJlkEO+Quyls5xnpjqPpXLagbrw/4Ii0+0Cm5vSLVCeWKn7z/UDHPvWUp3i5SexUY87seS+MLkz6xe6tphaG2ubjy4kgfL3b5xuwSNq5JwCD1JwBXovgrQ4NDVkmNvea1G7B7hAcQlgPlXd04XG7AJ9hxWf4R0C3tL6TWbm3ZhAN1p5i5IcLu81AR6dDx2rbsjdagsf2NrW6ilCG6Drl1AHXcOMg4PI7YyMA1pgsPzJzekf6/pLRHRPV/1/XqYur2k2geIHvdFsLeRrpCzRMxRncnLODnGemQRznI5rb8IarBf211OYZo4orZw5lQ5Oz0Yn5xuPBHBz2PFM1iwt9ds42Ml5HcWqCWGaKX585ALEcg5Azt6+vPFP8P6MuiSG7kfULmZowpF7MQdhYnbtUYBYrnnoMYIrrlzqPKl66/ihbx1OhWRpLCVlU5UEGPcBzj7ufU9vrVeRLeyJ+031vFcyoArSq+RtGc4UHaoPr71Fo1hLZW/lSmGMyIxmMYLZLc9+u0ng/Sqr6W14sX2yGSJYome2vxL5iAAj7rDqh6jPzdc04KKb1svxISSe5O14Ib4Lbxo87AO1zg7DuIGVbOM4Oe5IHNaVo01zpyJcbZJSSSoUD5t2VO314FZEtv5brAjwSugG9dpEic9z/dOR04PTNS3f+iRIFlgguyVEKNyJZM5wFBBYDOTg5xntTnCM0uXccknsU9bsb6JD/Z8K3UZPmsH4faSdyMCMEgfdOeRxlTyZLaKGfyxLIsU0cIfDsD5gY7cHByWBGPm6Ed+TV64le5ihuVuWhVJd4lJwEYnBRsfwYXkf1yKrM2l3l1qEV9a3cMVk5z9mm+eVi2CuFHp0GTkMeRmq5pOFmtuq37CV+pqCxgkdlYllk2l2YnPC+n+FZnijTrrVtOtdN0i8mtmikVpBCxWV4geQvbr/IVPc3GpN4jtBp0fn6JfK4WXy9i25RTiNj1WXeAO4IJqHUreW4hkty4ivCiqrSSY3kEj7w5HTnAPv3rOlGcJxcpa797dNV5CWruyK7W6it9NivZdupL92CWUK784zuxjdyMjv0GelFvZ/a7+G/ijnVn4nM2F3AddqnnHseAee9Y7SXclvFbqIL+5hYOLFZw8mzIwCDg/Pk4PUDFaM0d7beLriSSMNatI2JfMUyBDnaW5+6AQDn+6MV08jiuVNJ6/n/wf+HLt/X9f1+mlqNpvnhMMgSUMEiYQAuvPAU5zkk9RVp7i3kiF1LteQ4X7RC2QWwATgHbn3/nmsy0tb+xbzZ1FvktEsbttVlIb5kB7/MDkHHPWquqO+gaa8jpEqTOwDyFpVMgxgc/dY7uB2UCsFT9o1G+vTzJtzOxts0z27iOPDqSEQsDkA8H8QM+vNR6MkzWB85FEskm3bJgEEcFwM5Gc/XgVi6rNf3vh3Sry3mh86Zt4aYGIOuMqf9k46YrtdHUXulu3mFJSgK4xg5X86yqRdKn6t/gTL3YnO3cdm6XGmWkzRyzqRuiIGMNyTgcfdxuzkYFV9P06V7+JfLQKjqQ27eNoXgbupJ9cVfv9PeN7kSRBTIQudm1gvcjpyR39xUGgTSaejz3jZikCRQpID5pwNpL55J5HNaqX7tuDuWnpdakmj39lqWnNqmnzyNY3aPskOU43FWI7HlSR2NZNhDcW4v57ef7ZcIECxqSQpJwSynhSBztz6E1reJroWBhs7G3+w6bawDcsSrjJORGi+o546d6z4Yp723t7jRnFoWd1uVbKmNs5LYA+Ykeveqivd5tovvrp2ZMVpdnKx2s+qXfia0WCOG5XUYbiRg+A0YRXAwBnB2vj6CutgnilkcwPHtjw8iAAbN3Qso7H1GauQWjQyTzSuDfzTB3mI5JUBQM9cYGO/JNVLq2ttOuQyjEd0DFsjiyq56DPTAI4GOKypKMrr7uwKz0Fu7poClwAWjI+WSNSwbnFcDpmj2mqeK7y51R4LiKbfFA7OQ0ExwFCDOA/3j7cV18ctuuoxaRHeRxXd6wkiS5yqyJkbifYAfXjjpUV/rOl+BvCP2rVxavLcalKttJbwkxrMWGZN+0kYXLZ5Jx2rnx3s+Tktd/1o/MHJRINIOr+FdA1KOS/F68DosIgX7sQwoXceN2Vweg7V0KeI7BJBFqDXVnNFZRzXECqCHJjDlVHXIBBP86wfC8tzqOpwyQzxGyeYnFvOoj5GQQFOG3Ej16knmu11LwvpWurfTbdt9cIYJCvyyEYxtJOSBxzgdOKqr7OnHktd2umn10tcmVlucXcWlt4m1ZrmwOoQ3CQoHh3lGjzyDjOOcDj2roJdMs5mL3GpQy6kIxBcAS7Srdvl4wa1dM0Wz8Pi4uZLjfdIVjyCcL6Agk+vGe1cZqumXVx4mvUsreFY5Z2cb487pMf38ZXke9VBuT912S8tegk9dDZ1DQX+xPFbvJIMgyFzgnHQD24PFZixW1pLbyyOAPLZQpX7oxjoaY/iW/0O+tLDVmS/mgbdcyIpDQ+i5OAwAP1rpPEllY+IoEutOljlKKGMSghyvXjH8XtW0K81ZVL2fUfM1pLYz/tUNlCmdrRkblViTtT/OKoadeWsQudtq/lIcyTnBCL978QPWo3v4r7Ure00zTZroRxh+TsZecfNnsO5rmfi3ZXVqYltEtYNOkbykuxIyiQkAkMoBPynPas61dU4aRbk+gNpK53WgXFp4iupNMikdSsIlfd8rOh9PY5zmuh0fw3ouj3d22n2wtycByWPQDPU9ua8p+B2jahFrcmoXVnN5FohtLa8YECRsAEvk59ePftXS/EnV/EN3e2mlaFp13OJW23TrEAsgxkR7ieAehPpmuCrJOSb19PMzd29DN8Q+MrNtX0q5luovstzM9hZPPENgYOv70sOqjOeSMde1UPjXaSaP4isC0wnsr2IxSQu4Dbk5LdPunjP/6qq+KNGvNR1LQNGSwtJEjEkLFiVjkaTDPkgdAVXB6jbmui8T6Do3/CM6FoHiK/+26/pmyNWtJCXWIkKQxb1UDrzwK1p03QqQqvXr8v6+4d2rJHm/g+wn8Ti7/4SC6+zaYozaJK37sdhtODwDk/5Nej+HvCSS+HEsJrdWLzNMbjaGYR4xx2+7WvodjBpNneSBHWwjKxL5mWDRgEru6k7cnt61Pa+KLa88VJ4a0+NpwqO1zcKp8uLbj5c9zz2+nbFcPs4Va0q8VZvWy6a/1qaqTguVff+P8AX3HnXg68vvCvie7sY7OMTFjDJNMNxYA8AHtkYI7da6aC5uo57i8uSZ7e6mz++GRgdV9qrvZaprPiPUL7RAgFjdfZ3M3/AC1XHJB5wcZA9zR4mTxGhi/sGKBtKiGZ8sCpIOTwe9ekqzhBxqq7W997b7k3Vkza+xeG/wDoDRf5/GivMv8AhYY/6Z/98x/40VH1yH83/kxWvY9J1FXt4ZTaTeXOY41WVQG2AH+WB+ozT7AyWGZkDzQzsHeO4y/m+vToM9MdOKs6ZpKuY7q5aKOZI8bUPPoAexI+nANOvreRpSE80q4CxtBIVII55J5wT19c16jqR/ht+pd0/dZnTX0HiizmtNNtJILqVGurXnP2ny26buqSDDKfpV3+1NXm8H2EQia31KR2QoXAk2DvnAwRxknsTVnQ/DJg1C2uopQJ4onJQfcV3ILOOc8njH51P4gt00+/0rV5Lr7PZ2955xluDxEHGxlz2GT36Vw1atuXl6fn+fYi6ukir4dvNSudQ043U/nTGF43ZBmNlGMkN6/d64PPSn67rcZtru0t4lku1dIFMkfysiYyMde5+prbk1G0fWLyK3mhVvsu1EQgZTdy+fQ4OPYCuD1PXBqOqW8bGbT/ALfMtvp8bgMZVVS0rjjjp37YFcLUuXm7v8wjaTu0bU7iGcJHBC4gmOY3kZdoB+Zzjl+Rnb3pbx/tVnM0Jgtn8w7tsQ27s8ll4yCO5PGRUt2DLMokaJn+/tkGR7jPoPXvzTFkgW/gZ1JOCm05DZIP3Vxypxjj6mvYhFJKy2LS2KKt9nuTezK32YEndnBJ4AAyOM/j/WrdlckTPdJi8WdDPAzjo2MhRjOcD+WRxS28+n6rZiXTER8ylcMdyOVyGQ8cHkjPTNOgsrqG1thbBlkVAFELZwQfkGehA5GOn1rSbi1aSs9inZlHw9qU97rt1DeSO1vOslv5zZAnynBX0PXA7YFS+HRdWAvLaVHVIDGj7yWWQ7drHnqTjdx6560s2lTi6txaxxEKqyTZkyIMnkDOPlODzyauX8889us/kPEqSPDKj7cnnCygKeAw6dDnrRVlGekLWdvlb/MTabt3KZW+a4ljktle3kuFMcUBLZCAEPnIAzwNpyOO/FQXN7YzWi7JY5vscjq8sMwZY25byzjmM/MQQeox16VrQSxvbm8FxtVcRxyKxyPmz0/HGep/LGf4kuLIHUPs9vFFqMTNK0MShJJ+BmZvXOcZ+vvShLmko2+77hbso2/iKDTb+KOS2kntCilxbK0kxeRhgMh+Ux7Pm657Yzk1vXMapewK1swadS0l9vAUFB8iOpIJJBOMc8D0rG8M3L3FzLqbXck0iQLCoQp5cTLglo1Axk525HP8h0eoXC29qJpEJkV9qrt4JPAz7dOtRiEoVFGK166/8N/W6JkrSK0VoY4Lh4YZLhpsrK0Y2yEkFDgAlhtXkYyTwe5rOkMeq20ckrTrf26lEZWAM8SttKupIBZCfmOeQAeecLp8rSNKbz5pZCcpIcudpOGXvtIGQfcetXpYLU6nDJdRLHdZAlcKW3KRtPmADgkHBPp19aV3Tdpavv8A10/rtZ/C9TJ07T4TeQsZrmeMDfGqxqRG4TZudgfm2847DJPJrQnsrttrPbwzxxQZj3XG0xspyA/HzR55Geh69a6RbOO20+WCOULAYmKKgHlwxD3HsOc9azdJez1fTpZ9Huzc2zOuJ1YghgBgFTzyOemMVHt5Tbn0X9fJi503c5ONbbUnW2t7q6kmt3eS4MBEPmuQGGD/AMtF5AJ4yRnGMVsXC3dotuVn2DyQlzb+WHUDfwxQ8NtLBT3GQRxU0uhWiWYN0stpuLSOLc7Y9oPfdnB6gbcYH1wJJLvTopEgnuLeK4uYSkUk6YEijAC5PykgEDB5PXpWs6qk1yJten9f8DQcpJlW9vL+dI8lY871LouY9yPgbs8YIxx0zn0rG8RajK2rwQXSzCGS1kmikyN3mofmCKDuztOcc4AIzWjomkXsV1fX+osiRsDDHAPlKgBQQNvG0feHA5IOO9V9Y8OtqOt2ms6dcoZFiWPbIgZIyjFklAI5IbAI44J57HCtJUnF0knZ/nuhrlibmiXj3WlpLMxmkY5BGckdiffBFYN39gilk1C3nbUb2IFoLVAUduc4DOOF6HA9M4roJp49Ht4GsrUz3V3IIoY1jygwCWLcjaOOuc/WsnU9FZr3fAB5CHfu/hx1b+uPrWlHkUm3on/Vv008xRtd9Lk2oSvqWirfalbNa3AG0xiQAlgDgJnruB+uelX9GC6bHHJbySsjHLLJ23dVP05Htis+G1gudQsI9koNoysyouDLtBCjceg+fOR/hSXl6ba5a3lQBPuPHtbzGJHBAHY88nuPrXOlUqVHS2jvYnlbXKjYvbhFYnHlGQ85bgLnGM9fTkVh6+l0buJg3m2vCvGWz2wQe+SMcjkH1qxfW1xLPaR2bbl8wK7FSxaPrx70XpuJfMS7hurJTOYkG07ZkGMMWIxk5xjNdFGKg04sIqxzlr4T0zVviDaandy3CraM9nFbykBjIik8dmUqwIHvXL+P9Ivdb1y003S5oLi3jljumaOFngguEJQJ5fRcqEDEHLbTkcjHomkzDVbqPWLuR2tNGkaExyR/vJpcGNQpHAA3Nk9c4rsdNfTUtXjttkcMx84lcDzSwADbhxu6D2xXDKkoVL1YttPvbXe/5PoTKSs01ueP/DHRbPSPEsengwtdbWkmktEYQYV8lRk/KeQMDPXHWu4g1rVV8TPE0Qe2f99HIpxkK2GBzwFxznIxx61d03QIPDVpKtpdvNcX0pZ5XI3qD/DjqBjPFM1u+ln8Ayavp0EEkAt32AsD8isRnJ4P3QSPr17k68IuTtzK27F7rehR0eaxtNU1CdL+5c31yu5LtxuZ8btqcZ2gEcGtK71JLeyaeSRYShwORwqgHn/e557da4vw9oZ1XWtO0rWb2C8me1N5HdWx2tGybVCOckspzlW4OF6c1rHTY5Pt+k3D/ab0u8E6SjMcKpjaXfuWGCMc544xXPepKbjVdn3G1G9zT1DVY5L+f7dp7rO37woRlU29Dkdzx0o8NXFnepqc1veL9ptNvnKw4HBPT14xVTXbSO6s7m7i3XVxZRtHNBbcv5m3cIz1IJyPz9aT4LXVhdaPrF61l5EqXjR3K7zIu/AOBkA98EHpzXe+X2TlDpZPb5f0hTaSdhNeivm0lNb01d0D7g2z75UjgjPXBGf6HpXGeA/FDt4jGneKJXljcllmuYTiKQn5doI4yAQOmCe9et63Cbvw/IEjxCJB9nVRlEz3IHUYyKxvDemalp0+p3kkFhLqk0a28UqqGEcajjnODyQdmPxrhnTjrUg9b7f1/XkEZrlGeNZ72C2vUsY4rGSKIpbbpQrNKenPbjPNZvgu78SeINBmspbs6dqFukamWVAZHBHUdsHDfN71m2+gaxrup3NprtzHMFnEjPCflJXPLf7XzdPautltv7Dil1GBJb7Uo7Ux28YIRZAo4B7nr3rWu4Riowd+/l/XUOWxyuhLrsEFtJq6O9/A3ls+wFXIOMn0BHINc74iF1ZeK/s/mHyWkWRDJGGeYNz/ADzXaaDP4gtTIL6De13IGiyctHnORx/DgVf17UzJf6XFbW9tckZZvMGWQjpgnoc12+0d3tomtH8xq6OQiutS0b4myLq0E7WFwm3yCMpHwNsgP8xjvXQKtn4cl1PWjkxToxQhdrKvUj35+lY3iLWrO7mh1S41HbqCkhoj1Cg4I2kciut0R9O8W+EopImWS2fKNjqOT2/HrXCqilDmXknbsLRI4Xw1qaS3l5/YF5JKJpzLPHtIZuOQPceprb8VR6jF9n0/TknNhfwlJmdt218jAx36n6YqXSpfDXg/VHkgvIjDp6lZkVDvUkA8f3uCM49xVSbw/rPiPxdH4g8M3ONKlnV1nnlZdidGHl9SeoHTrW8uZzcqnrrpfsv67BdXsc7/AMKeu/V/++f/AK9FeqfaT/0Fv/IX/wBeil7SoR7SHkVIEEUZeeRQ0jNllG0Lkev9Rx9KXS4HtYnVrqW8+YB5XA+Udhn2wD+dYXmX017bvFNHJA0MY/eKWAXBLHHpx1z6Vf0y5jF5JA0h3hNxIjMYwT0X1x+fNd1Sm7PU6WnZmt8P4hpct/pUjRuqzSSwknLkN8xAOegpvxEtmvvB+oW4gF0EZSyPwqgevr1z+ArlNansNUvRYX9vDc29sPmKOYp4WI++jAgjHPPK1rW91rml2dxpl7qdvc6JLGUt71lLXOW52yDG1uON2a46tOrGopTV76kODUlLqZHgnSjrU2jeKLxjbStZItym3lzHlQoOcbWwMjHuPbkm8TWf9sReItOka4i0q7ltr23fa223lJXzos8jbnkDqBz3r0q2RLDwnsWaUrDEJYpbfAYKpwfLJ4BxgAdgO9eXW2n+B/7bvdP8R3eqaNZXC/6P5kI8xyTklpQCAMnGNoz3rnjCc1ecW0l06FX0cv6sd1Z6pe6jZRSWcFvDCZpEd1ztZQw2uD6E5IHQ1swonlETDyfKPyBV3Ak/3fQ+oGDz+NY+hXmk24h8PaNqv2+6sIfM8u4TyZWTntjBCjoQOB1HetaN7eE3RCSGS45zExYk5A3AZAzx24HJ716UKjceVqz7evr5Apq1kTRwW2m6bcXSwvE0WZJVjAzGD1xjqAc5788nvVi5uFMlkkV6kFlK2TGP+WikDbwB6kc+46Y5qWtwm8xxGRYhEA0rKUKEkj5h26YwauSwhILWNQHeOMqHQAkk9F9sjHSs5NJ+9r/wwO3Uq6lLLHeokUZSPIZpFXO/pu+vXggUy0WR7yOCck7lJaN0GNvoMKMqRyTk4P1p73TwQGTcrIh/1EcJkkJ7YXjnnkdv5aivtQ/aGaOMJucMDtXnnj2z06/nTlNwjawOWlrFG6v4o7kW0UEDzSksE8vChM7S3A2gcfpxUNwIrmwvXEzho13S4QB5MYYAydSqnHG054pvmabeaotms03mgLdvbOrhQNxAYkjHUH5e/XHetF4o7Sfz2kij+VhkyDbk9Tz14xx7UnKMLJJpiuuhi6chtrm5ZYYmLMEEoBLuQFLAgDhccBTjpnir4nN67EqFiZeUlGCx6Djtjvn146Vg6xr1pp3iBtOtJrRb2RUaKCNlaWXPdk645J+Xt145qDxBPbFLaGeaaW4SUyyESKgOSFwc9GHBHbH5Vo+WUlKT0f8AWvYtJSZrjUnWdQbaO0YOFMYQs5DKcnGCQ3t3GOeeL2kWUerXkcjNDI8cpZjFJkq4HOejL2JDYPbpzWTcXySxaNba3DmSaXbuGVdHAyGG37wzjOcYAz9e28N2SW+m+ZCuxXlLHPLSooPzE9TuPP0xUV2qULpWb+4zm1FXRYlVZbC7t7Y+W80bxbtvc8Aj1Ncz4P8ACi+HbKKZJHE14V81D0IDEBR+f61b1K9/4R3w7Ndal5uS33o1BbJICkKSPl4IPI4PrXO2PiVZNFGowXd1NqF0hisldC0rzMrbiABhSOdq8/dzk1hSp1nSbi/dbt6/8NuSk7NI2PEKO19cwwb7ieNShZCdpOSSv/oIPcDPtWTpmktLoMlve2+QH3hXQrg4w20dVGentSyWr2awW7yKw2sxtJZg7IWxvdnBIZmIJI3cfnVcao+m6ha2Ntp2pSpIv/H3NCFicschFYfeK8g8dByc1v7T2dFJPqjVL3dBuj2P9lXc+nW6ypaRuERMF8A8gAnsN3A9vet+1ZIIh9nksb5RO8V8Uuf9RhBkYAPz8KNv40k2oeXZi5Npaw3Cg/vyGxEgUlm2g8sMYH/1qydLs9Pt3v8AWrHT2S51OWIXCwIV2jnLhTj5cnccjcOetOtUc1zz/p/1r+fmpXka0mqC0hCIh+zswSTruUHOP8+uKx9QTVdH13zLuWOTTbjLxNEu6OReykk5BA6gjH1pbfR5MXS3dzBJDIjJlAWA77j0xggVetf7UttMn3rFcPcbSsON6u3c/Nxk8DOOlWuSnflad979f8gsk9Cz4bvVmmt5YFWIsHiXaCfn24Uj2yahiuLS/wBei0fV4Jby4SSSNb9iFlSQDcVCgcx4yMk/hVG6vrmS9dNJ0vSotBiLW2qFkkhe2df9aQcjCgH5ffByeBS+GrsNeyxiL58KpuTHslk3gkhsdenPSs50/imt7bX1X9duqIcb3kjolOC6x5LQoVYxjgDsce3Tism2a6GqQx25aQO6R7QOevzs/Zl2nH+c1l2k0tp4qmKSbY/PMaxplZFUruz6Eeh9sVpLrVwtzNZzsxikUmGVRtjk9FfuCT24/rQqMoP3dU0Pka8yhBouoX9jqkgvF+zT303kQKoIhcfLhj6HBOf9oDnFbfhyyEWnNpV0rukGXkLQ4iO4jKqfTqfqT2rkdW1Ofw/4hF19m83Qb0CS6MQbfDLjAKrnABAGTz0PtXoGneIrTV7a3aC9DW7qGO6MpI47Bh26dsfrXLOrNKSns3p/XoKfNYgt7yG/1C+srRHePTmNtIhfBOMZIJ74PI9Pwrg31S58O2reGbfc9rM8pgmVAG+8Mxquecc5yBkHjNbN/rFxpepS2kUSxw4e+ubh0JKA5CKPXvu644qO3NnN4hivQkP2mbM5woLFAMKwbt/Xms8PGU731XX8f6/UIxt6Fm6l1eyheKTQ4tLuZQIraSKRH80YySAPukc8N2HfOKrLpluFKyzFZJiS1xGuS5A479qgGqXSaldrqMbsFkKGU8fIeVx6jGKdBFcrjayu8RZiy8Zz0B/CuqOB5G5SZXI7amx4Ut7PRfFOq3B1Iww6iY3iguAACwHzHdnG4sWIAx97pmqzz/2X47v7u5vWm+0yqzQRPmOMAEDK+p/WsLxFLbmO2GolJbedRBKGTq4B2kEcL1rATS7GO+1bw7o9uz37QJewxFslgF2lFY9T2APQCo9gqS5Yu99/v7/1oS463Z2F74c1u88XjVrDV5pLCeZZ5bfaBtwmBtcHG3/Zxjn2rQuhrsF5dyrquxZmjSOFowyRoHBbaOxKgjPbPtWH4Iude0jw9bWWqLcWc1zESsc64khPP7vp0xyCeaux3fnTra3riK5GcEZKMAMjms5QcnaWiWl/63J5fuNjWNWFzYyxpbiKeJD5axONm713fnwR3riY/F99JcT/AGu7Fs8bOgVow2cdlOBn64rV1SdrPTriR4mJUDYiAjcxPygH1ryiAxbL62abbqFzP5gWZsB8cAA9AOfc9fStY0qdOXKlzO39bdWVypaHb+Gda8R+JJXkOoz29tbuYng2DdKeoIfHGePXrUS6dc6Tq9nf6PfSiXzv9KtZX3pN23D0fn6HvVGxkmWWWXR2u1jx8zKcgnGMx9iM/nWvqtxcWejaVJehbe7nkVHlYEBCeecHj6dK6KNJxV57tf8AA9NepfKR+P7Wwu9QstWu1jtXud8U0Ez7VjfA6jvkZwc9q0P2eb+xj0PUdHgmRLmKZ3STJdXU5AYdeMg9+lUPFOqzx6iNLtbmPUY/J2lrklRuJ6Ej73Q8DGMCsX4fz3ln4pupLe2UXpfy5zE3YfxLx/tAEHoMdK86U6s4RT+Hbfpulb9TO138jvtQ8K6RfzahHcbZr9lImMWBnPfZ2z1/GpdMs7rTvDd7YaMzxTQfPGc5LDvj3xW3pumW8mt3GpsWWaSPYw/vL/j1qXUtBld3nguTGCp3En7uPWtXKLdpN9N/IXk2eO+Tef8APrqn/fsUV33/AAlWh/8AQetv++1orp+sz/lX3P8AzHdeX3f8EmW7a7053tnWVowFzGMbW68jt349cYpNOuxLELzzI2SKRjHGoYHAHzZHO7kdQPamPF9okREt38xJwSf9W7bSMHPTB6YP0p287UiSJ1O7LqPU4APsM9fSuy0Wmoo2srWRaaPT7l/PInhxgPAyY6jd164IGfaqOvXUF1EIhI2Y5FYuFJO70HTI5GRSz3Nu1xHBeyTKzAoq28ZUbsgE5xjB4yfwq5bWQSVEVd8/Vn3DDNjgexwOtRy8nvNu/QaVrNljT7s6S1jYTbbhrl3Z2CnaCxzhfxqBvDmiazEY5dPinlilkJldAWijPDIBnKsDja2MVBfKgmsru5jl/wBEl3jHQ8/dPpnGc9OKoz3spu21KCb7JqCEuWY8gejKG5GcZA/nWE8N7X3k9evm7i5Xe8Xr+p5L4p8Op4P8QxjUZ9XsmnndbXU5G+UbuUl81WwpXjPbB7V6IviZdum2fiOCzE05ZYLyybdbzFW3Z2kh1AIB7qcHtXS+frGoaLq9trdvplxBfLEthHcxfup3dSWiK9RyFI784PNeO63oumeHZLLxGmjB9Akn2XTW07wtCxIwmcERkNuGcYPAODzXmV/a4NuaV33T8uv+e99B25tXpb+tP8vU6v8A4WCI9dntbfULEaRLepEfkAEvIBkDk8ZyOD2GOK9Dhvkl+0G23tLbLLCUERBLdV+U4zj5ulcHJJ4B8QbYNDuvsF/MqiKG8iEqzYGFXA3B8biMdeM9MGuo0iy1ix0uNtKsrO7gtYAVt0naAjB+5+8+YMMHrx/S6eN9p8cVfy2+fmKSjbmj+OhoWF9P5CuzM87IdzquRG4A4LDHB59+DVTT7+eea6ik2nIRodzZBwc89wM549qt6de217phvLu1n06WRxEbObImDHuoA+ZcckjgAc4xVPw9daP9rudPtZJPtNtEZpFuGKDkcDdt7YHHpXoQrU5xlKMfu6CdrO6H/wCh2FtGt/dy2yyZcR/NcbeSwLMOmc9OwzWJZXkD6bZ3d/PPcTy7hBFan+DsBvByflJ7dBmue8T+Ipf7WE9tHbXFqF2SJbXG4CNRtYq/ROOuR6eta3hiK+8TW+n3mjrFBbz+YskDzouGQ/N8gyRwemB19waPb0VVi5T1s7/5aD21Y238PadpHjZ75PKluLl9ysI/3xaQfNGecBuOSMAg+5qp4st7i+1A/YLeSaO5Xy/JAyySFtrLz0ONpGMcde9dPa+C9Uu/Et1fX+pT2iQO0UFnYJ5sbR8480yHlxnhh0wMdK6PSPC8OnXcN7D9pe+jjZEuLucSBFY5b5QADnrnr79qzp4unC8oq7/B37i9olq9zz/Ubyfw3fNNBpstzaW0Yh0/T7iQSSTuoCFpSf4MFm3dCOOnNemeC9audWsPPmRGVSwWIPuKnGMbh1+o4PUYrWi062huE3QZdYyqjqcH+VZHi2aKw8KX73M9vp8Hl/Z2knRyMthVyFGSeR0GPXjNc0pOtJX30S9Pxd33MpNT0SHaxPp2ueE5pR5d/aRqVbawYF0cbQCCcHeP5968K1LxLd+G/HEniCzubXTfskltZ3OnXshZrhXU/vkGP3SmLG0r83JPQkHvvAlvp3h3wfeSpqLatcvdvDEZXAEZ8tmDuoI3glS2OvHHTNee+EdP1PVPFX9r+I7g6jYPq3m6nlB+5mt4v3UhdRtCZ3KqfdC/gaeIw81Ravs+9t+tvJ7/ACBp25eh6bbtYz2lpaadAsVuIswQzhPkDcgHuMn+9zn8ansC5trZri3FnJ5ZD26ENGr4JCuAM7eRyuPmXGOQBoSW+ktf/bNKb/XgSxWskqggkYyq/e59OcEnpXJ+PJbuHT7m/wBLUrqkUaPbSRnHlOCqbQD1BJB2nrk56V2wnFU7JaJfiap3WhvyXdvb6fLc3n2mPkRxEKV81j8uEJ5Izn3/AEp+hXN7axv/AGpcQxee4is0eTaZX77M87QpAJIHJA47+Z/Di6u9U8ZR36xTy2C2jJcrvkmjS5YswmKMfkJOcYG7A5GWzXocslpJG9xrsVy80QUwXO5BiIYZmcHb0IA3D+8Aeaww1Z4iMlur9N/lf8Q1as0W714p7qeK1u7WHV4I2eCOK4WEPIOqODwCQTgjHQ5yDU91KLC4mntZ5LmWcJ5cLONq7FwWjB6Ak5/I8Vz9wiaheC5ltYGklVzLLgqzhfunHqeAfqMVpwxi8tYYi5KRY8pwQc9AqgdSCM59MV0TpRio3BxsT3kkms6dJBfwvEJlzJENuJkB539iQBwDwcYrKjg1SwlZoXe8d23JIIxzjGDx0Pt6VpxMlpazXUC+ZMjYlDEsUGc55PQ9fyp2m3Hn2cskOTLG+8xIOdhwOAPf+tVGTinyrQForLYrNqENxrpt7IwyXqK0rWyHL24ABeGRgCAeTwTkjoMirN6IISzMQ0X3lSRhk8cKeeD2zU2pvdx2tpqFreJYXEQM99ZQRRsdSVVwI2fGcDkA9cHGcgGsO9ew1Oxjm1iFJLeXy3DwEsCwHUryDtO7jjjuRSpvmaSWltbf0vla5Ebs1IJ5Lm8S7YdBjfH9089efxH6ilvJY21G3kkdlTzD5eFxt4wMDswz+PauF+LfiW60Cy0qPRpUUm5KSTlT5eQqsFPOQcdVPUHjpWrp3iKwvNLS6+1wxm6nUrFcycqx6qPbtuHGKwVajObTsraff/kNNNvyNezuZYr4QXcsckMxJVzyVOCBj0HXIPqaih0+W2Uf2bDDttIzJsMqhlBbgLnqrHPyj6elQafq1nqjTw2NzBLdQsqy+WuQCR8wHsccY9PxrK1bxJ/YF9axXVyq6aSw+4MpJwAS3Xbzn2I4rerL2d5Jf1/wboblpeJ0V7pCXl2t955QyIFPzfKSOVz/ACNPtb22+zJZC8t3vY4z5kaMAxBzg4+h6+lYPivSdTmmsLWSLyI9qSRZy6uSQW5HC56Z46132u+Abb/hHdPtfDEFpp9/pwUW5bIQ5PzqxHJzkkfhSqTSVNTno/w7fIUppWvscfqugS6zbtFLNIbXzEdRtAGB1H1PPPbisl4LmXxSuq6dd20VxYgI0jgnPzA7cg47cmu81zwnqkOmf6DqMjycM0axjJ4+ZVPBwfWsnw/4AvYdFmhl1CaL7RKGaHg7Btw3Y47dPSsPbqV5Ow1NNX0KV1cX15rF9e3UbrHIxkhQnfhR0APSqzXVzc2c06ozSq2ESXCsTghhn6gVc8cWGqeD9GsXS4GoWpl8hp3j2unHBbHBzyM8VjaFrMN3plzfXFu0TWsjLtlJ+cjgMAe2Tj8a3py9rTSt1svlYIyTWhmzatdajFZ2VxHLbzC5EhikH3Np43H0xuA/A06/8M6dqlzJLqeniV3CgNkguoyccenGKdYTrchJEjdpJ8u7AEksevI/KutkciyiWB0LlenVQ3cVo8Kqcmpa836FOPLoyC00pUMJtSsUKpjygR8oHoKs6qunXlkLa7tkuIGYMyvnHHt3qqJT9lhDFRM+QODyR1PtVqximxGqKWUkt8x6Y/l/9epnFP4ugmr6soHRbJtZ88WcCuxBUMOqAcFf/rUsEEdjcsLGMQzSZZnYDcVJ9eueRxVkadLDrEly7M7M5Kru4UYHH4VJKLhp5pJkRZVYBCO49TTjCF01bYSEGvXFuUTysLyGdjjJHoK0dO1ia/mEcsjwlsh1zkEev/16ydSsM3dtLDGjI7eZOJDgg4OCvbOfpWb4itZWaH7FcLCGwXcH5xz0x3qXQpYj3LW8xqKexqf8K/0L/n3t/wAh/jRUW7Vv+fyD/wAeoryf7NpdvwFzeZJq9zeSWyNah/PCeWkTswSU55yw59eeOat2osHZxvmRgBG0ZZickDjPGSOeT6D3qTT9bW9v5reaAwlckEMTyq5yxI5yOQRwORV6V7Zpo7qVI4rtgQF2DcV6g4HU8Z9R7CvanNx9xxt6D20tYbqclraWN3eiPzSql2VZD++wP7vTcT245rBEsuoxWd9ALu1kIEr25Ox8kdHHTIJz/jXRJZMZJpCCzMAylehI7kdPwqO7hhuZI2kBlfG4uoAI6cHv+feppTUP6/AI6M5271BbyJ7OedlNrOkk0kalTuxySOmD7fgKsFSIkjt1iMcUeJY9x3p67j14JHPQDjtVjUIktyskUiImAVkB4eQj5QT9eB7/AJVmyWQuYJLWbAWctCHtZGR0Rl+9k/xdckVu5LkvBbfmaW7HY6ItrrWlWsN+LiOO3YgxMjKzyIQRIp9MrwR19fXTawtJRf8AkRRGO/Obm2uIw0cxI5LIepI5579azdF1E2tlDptzHcpa2pMFte3v35ihwTu9eOSeuc1qW99BqOoXllC8ks9uwEoWEgcjcADj5hgj5h0JrxHzTjd7fgcjbTOTk8OeGvDs63ostF0m4IKwtHB8x/vNgc5PT8a3dBvI9T3TC4sLmFlVrd7VjkpgH5t3IO717VcvLrRZVK6pDZSNb4KeaBJz22+pz9KoLZWV3dJq7aTBBO+B5kcawu3XG4nGce471SguRWX+RTfMtTXufOQrM/2c/Nl2aLBVcchcdCa5fVpfDN0841GC4fz/AN26SRsVIXBA5HHat/8Aty1SAyRytcIpUqrjYp9+gOPQ9DUTeJzJbvJJbwlUUuyunAxjjn+Yq4Uv543/AA/QI3XT9CjbWfh99LntLaKBLGZv3tsYQQ0nXlSOuMe3pWfovhHQ9I0+/j0GSW0nv8EyzCQumOFVDj5cZOMdz9BWs/iSyBe4fQ0d0+60ZAYv3Q9O/PPGMniq1342WGGFLmOSQTS+QFAxgliBtIBz+H1NS8I5yXLH8hr2myuc5d6Rb2d5DZ6lraDXWQTLbXE0mVB4ADZwGJ55yfcV2GjrdaPEiajLGJnXfk8lh6Y7cdiT/KucuPBXhfxN4gTV7y51GDUkcsiB1aJSeCPu8g+jZA7eldez3cdu0FpFaXUAQJGvnASocYxlvvdPxrWpOUoqEt/Oy+4JtvR/1/XzG2Gu2V1eCziV4btwGHmgEODyCv8APHWs/wAY2kutac9pcrLZ28SGRbuU4G4kAZUc7fXOBhvesnxDaakukyyXdnPO0YEqxrJsljYH1TkD+Ljr071wPgCS11bxraanqmryR6obhoXs7iU7PLIzHGpbILM3bKluo5FY1lOglWpbJpN3W5UaaXvX2+Z3+l2p0Rbezn0eznvbp/Lku0hG2EAExvtOcgEnn0PHvwawa1p/wz8Twz7YLW4lWUyK6hZ9x/eyOBn5QFABXAIOMHt7ZbafajUC8vnuyqyhC7YQH72PbJ6Hp2rCufC3lzXFpZtEdMuYNsTsi5hAJJhI6FctuAxwS3rTdbnhJNK71/F7Ppp+HmT7SLZ5N4V8T2l5DZaZqlmLVp7ZYrZk2sHgDfImcnDZO0EHOCMgcZ7DWBukSfUreEmdlSUMMRkHuQxI6DBzkEjjJ68d/YeheJ9W/s+zhn0eS182OKeGXLRSodimaLYBGrkEAbt+SPYj03wfZx+D/CjSeLlWa6tiUursK1wHJPyMVIJ4TA/PpnFVSr1cM1Sqxv29DRvl1Od8NTaTo2ry6XZTSS3+oytqEwVdyQsRuyfTK4wMZ6ZxWh4qurKzLX2qXDRxZjjYhd6gE4Hy85XvyMDrSa/ceHIpj46014BaXiCEXvmFUaTBXATGQxC8gDOR25NeZXXiS51jTrnTHsp2S7VLM6qufnVgN7NHgMCQCQnYg89zNKp7JuUvd3+/s+oQ953R6ukFnNoGy0uJlebzI4Z/L3AZz865+9hvw4rCvV1SHRLawN8mo6hBA0QuLqP5AeuDjBHZcnPQEnk52/8AhItPilmmg1WOawlWKO1tY0IFuMYTAA4HGST071WvdTu0W2iv9Ndg5CtdeUJA3bHBwCTjqMflWlOoqllOXnfbX1sK3vank2kXurandWmoXt9dXEsMxa7W+ijha3WNsnyjkJnnDIQHbgAHofVtFj0+BPtEa+WyK0gK5AdD97K/Qg4x+AIqpc+HYtRnQanbKgRdqpOWVRj+8ByfXPJJ7nFXNM0y2WGBotzlNzKxDJIoI+6wPpz9M1vTXs7qTbT3t8+t/v0BJJNCX9xHd38MU6xxJCfKjdAQ24nIO7OGz3A7dK5vWNXuPCt9LMkE95pN0DHItrGDNasrcvjgMoGML1Jyc9q6+z062W3kNzsdLd96LFl/LUAHHGeR7Vl+Lok1LR2awnRZIHF2uAUZWXkhlYAncuR9DVzlGStTbVvu/r9Ru1rI4zxTpumeI4tLkhKXcjr9qGoRoQqRKMguq/MQx4A6jHasPUY7LQp01bU7b7VZPZzWp+xvtFvNKu2OciQH5MErzkq3c8Ct2z1HTdMtLm8tb4TPMiPcWaRNk4PIx1Tgnrxk/SpNZ1rS7m2nixI8E8WCZ/8Ank/BTngnrkAk+hrjeFp4uT5l77ejW23bv1fUUldW2ZxvwrvrHQvE14+qHULeX7JCsSyqW8xyQcjaPukY2g+vXivQfCvhuLxdDfavaatah1vxvtLmBnWAFTwGPVsZxxxz6iut+Engm+0V4dTuXtY7do0WK3Cbw8e3h1PVDz0P9BXqMVvBbq4ggjiBJYhEC7ie5x396uVWOHbVN3fR/nfTXy7djBSVJcsWc54N8IWegObkTtd3BULG8ke3yk9AD37Z/wAa6g9ARz+PFNBPGAc9s0wyKrbcgso6DtXHOpKo+aT1Mm3J3ZJg8EggUjcHJAGe/c1Xu7uG1tWnuGYRrjkDJ546dzzjis86sl5mK2MkZYgLIeCajyCzNdlVwQyKw9H5FcL8Q/BZ1p0u9KgVbw5SbYwQkYwG5wDxwfoDXdA/KPmDHpu96UHOcYOO+aunUdOSkug4txd0fMk1rrPg/Wb7T9YtpykYFwlzAymLYSRnA5AzjGfTmul0LxRpGrSyWtk4MyjcVRWPB75xjJ/OtL4r6WuueNLArFFcwRxeU8YfY02DuKDkZHXr6HFcxqNxbWy6bDHA1vNaSyRq0YCAQqpyWHBJGQCf1ya641a0pLtf5/L0OmDbSbZ1Y3XduY7MiFkDLyec/wB7HocVqTSmREWPAZUAI/vH2HtWTpRjFsbuOVWJAypGQOucY7dqYl8qK7zxByr4iO7DZJxXdGKl8OqRSXYu/wBpMlwNg4QbV3j73Tj2rUmCSukzIq5AOB2qolutzaMLaERyAs8hRsAH+Zz7CpbeYeXtb75UHGcmsa1krxWxMu6KEpSK6mW5nQlAXKhugGCM4/lWRbSJdXivLIqx8tnBwfQUn2K/t9albUkWW1dtyyR4yoxjB9fX8a2UtVZo1BjZcgbBxnmtKFW8LvcuL6lb7N/0z/nRWx9jT/a/Oin9Y8xc/mQaaiPI13Hab1+6djkhM/f+U9Ppz+FTbYobtTJPEzyyDbMFywLcAEHp1rkbW8uEkjjt7d9+XChJDgkHqcevHHvXSwWN2qNJLbMwADyyICzZHIVB9e/vWtan7OV3Lc0lGxoPMZGSw+zSQWoyguWnBYEDjcvGM4PAz2qK6ZZrM2/3fMJyVfLEDoxb69PrWLpsN3uefUJpFSHcMO5AWQ+mR6Z+ma09M+x6hEsUkeBwBLGw3Agj5h2B6fXuOaiVP2evRdg5eUzkM899cWd+HXT9gO+LBZFBGCE7nPPvzVzRFure5urO+MJuQxeCWMZMkJ6MB1PPWtOSyma/82BoZoZMgSZCkY+bLj+Ee/Ss3UFEytfIqvaWbFGuLV9zxZxww4K5I47c/jR7RVFyrZ/n/n0FdPQg8f3OvQ+GbqPRIVacJ5zK6q+whgDhW4J2k4yK4K2m1O+1O30qXV7iRjdBo9TbMVw0AGGXbnYsQPLKc8HI45r0DQ42nmvYbm6uZLOckRlvnCnsqkckEDkHgEVhS6LoEPiOx0ua3ku9VljkuUu5ZAVhiRgqqIwdpyf4mHauWrTjC6e/S3n+q8t9hNKLszW8LX9xc2enNd28NvO6N5xjQbd2Th1OO+3p/tVtiZ55SJLhHlZVYRSAZjJzxjrg4x7EDBqC/NlFAVLOshOF5JLDHPGOeAeferAMcPnXE4aKW2cwtcBAxdM5Q7vx5zxnnNVGPKvMLW1sZti8t1czQbkNusKrFIjfvdwOfmB6D0qTUJBbAiQsmyWOVyfmA+YDv15Bqnp+3/hIPt9ozfYZQ7iAR42kdeT9MYPtjrV/XLZ9Q0dktHtJLi5ZZYkwVOEbuf7wYA7eOnXNdMrRqK+i0+X/AAw29TMnjjNtfabboQk0WUeSTLLltpJJ5/iOSScVqWEq+VLAFjIJaRScKNhOMqcZ6joPXiq0QvoZrCaSOKIeUomgEPzluhGR8oHLMR6n0rO8ZvLeR2ltpqxuiuu6QgHe+7aE25DBM8bumc9MCrUfayUb6Pr5jvc2be9dI7+dkmgSBSkfmxqC23+L3XJ68fdqOG6afT7nyFlvA21oY1YK8hfphm4H3Wbk/wBKdZfZHieOSQSTICGLjcCu4Bj05G4HKnpxSz2BFqIII9zvCfmeAOsTcBAUzggAHG7PXNY80LvmVtV+H9fiK66li6mS7hOnXq3yyW5WWGaFjHKhU/Lhhzu6/UEjoa83+IPhnXde1X7bHdtfacsRilCxBZJQC2bcheMDP3m6E5U5Fd1pkAea7TYYrdxiPa5RlZWPC9AB34PqO/M0pniuDag3Ubly42LvCqMZBPTkDHoPzrmrYOjUl73TULW0PNfCfiPxrpdzpqavDqOp6NGzC42hJLq1XaygxvgZwNuQ+ScNgDrXqXjnxhdaF4VsNU8PQHUG1WRLWyKEELId3zkHg/Kp+U4wawfEPgq01+SS4RGa++z+VNAr7Y7hAcgZ4AIIHzDrjHeo/wDhDb5/DmlaZpmrSWscyy3M7zQZRnDjiQckEAHaB75rkWHp0oXi3zJ6p223utvuM1CL0uWdKk8R6h4GWSGMRXEkizGOJI7iWNA7BsHndkAcjOOnsNHwhN51m0HibT4o735l8+dyYp03EqHReM4IHAzxzgmneHtG1vwzNZ2rtaXGmrgiIRsjw5OHIIJwOMjBIOBkCus1O60i31DT7a4jubprhwDIHYpHkfKXxxz/APXreVVTTpxSave9rP8Ar8CZPWy/A8r8deDYLq6jXwzqs2lfZ5l+0ae0iRQyurKUMcZOwMecF+GwOp5OHeLPqs+q3ujLqcGrQ3Mtrd2Ej+Y6lSqs0bYGSoYEKMY3Z6YrZ+IL6jdfE2Cewjtl1F7Z7Swt5tOEyXW0ElZZBhkIwME5ABOO+XWfw78XX+oW2p6ZcaToOorCga0jti4s5owuxjLk7ywHzHk4VRggDHC09tGnpe+33ffqvmVzOCu/6+8z9H0p7bVUsJrhNXuIrxoCkMYjeNNu4ruGAhGR6E4POeD6JLDINWaNtqSR5Ei+aDgAcg46dRVXwXqy6vruo6RrL6dLr9rMJ5ZLSELbtKgK7m65fHc1Uh0zSbSDWdR8P3DS3HmNG1tdzmNY5A25gsgXJJ5P8XHSuxWw/uzVmkrefnra1wcrstX/AJ89wsheaGJWZSY+Bu9D269c47ds1Yjvw7GFnDTrHlxGoby36BmTIG3I7nnoK53Vr65m0NLCeO2stRZV8pfN+ba2BI49SMEjPIH41Yh0i30drgQpcSy3YQG4uH3vMVBGG9QMk4981rGSmoxtYas9Cpo/2+TXl0uW4SF5ma683G1SuTlwABjd33Y9K2NV8Nkw6jImsmK1RliMUsmVctvL4PJDtvGAODgDAwK5zXpry61aDQbCRIn8rzLq8ZAzWkZzg4PG5wGA/EnjFTaiy2trHA1lZXdnaMsjQTSHdEUB8t1YDAfDNnOQQ2OpzVV6U6zTja/lp/T8gak9jzTxPoN3ZfZbnRtWubvStUn/ANGl099kb5OHVtwBV1C5CEEMCdoyprpfAFwtjfxLq5NxpL3JjeCWBGeU9NxGOCScZBX6UzxPZeJ/D3hy/t9F1C2Hg+C3KQI8B3Bd+8O4Kli6ltwbIwV475peCPFCyeKbPTviNYacljGguYbmCVhhlzt4GQ+8hePl6E9MVFOSjTlSUW430vb5ad/Qy5uW7kvuPqKP7i7FAUDaFB+6B2H8sUDp3FZejeIbHWptllNHLORvdI5klMY7FyhIXPoTn2rRc+YGUNgn171wOLi7PcwRm6lqKyQXFva75HjVvmVtoLjooYe/GenauM8NeI/EMcdtD4n05LO+urlkWKNhIBHgbTuGffPbitjXNQhEq2tsqqUVjJKnBAA4Cj64/WuL0bxF4g1TWZYtQ0wNpU2RbTRsjLCm0jBP39+QeTx6YHXVPlg00tddd/lqaxjpsd/qWt2F1DJCsxZlQ5U+3Q/p/k1zU/iVtOV3so42mPCtLn5Rjk4PUkfyrn49JVZjI10xfdjD8B279OnHFW7bT4ppma9T/Rk3Apu4AUnrx9elUo0FK6lzWNXBR9D0XwxfteWIkMm9m+ZgOgJ9q13BbK5IBGMg815/ot4ltcKLfbsOAoBGSO3H9a63R7m6vHnknJWMZHllR8rZ6ce1YPcxlG2pyvi7wamq6ijoJjHtBGDnbg+vHqe9cPqvgW7tdbtX17VjeFx8irD8rRj7qk9evJ57gHOK9yvbuCxtXub2Xy4IxlmPYZ/WvGr/AMW3viXxBp89vBAuiRSTKkmfnkbBxgddvyjnGMn2rop1Jtxv02/L9Sozcml2/r+v+CRQSSWuoyLdTW+JCFUpwBx/St27s9ls9wsYlVMOm3qzZ6n/ADzWbqMUF3MJoLZnYMBjOPr+Na2n3lrY2KwysrSsMJGCOAD/ADr1K1S0YyW/Y6JS0TIbSQxqbiaFoSU2CZxkhT2GP0JFO+0RRyDYcNG3Q8EDFVL57qS6KRzwy2sg3KEbOP8AP9awZdRii1JbbLxyqQoZ+APr9elZylT+07XFp0NvV7t9pDjdbEct2H0x/Ws62jvg8YSMzWcq7llxllPXacdfr1/nV+6jlsIZry4TzLIYDEHPUZzgdea0/DotxbyXVoWhsyxO+Y4LNxkAf56UTqRhBOHT7hN22HfYr/8AvT/980Vvf8JDb+9FcvtankT7RC3c1loVv5/kme5l4A6biOpY9h1rD1TTv7X0mTVFu76wnSA8W148TqgJJyV6ng474rf1bU4NOhBmliMYlVigAzkHoR+H4Yp9tf295tlUv83YxbN3PpjFWnOMeeF0+4r6Xscd4blTxNoNpDc3N4IYsJDd3E6ubsAcMzdyMkc8nHOaj17WofBptYYdKuNR847WeFwRHzgbgOTj2GK9AW1tYYQkVpANgLRoigKjc9OOuTXnfiK8uNQvTNbxSmW1ZoJop4uPLbDOhRc5bKgBumDWX1irblevl/w1iou+i2Ox03zLy2u7dgFkkt3CRrjErkAg7jzn/wCtXLeFtLl0TWdSvpbSa3tZbIWss8m5GuJjJlQFI6qB97pz1q1o3iDS9dtDPpN7C8RlePc67JInAyY2Xrkcegxg1oyXlx5QN3E0zsCFEzNJjPYN2/4D2rqpylGLS2f9f1/ww4u6t0ZVWQuwnhkuFfPmJvGVyOn48Ec+p5qLVbE3tz9ptmQMwMtkUjw0MmDuw/cEnlTxV1Ld90bM106RpsH7zhV7hh0DD19OfanRo7Rskx5XKsyfKjLyRtQcDv8AjnNVzK90WnrcwdDuLmdI/tNrdx3Jj3OrkEAj+Enn0BIGKnvbi4kmEkAiwIkXkuApyd6FBwVO3qfUD0pyXUcdol9IPkSTawZQqgZzkN/dAHOaZNqUHh62je9hubqIuTbkpENuByXwfkQkqB349q3k/eulrskUy5FFBHfTWiQyCKSQhpNxIXBAwT9ep6gcjpVe1vGhu7m1DvNHO5w7AboXPAPH4Ajn146mS0ivDpSXdyEWZvMmliVQgUbiQGHUYHIPYjn3j0eCCytS888Ek13IyRyTIqs0fynanT5VOBn/AGRipdrO+v8AW5L8y3Lf3kWoQwXlsIbWYhIXbHzupx1BIIKnIPHPGO9Qw6ZYJqpvIySSdwRkACjcTknGWwTkA9wDzgGpdS05p7IyRLKjRMpj8vBLMgyqkjoeoB7Zqtot1cXhQXEarNcny5AMDBxgkj26Z9qxU1a0NNNbCXkT2FhdHUJpku2uIRtcCRPLeHgg7cDDBuOp461a17zUgjisfNl3ZUuQT5eRgFscgnpnsBWVLrTw6mtnaRTPcM4hdZ0KrvH3V+UE8kjnrjkA06xlvL62s/Nk+zuIcXMcUowspzujGM5AOV9eOvWrdOXMpz2HZ82peR/sSxrIqSzKd0h3FyoIBwcZ9uOOcnvVOKN7jT5ZrWWW5naLylKTEMxJyxUtwvZc9AM9zVaUym/jhjaVEDA44w+7gZ5xgAlj6nHpWlBbtZaRPYIxibyygeLnaCeTnt3q5e4r31Y2rFE3zNPLIknmQxkZdpCA43EBR0+UHOBxnBJ9a39M1BpEHmSLHNIrKSGCRnDYBxn5WxgZ5BPtWbqOlpZSB4PIeKIq0JCjaFwB2PH/AOuodOjhgR9sMbearSQhkaSNpCScY9M4Iz7Hp0yqxp1YaCaUkdHp6yyQRzasW+2RFg6KgKsoY7SPfbjj8vSr1wsH2+HURPFDMmMFmID9O3ToMZ6iuQnNxamH7XFEIEgb/SBMyOsgICIg7pjJwM8jp1pIpY/Eysb20jnmtt32aUBhsDdQwUruPfr0/XlWF5Y87furt/w5l7Pr0NvxprT6No1xf2cK3t7dbY4IC3yYz1PqAO3fNed6NNquu+JIdWvzLICRPZ2Et20IhPcpGnQDBIO0FsHd3r1DQdNimhi+1LHczQKNgaMeVGMfdAx2xznPPrXifim5S3+I2oNLp8+l3VvItybgOWnuJA4wVODujYSEAE+gOBxRh7STjF8rSbv3Xb/htQgk9EtTqI7I+OvEbarH/wAJDDb2biJhbotvDcjOD5mMMxA7847VvaL4A0/TdUmudG1+eW8iZ2Fs9zFcJlu0g5bAbk9CTjPQV1iy2l5E17axRkKWTHl4fA4PXB/CuZ0Hwz4U0vWPtem2tlbX8ibg8LFmwemxSflzx0XI561jUlTfMrOPZb/fd/kiXLtoaGveGIvEtjbReILa2SeHLSSxxBg/spOPyP4VR8Sal4csPE+lade2Wqy300RkhltoC0SKeDnBzn12jgDntWFb3fijw1fXsOt6lbXF3fMtxBDZuZG08E5JdWxmPA27BuPGcdc91Za/BdRSW7XCPcxoFkWFlfB6hgD61q0qVTll7y6WulqumnQnVehVfw9YC7nntJEgvbpQHc5JlUKQqkHpjJPTNYg0rULeC9F1DEW89o4po2MnmIFzntg9tvTofatF59InlWLWFnilRvM2iVo5PZiASAD2GR0q3p81jJcNbWWrXTrKvmpBcYYsvcg4Bx+v4U1GUFeLduumn3lqTRyVtcGG7CTmR42VXMbRkxlWJBHPUkAjaR/FRfXlpcWDCbTre5tbfLtC6BghU7flGODngH1/OurvtGiuEVwfLdTklRyD+Ax+nFcdq/hq+m1fTrjShFNp0M6G8IlIkSEfeGzGXYnBPqBjrit/b0HrPRlqSZU8N2A8PpevpwmsRMoe4/ftukZerMCcDHt71veGNb1SzvLhLlZNQs5F8yPEm+RCT93p9P8AIrkPiV4ou9F8TaPbWdtvh1EqksrgklS+CiDOMgcnPqK7VJlsNdstQsPLS0jG2SMkjII2lfQ+oOeuBV16bhShJx+Lb5ENqTtbUms9T8N+IbyYSXMtlqCuYmS4/cuWHBHPB7V0mneF7C0jiCyStKmQrsRz9QMZwPyFef6zrcOv3s0up2ET2qh0SKaHcSg/i77jxwO1HhLxYbGOLS44oltILloke5dt8sW3cyxd/wB3lgevYDjmuWthJxS/roQ4SS0Or1Lw9cfb1KqrxAlgV5/OiHRJ4Y3Ny7FX5C+2P/rmksvHejSQpcwrfWtoQGWa8g2rKD365X8QK0rnxj4b+zxvLrVmGPKr5mCx/u4PT+dcfspq2hLm7ao4/wAU3DaFbx/2W8MNzOpVJplyokPQHjp0rtPh/NLdeFrO5vm/09wRcgDA8wcHg/55qyINJ8TaaMNa31uuA/lsHUHrj/8AXSa1rum+GIbWGeOQRFfkjt03FVHcj09/8Kq11y21FKV15mZ8UB5nh+OI/dkuVG4Lu29TkZ+leILY3lx4h0q3jeIRW1xHsmjQoGQHpjOOgwR3zmu11/xPB4p8QXEtletFp+ksFhV5dqyM0fMjJ3HLLzkjB+lRaFLb3VvulkjWRpCkEa8Yx/ED155I7461uo03QSlLW91byNKVuW79Tcu4RiTtKAq/I2V+uf6GuE8XeGdbluNObRllV5pWkkV3KrH93knGcEA8e9dNoHhTUrDX7q6e4hW0lJlyjnMi9BuB4HXkdj0NVvEOoRxytLLfsiwyZ3OCQrZ+UDnGOufwxW+IlDldpppK9ypP3feIJ7GLRoYhMSyqN8jk52uMEcH09fUe1bnh7w0nimwh1m+MIjkwU8v5gQD3PPP8ulc9qEHifU9Ktb3TLzT7u2vR+8jVFVYoipB3Fud2cZHpke9SeA9B1Xw0Iha3r/2dcu0stmBiMNj7yDsTxn19M1zVKsalJJO36+fp+oOUr6I6228I2UOr3mo3M/nmWL7MsIB2CMYIBB759KxNX0nT0H9rXdxLBpdoMW9kgIEky5+Zh/Fz26nFdw8xEbG1IkkdcgOCOOOD9a5XxHf3ltpyamqlnsZljkYndt3AEMvHIz8tZyrTno30tr2JTfU5D+zNR/6Cl/8Amf8ACiug/wCFpx/3P/Qf8KK19pLy/Efu/wAv9fcZHhO80jThpMfiHUby11p0O25ujmO5YZUlXGe2Ov4V6jbXkE9pG1lcq8e/a06nep9j7/WuGvtPs/ttveXPz29uirHBIMrGxON2MH5snA9Ota9vpd9/Zc0ukMtlcROWt2ljIjkBOWjdeMqTkex5GK09nyve0b9f6/z9CmuzOo1K2W70eWxG5ldAkrK2Hdc8rkY6gH0IrnpoBJqBt9Kjui0dstygkDYaIkrt3ddykDIJyODzW5pesWWo2tu52W94/wAk1nKf3sbgcj3I5IPUisfXn1KDxDaJYLcIkYM7MoDRuMjjjnPBBHTBzWceaFRdGKDexzAttK0rXLyBJVjvNSKfaIVZkDMB8u2Ts2M/ePIrchspJgML5MMhI5KkAHgk445wORUHhy5/tzx09vq+nBdVsUklcKmFeN/lCntnkHPXjpWTr2n2WoeNbiRbC7gs9MPlwR20/kxmT+J2I6ls9Ohxya7JSqwfJFa7/ea63sbyQ3EcjRQmdIgofaybAXB5ZiD8xx27VdsJluoZpblFt5ol8x8DIAIzjHqMZxyPTrWNNLNBqVhb2V5cuqYfyGBfzSVIKOTkqAeevUVtXUbPYzRSGJC7YJGNu7rycAnOKJNtLnVr9QaelzCury2ms1aF7Z7JhiNihdeuTlTznpx0HHPo2W6gumFpdA/Z5ZFK/dJZ15x7gkcVUvY7mHTLn7PHb21zlRCxUsisQQcqcZBA5H+RzOhxeJbmSK31BAlw4dy8ShVcjG3ac8bm44yBgHvga1eXmSa07+fyKejselWNzDeXDPHNFtiykg3D92T14GfbvnpWNqdtPqiR7WUskjeWol3ZVSDznpnBBA/uipLSA7JraZfsV55Q3hEMe1+ctuGcvzwwHP6Vfs1itnty0QnlAw9ycKSW6Z9SacZqm3KAou2pDaWMK3YuJCF8pQsWAVyBjJx1P1/WpbWK3jvp714yksRIDMvIRhwFA5wTkY7dK0b+KMEsEkclkLOzYAyeo7YBGa5+S4kkuTZyXcc7uZN/kgoAmCUK9cngktUwvWTf9WBe9qUPFNnLrGmyyWF3KtyU2QzRTN+7kDNtORyMN1H1x0Fa93b38ejWd1b3qtdRWsUd1KQ26ZkUK8hxzgkE/XrVEzJazKiJBGkgXMseQVzxkDsc/XNasMSQ2dnIsl5JcWgZTl8KQepdc8tjkfWtpycVFLZPTT+v61Bxs1IfpiCeCK6kIR5OwQDewOM57/lUt3eRQJcXNus8rQnyWVYnByoywQHBfg4BHX1xUGla3bXt39kS3EDoNxUOGSOMDO7OBwcn6Gpr77TfaVei5SazdULx3VvskUFSSCnUMRt5B6bh1rlkpKdqitt9zJk3zWYCeNbKN5h5awNyuOD3GQenynoelVNJuJoZ3jebcdofhSPvKGG4YwDtOcfh7VHc3iXEUtnFBJBKNyojrtXOASVOMMPmP4/SrsdxBPdTTi5RHSLe1kThhKVCrkY4AfvnkY+gesYtSW/9IfSzRUuLGa/LDZcL8pjOAdpQ9cHsOhJB59a1fDjWOnalFp13fKbi4tSYoi65IAOQMnhj8xAx91T2FYaIgvlOp3ssaKUmMCSlVI6AHHBG735PXitfXbOfTvEdjrel6fbahdSkRxRyjCxuV27sjphc++CetFV3Xs29LO3a/qxTTa5UY+raveah4qvLHTbqezSCPc/zFZWdcYWNQQepzk8cDtxXYatfxadBqF3fvHCYoVlugyqJF2kbCOuR3GO4PtWToGqrrDNqN3fWmoNEohWaCAxK7Dl1G75lTOFBOc9cenKeKtXub7UoRb3uoKWuY3t28ndCnmfw8EBgOQWOByAeDmuOS9snFaKK/L7vxIUOZ22t/XYreIfEeqjTdNvJLO/TT9cMtraQwW4gnEvLB3YFmAZM/dHYkkVlaL4hOlvi00rWG1cxvcRQSW6OsoCgM0bADOP4mKgnB+9Wl411ae68K3NnqWuapaTW+rvBaXVtATNdRBeUG1gAA5A3DAO3jnIri9B1DxdpGr2lwLjUL+RSA8d0jzIz7iARJIzFCVY5AP8AFjvXLSqcsVKK5tdrSd/uVl1L5JPS39fr/Wh12r/Z7jVrq8ju/s175MU097OglgidgdwKjI3Z4yeoB/DT1DULvxdpdtbaVpui+cqJHFIqfvCykPIAm0bFZl+VTzwQQc8c7LaXGrXF9JrPhbzLZ4yVtoRJsR+cllVlGTz8xB9sAYqr4dv7nw7r62d34e1HS7e6dCl2fMCJMThzvJ+5yOVz361WKnObimrLztfyXoO1nf8AzOo0PUf7Y1S+udXc29yhdFt0hjEGEUFnVsFlA5BU9Cffjeay0uG1tJLWSZ79Zd4nt1ChlAycpwGIHJxg9q0YdDt7q6haRPsku4unlkbXyBlg6j5wRg8+tZ/xC0ew0nwpLdef5YbEcVxk+ZGxOS+4c54zXWqnNUb1V9kun+ZD5dEmb+kayDxKqyXONpeEZGCPfByOM4z2q3eeRd2c07IwuIQSjRgo6uO+OMjvjHNef+Awy28T3sssljckSW8jRENIoODzx1PT1BzxXoEFubaeeX7UzJIcLuUkjjAA9e3/ANeuWyTa7GbhZnHaIz6ncyx+IJLOWeBg0c8ahJlVgCGIHpwM/Sr2r6PdJZzaik8c9jDuMjRg+YOcdPQd6zdSttH1HxOurTzX1osSm3uHRwFmZkIUkfwYyOmTkDIFb2gT2lmJNFtdQu7q4tASs1xhpJVXG5X4Akxkn1Fdc+elNOntbXy/ruW246o4LxLP9m8PXGq6NMZo0RYopFUnymY4Z+PTk/hWlZ2Mh8KSRWv+mCQbYmhXcdp4PT15Jx69a9J0+WB7K4V9OiWGcuZobfH7wcjdgf3v/wBdeMqmp+HviErRQ3droMFyrW8aybTJFtwwAXjAPO04P583TrSrSak9ldf15gp82hvyaeILaKzntXUbdrh0Occc5/Xn3rmvEfgHVdR1Sz1HwxpqAW0ChXilVFZhxkBu+Of8mvZr2+WOFLy4vrWO0WMsXl/dh1I4IY/d/pXK6pJqt/ogstPt3Nq5MkN1DcB/MDHgqw6f/q61MKjqyi5RVl3/AOCLmb6HK+HfCXjDSESbUrWJreVGWaCC4LOjg5DkD5dvB4B4zVjTvC8mo+Mnv3mnhhktPKulLMBIA2VXPY+uOldRpmuSLbrDeq8FyhERkSf5JyBwQWIJH4E5zWtp97cNNKtzYiO5DELE/IcYzkEdPoRWTxUpSv1fl5WJbtrY4X4i3egadZQC0tVttVugqqsESl5IQcAnHQHHXk1gaHbXV3dW13p5imv8CSOJTygJzk9jgYz+Fdd4xj+yldWvdFs7m6LGMbskRx8nGfXr06E03Sf7PsdXNnpVnNBcXEIZZAdyQFwWAOfyIxxTWF5kqsE9V32a3f8Aw5pG9rvUn1Ox1y/TULfTNRtZrJZBJIXBMkeMNsHHXPHXGK4+50ufxOb5ksLiwnjmwY5pz5RyP9YmMZ7gjr+ddt4Lt9U0bSr1teugzzylxEOuBwPz61o/Yn1kCayffp7AEnOPMJ7gemK0qVYKfJo7dfzuutyVo7GTppOleF0XRYrfUprVUV7eID5hyDj0PFbUkkur+HC0UM0DXKIQh+V4ueQD2NUdM0vTvDWoiS5vh9suZNsJJwM8cYHX8q2p9ctoNP8ANiWbz3Zo0ilQjDZxk56j09azqxi3aCvfW9revlYUt9NTMvo7/SNBvri2t3uL9tiW8LPuBHGT7dSevPAqK7Lap4Va0vyY3uIwJkJwy565/WpL7WzbJE1+oZ5m+dRyU4zjpVfyme7+3iQyWcqD5SuCvHr6e1JYZt809vwGovdnNf8ACI+H/wDnyX/vgf4UV1PkWn/PZvzorpuuxdye4llS1H2ZvKQP8/dmGM9evPesZZLmG5S8huZEg4CW68BSOp3d85oorSi9LFR2IdR8m98d2FpcRlbw2qTxzJ0X5jxjjkYIz6Gu7uHMLJNkFkQ5GOCfX9KKK89Tk3yvZXsZyeqRV0XXxqUIdIBFdvuRWPzDgcE5569q5B0k1G8a7uY4f+Jg/wC8jDErHNFwSOOUYY4P/wCsorupRUJy5ej/AM/8jWMUpuxdjcNdSW9rHHHcIobz3UsSRwCefm5zx71piXzV8gOw8xnmmXb8v3SAF57YznufSiinXdrBPQy9SuBHJBL5CySuBuZ3OOQBwPXjr19Kp6q8nnbo44oxxtcElyMfMpJ6ZIHPPfiiiuhU4tQNEloW4BLNoUyPKykb8SA5dQfToMg5PTnikstQS0klhMXmT2dmtxGTwNpDEDPrhTzjjPeiimoqTlF7X/yIe7QaVqx+xTTIHwUNwI2OVBIBx7jke/Ws93kUidILeaWSRUJlJHUnPA7cHgEdfrRRWsKcVOWhrCKZuW1ok0UV6ryef5YkV3IYjI4U8DcBnA9hVKBIVe9gtg6A9S7Fy2/Lck88Hdg++OaKK4oyb5l/W5jFvYp+H7KS30+/nEnmSBvLjSRiU/duG5xjG4hc4/uirUFnH4f0GO6tkS2V55JZLeFdySMeDuJ5O4jn0wD1ooracnKbT2cv0Llu/UkstPM8MF1a3MsemoweOBuWjO1WCg/3R07ZBII7nT8lWkabBWSQJyDwAMEjb05PfrxRRXBOpKUtWYSk7o5nUFU6nc3SDEFsxVUyd0kmdpLHPTjgdsCui8N6u97sgmaSWYBpRI4HzR7toDAfxA55HtRRXbWinQTfT/I0qK8TdsvDFhZ39xf2UKxyToBtz8gGOgXooPfFJIyyRzW1k80MpXyGcNtCKRn5ByM/gKKK8j4n72pim29TjIr6LRtTOn2dqkJRTtZTnv0JPzdM85rVudUdGRlHyKrF8gZfgEZ+m40UV6apQtDTp+hvJLQfHLP5kkltIqLApZd4yXAGfm9Pwqta373wRJIo/sNzHJK6HlsKc4/r1ooqI04yhK66foQl7tyoJ/7NM91p1tFHhYnkti5EcokYrnODtZcDoMHvUK+IL7UdElv47OxnseZDBdMxYkPgDK8fiRmiivOxUFTb5dP+GLhBSlr/AFsb3g3xaPEmnpO1t5EoAwpAcKOQMNx2B4I/Gptbvk1PwlqtzpxnslhZ1kkDfNlODtXpg8d/15oorOhN+7Lqc8ly1LIhn8KSalocN480c181qP3k+eBt4PHUngHNeQeJNaufCHjHToLNFMIEqyeYxkdwq5YbiAFyoOCoBHGSaKK0eIqU+dRenLL02fQVaTjTbX9ao9A+HHjzTdV08WtpZXUFxb/MQxVlHGSA2cn05FdNqcdxqUF5d2c/2We3hPlk/PtbYfzxkdfSiiuXBVZPVjWq5nuYPw9vr7XtEudF8XfZ79GUojKvJTGCGPGTk5BAyP1pfDGg3ujaO2mpdIlrHdkkLlsqQdwIb8MfU/iUV6uJk/3sOl1p0NXFRckjKn+H+nweJdKuotU1F4rSTzBFMqtj5twCkY2jJ54r0triSSM7todyV3KOnOB3oorghUlJcjei2MZu6Ry8Vrqf/CaTi5u4ZtKa2fFsycrt+7g9q5q01efS5rvUrqGKW8nu2t49jHaCM7ScjgAYHAoor06jfsnbTSP5miS29CPwvql5rtlqMF1KGS3CyyOy7mbLEkAenGMZ6D8tbTfFCXumC30lJLYFf9bIAXzycnnB6Hj3oorzsDCMrt62/wAymle3kibwTqDa/ZeXexozWzsFdhuLYJAzn2HWtrVtRWQwqsWDxg57/wCTRRW9P3qjT7syjq0YGqwh9Q/eszJJgEe9LHd/Yb+2sEVTDLxnHIPHv70UV6cVzJRe1n+RutdDY/stf7sdFFFcfNLuVZH/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chromogranin immunoperoxidase study shows that some of the tumor cells contain reactivity for chromogranin confirming that this tumor does show neuroendocrine differentiation. These features are consistent with large cell neuroendocrine carcinoma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Large cell neuroendocrine carcinoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 261px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Synaptophysin immuno-peroxidase stain showing diffuse reactivity confirming that this tumor has neuroendocrine differentiation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jeffrey Myers, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27578=[""].join("\n");
var outline_f26_59_27578=null;
var title_f26_59_27579="Laxative herbal ingredients";
var content_f26_59_27579=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F72359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F72359&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Laxative herbal ingredients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effect",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Aloes",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cascara",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eyebright",
"       </td>",
"       <td>",
"        Iridoids, in vivo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frangula",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Horehound, white",
"       </td>",
"       <td>",
"        Large doses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ispaghula",
"       </td>",
"       <td>",
"        Bulk laxative",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plantain",
"       </td>",
"       <td>",
"        Iridoid, in vivo (much less than senna)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rhubarb",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Senna",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Yellow dock",
"       </td>",
"       <td>",
"        Anthraquinone constituents",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from Newall CA, Anderson LA, Phillipson JD. Herbal Medicines: A Guide for Health-Care Professionals. The Pharmaceutical Press 1996, p. 277.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27579=[""].join("\n");
var outline_f26_59_27579=null;
var title_f26_59_27580="Recommendations for driving in patients with syncope";
var content_f26_59_27580=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79808&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79808&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Recommendations for driving in patients with syncope",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Group 1 (private drivers)",
"       </td>",
"       <td class=\"subtitle1\">",
"        Group 2 (professional drivers)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Cardiac arrhythmias",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Cardiac arrhythmia, medical treatment",
"       </td>",
"       <td>",
"        After successful treatment is established",
"       </td>",
"       <td>",
"        After successful treatment is established",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pacemaker implant",
"       </td>",
"       <td>",
"        After&nbsp;one week",
"       </td>",
"       <td>",
"        After appropriate function is established",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Successful catheter ablation",
"       </td>",
"       <td>",
"        After successful treatment is established",
"       </td>",
"       <td>",
"        After long-term success is confirmed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        ICD implant",
"       </td>",
"       <td>",
"        In general low risk, restriction according current recommendations",
"       </td>",
"       <td>",
"        Permanent restriction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Reflex syncope",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Single/mild",
"       </td>",
"       <td>",
"        No restrictions",
"       </td>",
"       <td>",
"        No restriction unless it occurred during high risk activity*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Recurrent and severe*",
"       </td>",
"       <td>",
"        After symptoms are controlled",
"       </td>",
"       <td>",
"        Permanent restriction unless effective treatment has been established",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Unexplained syncope",
"        </strong>",
"       </td>",
"       <td>",
"        No restrictions unless absence of prodrome, occurrence during driving, or presence of severe structural heart disease",
"       </td>",
"       <td>",
"        After diagnosis and appropriate therapy is established",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Group 1: private drivers of motorcycles, cars, and other small vehicles with and without a trailer.",
"    <br>",
"     Group 2: professional drivers of vehicles over 3.5 tons or passenger-carrying vehicles exceeding eight seats excluding the driver. Drivers of taxicabs, small ambulances, and other vehicles form an intermediate category between the ordinary private driver and the vocational driver and should follow local legislation.",
"     <div class=\"footnotes\">",
"      * Neurally mediated syncope is defined as severe if it is very frequent, or occurring during the prosecution of a 'high risk' activity, or recurrent or unpredictable in 'high risk' patients (see Part 3, treatment).",
"     </div>",
"     <div class=\"reference\">",
"      Reproduced with permission from: European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), Heart Rhythm Society (HRS), et al. Guidelines for the diagnosis and management of syncope (version 2009): the Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). Eur Heart J 2009; 30:2631. Copyright &copy; 2009 Oxford University Press.",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27580=[""].join("\n");
var outline_f26_59_27580=null;
var title_f26_59_27581="Causes of neck stiffness in children";
var content_f26_59_27581=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F67226&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F67226&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of neck stiffness in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Clavicular fracture",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Epidural hematoma of the cervical spine",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Fracture of the cervical spine",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Muscular contusion or neck spasm",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         SCIWORA syndrome",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Subarachnoid hemorrhage",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Subluxation of the cervical spine",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Infectious or inflammatory",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Bacterial meningitis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Branchial cleft or thyroglossal duct cyst abscess",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Cervical lymphadenitis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Collagen vascular disease (eg, systemic JIA, ankylosing spondylitis, psoriatic arthritis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Infections of the spine: vertebral osteomyelitis, infectious discitis, epidural abscess",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Intervertebral disc calcification",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kawasaki disease with cervical lymphadenopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lyme meningitis&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Muscle strain",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Otitis media and mastoiditis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Pharyngitis or tonsillitis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Retropharyngeal abscess",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Rotary atlantoaxial subluxation as a result of local inflammation or procedure (Grisel's syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Upper lobe pneumonia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span style=\"color: #008000;\">",
"         Viral meningitis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Viral myositis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Tumors, other space-occupying and vascular lesions of the central nervous system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Brain tumor",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Other space-occupying lesions of the spinal cord",
"        </span>",
"        (neurenteric cyst, arteriovenous malformation, syringomyelia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Other tumors of the head and neck",
"        </span>",
"        (osteoid osteoma, eosinophilic granuloma, orbital tumor, acoustic neuroma, osteoblastoma, metastatic tumor to the spine, nasopharyngeal carcinoma, bone cyst)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Spinal cord tumor",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"red\">",
"         Subarachnoid hemorrhage (aneurysm rupture-congenital, sickle cell disease)",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Congenital conditions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Atlantoaxial instability secondary to congenital conditions (Down's syndrome, Klippel-Feil syndrome, os odontoideum, Morquio's syndrome)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Benign paroxysmal torticollis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <span class=\"green\">",
"         Congenital muscular torticollis",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Skeletal malformations (Klippel-Feil syndrome, Sprengel's deformity, hemiatlas, basilar impression, occipitocervical synostosis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Miscellaneous",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dystonic reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Guillain-Barre syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Myasthenia gravis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ophthalmologic, neurologic, and/or vestibular causes (strabismus, cranial nerve palsies, extraocular muscle palsies, refractive errors, myasthenia gravis, Guillain-Barre syndrome, migraine headaches)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pseudo-tumor cerebri",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychogenic",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sandifer syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spasmus nutans",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Spontaneous pneumomediastinum",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <span class=\"red\">",
"     Red:",
"    </span>",
"    life-threatening diagnoses.",
"    <br>",
"     <span class=\"green\">",
"      Green:",
"     </span>",
"     common diagnoses.",
"     <div class=\"footnotes\">",
"      JIA: juvenile idiopathic arthritis; SCIWORA: spinal cord injury without radiographic abnormality.",
"     </div>",
"     <div class=\"reference\">",
"     </div>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27581=[""].join("\n");
var outline_f26_59_27581=null;
var title_f26_59_27582="LH FSH lack in GnRH deficiency";
var content_f26_59_27582=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F56592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F56592&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lack of gonadotropin secretion in GnRH deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 428px; height: 350px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Serum LH (blue) and FSH (red) concentrations determined at one minute intervals in two men with idopathic hypogonadotropic hypogonadism. Patient A (upper figure) had microphallus, testicular volumes of one mL each, anosmia, and no history of spontaneous puberty. LH and FSH concentrations in most of his serum samples were at or below assay detection limits. Patient B (lower figure) had a normal-sized phallus, testicular volumes of 20 mL each, an intact sense of smell, and a history of partial onset of puberty with subsequent regression of sexual function. Serum testosterone concentrations (in ng/dL) at six-hour intervals are indicated by the numbers at the top of each sampling period.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Spratt, DI, Carr, DB, Merriam, GR, et al, J Clin Endocrinol Metab 1987; 64:283.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27582=[""].join("\n");
var outline_f26_59_27582=null;
var title_f26_59_27583="Colles fracture child";
var content_f26_59_27583=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F67542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F67542&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Complete distal radius and ulna fracture (Colles fracture) in 11 year old child",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This common pediatric fracture is described as follows: 100 percent dorsally displaced distal radius and ulna fracture with volar angulation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paula Schweich, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f26_59_27583=[""].join("\n");
var outline_f26_59_27583=null;
